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Abstract  
 
The aim of this work is to identify the biological mechanisms of ageing, 
which remain poorly understood. One model organism widely used by 
biogerontologists is C. elegans. Here lifespan is, one assumes, a function 
of life limiting senescent pathologies. However, the cause of senescent 
pathologies and the identity of those pathologies that limit life are unclear. 
Therefore the main goals of my PhD were to understand where 
senescent pathologies come from and to identify the pathologies that limit 
worm lifespan. Using Nomarski microscopy, pathology within various 
tissues of the germline and soma was examined during ageing. The C. 
elegans intestine is the major somatic organ and is a likely location for 
lethal, senescent pathology. It undergoes major atrophy during ageing, 
which is demonstrated here to be driven by intestinal biomass conversion 
into yolk. To determine the pathology state at death, we performed 
necropsy analysis on the corpses of elderly worms. This revealed that the 
majority of early deaths occurred with an enlarged pharynx, reflecting 
severe bacterial infection. Combining survival and pathology data into a 
new pathology-centred approach has allowed new insights to be obtained 
into the determinants of late life disease and lifespan.  
 
It has long been widely believed that ageing was caused by molecular 
damage. However the recently proposed hyperfunction theory, which is 
related to the antagonistic pleiotropy theory, suggests that a major 
contributory cause of ageing is actually quasi-programmes. These are 
biological programmes essential for early-life fitness that continue to 
operate in a non-adaptive fashion in older organisms, such as intestinal 
biomass conversion to yolk. Thus hyperfunction may contribute to the 
development of age-related pathologies, some of which will cause death. 
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Impact statement  
 
Thanks to numerous breakthroughs in medical science over the last 
century, we are now living longer than ever. Unfortunately this has also 
resulted in many diseases that were once relatively rare, such as 
Alzheimer’s, becoming prevalent in our population. Therefore treatments 
or cures for these diseases are urgently needed. However a great 
frustration for medical professionals when treating the elderly is that when 
one ageing related ailment is alleviated, others may subsequently 
emerge. Thus old people need to repeatedly return to hospital for 
treatment. A more efficient approach would be to treat a central 
mechanism of ageing to delay multiple age-related pathologies in 
tandem. 
 
In support of this, findings from biogerontology using animal models 
suggests the possibility that one could combat many age-related 
diseases at once by treating ageing itself. However a more realistic idea 
proposed recently is that during ageing an array of pathologies develop, 
with mutliple underlying causes, some of which are potentially life limiting 
(Gems 2015). Interventions that inhibit mechanisms that result in lethal 
age-related pathology, particularly those that generate multiple life limiting 
pathologies, will cause large extensions to lifespan, such as those seen in 
animal models, by suppressing senescent polymorbidity. However to 
intervene in and delay age-related pathology, one ideally needs to know 
what biological mechanisms cause them. For obvious reasons, studying 
ageing in humans is laborious and time consuming. Therefore short-lived 
model organisms, in which genetic manipulation is relatively 
straightforward, have been employed. This has revealed signalling 
pathways that modulate ageing, including the insulin/IGF-1 signalling (IIS) 
pathway and the TOR pathway. These include targets for drugs which 
proved able to extend lifespan and improve late life health in a range of 
animal models, including mice (Harrison et al. 2010; Kenyon 2010). Thus 
model organisms can help us to understand and to treat ageing. 
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My work has focused on the study of senescent pathology in C. elegans, 
in particular what causes them and which of them cause death. For the 
latter we used necropsy analysis, which identified a lethal pharyngeal 
pathology (‘P death’) that occurs in a subpopulation of shorter-lived 
worms (Zhao et al., 2017). By combining mortality and pathology data, 
mortality could be deconvolved to reveal how different interventions that 
alter lifespan affect the timing and prevalence of P death. This can give 
indications of conserved mechanisms that promote age-related 
pathology, which could give clues about the origins of pathology in ageing 
humans. For example, both P death in worms and osteoarthritis in elderly 
humans are promoted by mechanical damage in early life (Davies et al. 
2016; Zhao et al., 2017). Thus, age-related disease in both humans and 
C. elegans can be promoted by conserved etiologies. This validates C. 
elegans as a powerful tool to study senescent pathologies. 
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Chapter 1 Introduction 
 
1.1 Introduction to ageing  
 
Ageing or senescence can be defined as the gradual decline in fitness 
and emergence of age-related pathologies with increasing chronological 
age. It is something everyone has sadly witnessed in their older relatives 
and friends, where it cruelly strips away both cognitive and physical 
wellbeing, leaving individuals in a state of decay for the remainder of their 
lives. However science has still not been able to definitively explain how 
and why we age. To add to the enigma it seems possible that in some 
animals, such as famously in Hydra vulgaris, ageing can be avoided 
altogether (Martínez 1998). Moreover, ageing can occur at a very slow 
rate, such as in tubeworms belonging to the Lamellibrachia genus, which 
can live for around 250 years (Bergquist et al. 2000). However 
evolutionary biology and laboratory research to identify longevity 
mechanisms has begun to reveal the mysteries of ageing. 
 
Ageing has become more prevalent over the last hundred years as 
advances in sanitation and medicine during the 20th Century resulted in 
large increases in life expectancy, particularly in the developed world. 
This led to an increase in the occurrence of age-related diseases, such 
as cardiovascular disorders, cancer, dementia and arthritis. The care of 
elderly people is therefore becoming an increasing burden on public 
healthcare resources. Thus treatments are needed for these conditions to 
reduce the burden of late-life disease. One possible approach is to 
understand and treat the ageing process. 
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1.1.1 Treating ageing as a disease 
 
The notion of treating ageing does have it critics. For a condition to be 
considered appropriate for treatment it must be considered a disease and 
historically ageing has been viewed as a normal and natural process. For 
example the bioethicist Leon Kass stated that ageing is a biological 
process that should be looked upon as entirely separate from disease 
(Kass 1985). Whether or not ageing should be classed as natural does 
not diminish the suffering it causes older people and thus it is right to try 
to intervene in its progression. On the other hand, society often 
encourages us to not just endure ageing but to actually celebrate it. For 
example, the charity Age UK currently has an interview with the actress 
Julie Walters on its website discussing why she is “embracing ageing”. 
This is an example of how society propagates a confused view of old age. 
It is true that an increase in calendar age can have various benefits to an 
individual, such as an amassing of knowledge and retirement. However 
by over-emphasising this aspect of ageing, we conceal the abhorrent 
reality of senescence and the pathologies it causes. Presumably, she 
does not embrace senescence. In truth, elderly people often experience 
long periods of ill health. This in turn has resulted in the widely reported 
crisis in late life care and overburdening of the NHS. 
 
Currently, research into age-related diseases is fragmented, with each 
being individually studied by different parts of the scientific community. 
However it would be more productive to unite scientists to study the main 
risk factor for all these conditions, which is ageing. If we could treat and 
therefore decelerate ageing we could hopefully delay the emergence of 
many age-related diseases and give people longer, healthier lives.  
 
To treat ageing, we must understand the biological processes that cause 
it. For decades, biogerontologists have mostly attempted to reveal these 
mechanisms by studying the effects of interventions on life span. 
However this ignores the core component of the ageing phenotype, which 
is pathology. Pathology is what causes sickness and suffering, and of 
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course death, in ageing humans. Yet those studying ageing using model 
organisms, such as Caenorhabditis elegans, have largely ignored it. The 
work described in this thesis focuses on the study and development of 
age-related pathology in C. elegans. Additionally I emphasise the 
importance of investigating pathology development in conjunction with 
survival analysis, a practice we have called mortality deconvolution (Zhao 
et al. 2017). This has allowed the relationship between pathology and 
mortality in C. elegans to be unravelled, helping to make sense of the 
sometimes complex, and previously enigmatic shapes of survival curves 
and mortality profiles.  
 
1.1.2 Evolutionary theories of ageing 
 
Billions of years of evolution have resulted in the remarkable array of 
organisms we now have on Earth. Natural selection has ensured that 
beneficial genes remain enriched in populations, allowing species to 
continuously adapt to changing environments. However despite this, 
ageing appears to be ubiquitous, as most species we know of experience 
ageing in some form. Even bacteria can exhibit ageing; cells that inherit 
older cellular material during division have a lower proliferative capacity 
(Stewart et al. 2005). This is despite the fact that selection should favour 
individuals that are fitter and fertile for longer. How has ageing, which is a 
wholly deleterious trait, been able to slip through the stringent process of 
natural selection? Various evolutionary theories have offered an 
explanation to this conundrum.  
 
An early theory proposed by Alfred Russel Wallace in the 1860s was that 
ageing exists because it benefits the species (Partridge & Gems 2002). In 
wild populations, where resources are finite, ageing ousts older 
individuals allowing resources to be liberated for their fitter and more 
fertile offspring. However there are several issues with this theory. Firstly, 
it does not acknowledge that ageing is relatively rare in wild populations, 
with the majority of organisms dying from extrinsic hazards, such as 
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predation or disease (Kirkwood & Austad 2000). Secondly, natural 
selection mostly works towards the benefit of an individual rather than the 
species or group. Therefore one would expect selfish cheats who do not 
age to have a selective advantage over their altruistic fellows, yet such 
individuals do not exist (Partridge & Gems 2002). Finally this theory 
assumes that there are already aged individuals within a population that 
are suitable for removal, it does not explain where they came from.  
 
So why does ageing exist at all? Inspiration came from an unlikely 
source: Huntington’s disease. This is a dominant, inherited 
neurodegenerative disorder in humans where symptoms only begin to 
emerge from around 30 years old. This means individuals can reproduce 
successfully before they become disabled by their condition. As 
reproduction has occurred and the genes have already been inherited by 
the next generation, natural selection is unable to completely eliminate 
the disease from the population (Haldane 1941). Based on this deduction, 
Haldane proposed that late-acting mutations, that only exhibit their 
deleterious effect post-reproduction, are not strongly selected against. 
Over time such mutations accumulate in populations and eventually result 
in ageing. This would have little effect on fitness in the wild, as most 
organisms will die from extrinsic hazard before the effects of these 
mutations are expressed in later-life. Thus fitness is mainly a function of 
reproductive output in early life, with late life health being of little 
importance to fitness (Gems 2015).  However the majority of humans 
living in the developed world today inhabit an environment where extrinsic 
hazards are greatly reduced. This has allowed these deleterious 
mutations to exhibit their late life effects, resulting in an increased 
prevalence of age-related diseases. 
 
Over the years this initial theory proposed by Haldane has been built 
upon and refined. The mutation accumulation theory proposed that 
ageing emerges because the force of natural selection to eliminate 
unfavourable characteristics declines with chronological age, even if a 
species displays no biological ageing. This is because organisms will die 
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from extrinsic hazards and therefore there will always be more organisms 
at younger ages than older ages (Medawar 1952). The antagonistic 
pleiotropy theory based on these ideas proposed that given that 
mutations can be highly pleiotropic, those that are beneficial in young 
organisms but have negative impacts in older organisms can be acted on 
positively by natural selection and therefore not eliminated from the 
population but incorporated into the gene pool. This is because 
organisms will reproduce and pass on their genes to the next generation 
before the negative impacts of the mutation become apparent and 
prevent them from doing so (Williams 1957). Additionally, recent theory 
has argued that factors other than extrinsic mortality also contributes to 
the age decline in selection, for example the low frequency of older adults 
in an expanding population (Abrams 1993). 
 
While these evolutionary theories, particularly antagonistic pleiotropy, 
may help us to understand why ageing is so prevalent, it does not reveal 
the biological mechanisms that cause it. For that we must study the 
mechanistic theories of ageing.  
 
1.2 The biological mechanisms of ageing 
 
The underlying processes that cause ageing still remain largely a 
mystery, despite decades of research and discussion. Evolutionary theory 
implies that ageing is not programmed because genes should not exist 
that have the sole purpose of self-sabotage. However there is now a 
plethora of studies that show mutations of individual genes can cause 
substantial increases in lifespan (Kenyon 2010). This implies that ageing 
is in fact programmed by genes, which seemingly conflicts with 
evolutionary theory. One approach to try to resolve this apparent paradox 
is to consider the mechanisms of ageing by which such life shortening 
genes act. These remain poorly understood, though there are various 
candidate mechanisms and theories. Here two theories are discussed: 
the molecular damage theory and the more recent hyperfunction theory.  
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1.2.1 Ageing as the result of molecular damage 
 
The idea that molecular damage causes ageing for many years focused 
in particular on oxidative damage. It originates from the 1950s when 
Harman suggested that free radicals, which are often highly reactive 
molecules due to an unpaired election (e.g superoxide O2-), cause 
widespread molecular damage leading to cellular dysfunction and 
subsequently ageing (Harman 1956). Later the theory expanded to 
include a broader group of potentially damaging molecules, referred to as 
reactive oxygen species (ROS), including non-radicals such as hydrogen 
peroxide H2O2, and was then often referred to as the oxidative damage 
theory (Sohal & Weindruch 1996) (Figure 1.1). ROS exist within healthy 
cells as they are produced, for example, during normal respiration. Upon 
being generated it is suggested they immediately begin causing a wide 
array of damage within cells, including oxidation of DNA and 
carbonylation of proteins (Stadtman 1992). Unrepaired damage then 
accumulates gradually over time, and upon reaching a certain level, an 
organism will start to exhibit all the symptoms of ageing. Consistent with 
this, levels of oxidative damage do increase with age (Orr & Sohal 1994; 
Sohal et al. 1995b). The theory also predicts that interventions that lower 
ROS levels should reduce this damage and consequently extend 
lifespan. This could be achieved by administering dietary antioxidants like 
vitamin E, or by experimentally overexpressing antioxidant enzymes like 
superoxide dismutase (SOD) or catalase, which together convert 
superoxide to water and oxygen in a two step reaction. 
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Figure 1.1. The oxidative damage theory of ageing. Normal respiration in 
mitochondria generates reactive oxygen species (ROS). This causes damage to various 
macromolecules within the cell. This damage gradually accumulates throughout life, 
resulting in the characteristic symptoms of ageing. (Adapted from (Doonan et al. 2008)). 
 
Initially many papers appeared that provided evidence to support this 
theory. For example overexpression of SOD in Drosophila melanogaster 
increased lifespan (Sun et al. 2002; Sun & Tower 1999) and protein 
carbonyl levels increase as the flies get older (Orr & Sohal 1994). Longer-
lived fly species also have lower levels of ROS than shorter-lived species 
(Sohal et al. 1995a). For example in gerbils, ROS production increased 
during ageing and correlated with increased oxidative damage to 
numerous internal organs (Sohal et al. 1995b). 
 
However, more recently numerous findings have been reported that 
contradict the ROS theory. For example ROS are not only damaging 
molecules but also have essential functions within cells. For example, 
H2O2 is a signalling molecule involved in initiating a number of cellular 
mechanisms including differentiation (Veal et al. 2007). Moreover the 
presence of antioxidant enzymes suggests that cells are highly capable of 
managing ROS and repairing oxidative damage, with evolution 
presumably acting to improve these protective mechanisms as needed. It 
is possible there is a decline in enzymatic activity with age; however SOD 
levels actually increased in gerbils during ageing in a wide range of 
tissues, though this is certainly not always the case (Sohal et al. 1995b).  
 
There are now many studies that suggest ROS may only play a small part 
or make no contribution to the overall ageing process. For example it has 
been shown overexpressing SOD and/or catalase in mice has no effect 
on lifespan (Pérez et al. 2009). Furthermore in C. elegans deletion of both 
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sod-2 and sod-3 did not cause an increase in lifespan, despite causing 
hypersensitivity to oxidative stress (Doonan et al. 2008). Moreover, 
deletion of all five sod genes did not shorten C. elegans lifespan (Van 
Raamsdonk & Hekimi 2012).  Perhaps most significantly clinical trials of 
antioxidant supplements have mostly failed to slow ageing (Howes 2006). 
In one study, antioxidants actually increased the incidence of lung cancer 
in individuals who had a high risk of developing the disease (Omenn et al. 
1996). There is also confusion as papers have been published that show 
different results for the same experiment. For example vitamin E has 
been shown to both increase C. elegans lifespan (Harrington & Harley 
1988) and also have no effect (Adachi & Ishii 2000). Here a potential 
problem is publication bias, as previously noted (Blagosklonny 2008). 
Papers with positive data that support the oxidative damage theory tend 
to be published in higher impact journals while studies with negative data 
that oppose the theory are published in lower impact journals or may 
remain unpublished. 
 
The balance of evidence does not support the view that oxidative damage 
is the main driver of ageing.  One possibility is that damage does a play a 
role in ageing, but there are many different types of damage that can 
occur within a cell, e.g glycation of proteins. Therefore oxidative impact 
may just be a small proportion of a much wider array of damage (Gems & 
Doonan 2009). It is also possible that molecular damage is not the main 
cause of the ageing process and its accumulation is simply correlative, 
with ageing being caused by another entirely different primary 
mechanism. There is enough doubt over the role of molecular damage 
during ageing that new theories should now be contemplated. 
 
1.2.2 The disposable soma theory 
 
A proposal that combined evolutionary theory and the molecular damage 
theory, is the disposable soma theory suggested by Tom Kirkwood 
(Kirkwood 1977). The central concepts of this theory are that molecular 
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damage is the primary cause of ageing and that protection against this 
damage is very costly. In a wild population, where resources are finite, 
Kirkwood stated that organisms have to resolve where these limited 
assets are most needed. As evolution favours reproductive success, so it 
will encourage the funnelling of resources towards the germline and 
reproductive output. An individual will therefore prioritise the formation of 
biomass that will promote reproductive fitness, such as the production of 
eggs, energy dense yolk and milk. In addition, repair of damage within the 
germline, which is immortal, will have precedence over somatic 
maintenance to ensure the continued viability of progeny for boundless 
generations. In contrast, the soma is only given sufficient resources to 
assure survival for long enough to allow for reproduction to occur. As the 
soma only receives a baseline of maintenance, damage gradually 
accumulates within it, causing ageing (Kirkwood & Austad 2000).  
 
1.2.3 The hyperfunction theory 
 
One alternative theory that has been proposed relatively recently by 
Mikhail Blagosklonny examines the role of hyperfunction (i.e the 
excessive activity of biological processes in a mature adult due to wild-
type gene action) in ageing (Blagosklonny 2008; Blagosklonny 2006). 
Blagosklonny notes that ageing appears to act much like a programmed 
process. For example, ageing results in similar patterns of pathology 
between individuals of the same species, such as atherosclerosis, 
arthritis and osteoporosis – all common age-related pathologies in 
humans. Furthermore the fact that individual genes can be manipulated 
to control ageing in model organisms provides more evidence ageing is 
somehow a programmed process. Yet the evolutionary theory of ageing 
states ageing cannot be programmed because no system should develop 
with the sole purpose of causing deterioration and death. Therefore 
surely the only alternative is the accumulation of random molecular 
damage? Or is there another explanation? 
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Blagosklonny suggests that while molecular damage does accumulate 
with age, it does not have an effect on mortality because such damage 
would be random and not produce the uniformity we see in age-related 
pathologies within a species (Blagosklonny 2006; Blagosklonny 2008). 
Instead he proposes quasi-programmes cause ageing (Blagosklonny 
2006). By this he means that ageing is genetically programmed, yet does 
not involve an adaptive programme (note that “programme” here has two 
distinct meanings). Thus essential processes that promote fitness, health 
and reproduction can be called programmes when they are functioning 
during youth. However, when they continue to act in older organisms 
when they are no longer needed they become known as quasi-
programmes (Figure 1.2). This would explain some intriguing results, 
such as the fact that reducing the level of ribosomal protein S6 kinase, 
which results in reduced protein synthesis, extended lifespan in C. 
elegans (Hansen et al. 2007). Development of pathologies resulting from 
hyperfunction would presumably require continued protein synthesis and 
thus reducing it should extend lifespan. It is important to note that a 
quasi-programme is not a defective programme; it is simply the 
continuation of a programme in a way that no longer promotes fitness.  
 
 
 
 
 
 
 
 
Figure 1.2. The hyperfunction theory of ageing. During development, programmes 
function to promote fitness in the organism. Once development is complete (t1), the 
programme continues to function when it is no longer needed and becomes a quasi-
programme. These quasi-programmes lead to a variety of age-related pathologies 
caused by hyperfunction. Hyperfunction will then lead to damage (including molecular 
damage) and decline in the organism, eventually resulting in death (t2) (Image from 
(Blagosklonny 2006)).  
 
DEATH 
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Quasi-programmes will lead to overgrowth and eventually an array of 
pathologies caused by hyperfunction. A metaphor to describe this is to 
imagine you are cooking your Sunday roast in the oven. You turn on the 
oven to cook the meat within so you can eat it. Once the meat has been 
cooked, the programme is complete and you no longer need the oven 
turned on. However failure to switch off the oven will result in a burnt 
dinner. The oven has not malfunctioned, it is doing exactly what you set it 
to do, and it was simply not switched off at the appropriate time. 
Therefore the turned on oven became a quasi-programme once the meat 
begins to overcook, resulting in a ruined dinner.  
 
The hyperfunction theory can fit well with the evolutionary theory of 
ageing, especially in regards to antagonistic pleiotropy, which is in many 
ways its foundation. Growth and development in youth requires the 
activation of nutrient sensing pathways. These pathways have evolved to 
respond rapidly to food intake to utilise resources efficiently. This makes 
sense in a wild environment where food supply may be erratic and a 
young animal would need to respond robustly to nutrient intake to ensure 
rapid and coordinated growth, and reproduction. However in an older 
animal the forces of natural selection are weaker, so the nutrient sensing 
pathways would not be switched off. These activated pathways cause 
continued operation of quasi-programmes, e.g through continued 
biosynthesis, in older organisms leading to the development of age-
related pathologies. This implies that ageing is to a large extent a quasi-
programmed process, rather than one caused by system failure and 
random damage accumulation. It is merely the result of the continued 
action of signalling pathways and the resulting consequences of this.  
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1.2.4 Hyperfunction and age-related pathology 
 
It would be expected that age-related pathologies caused by 
hyperfunction would be robust and not be the result of a failure of 
function. This is because they are caused by biological quasi-
programmes. There are many examples of age-related pathologies in 
humans that could be driven by quasi-programmes. For example, 
osteoporosis is a bone disorder that results in a low bone mass and an 
increased risk of bone fractures. To maintain its architecture and strength, 
bone needs to be constantly renewed. Osteoclasts are cells that resorb 
bone and during ageing they become over-activated and apoptosis 
resistant (Glantschnig et al. 2003). The signals that stimulate the 
osteoclasts are not operating incorrectly, but in older individuals there is 
no mechanism to switch them off. Atherosclerosis is associated with 
excessive platelet clumping and over activation of the inflammatory 
response (Shapiro & Fazio 2016). Cancer is a disease of overgrowth, 
with no evidence that tumour cells in the elderly exhibit a loss of function 
phenotype. These are just a few examples of many that demonstrate that 
diseases of ageing may not be the result primarily of damage but the 
result of hyperfunction, which produces pathologies that subsequently 
cause damage during ageing. 
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Figure 1.3. Ageing results in the generation of multiple pathologies. (A) During 
normal development in a young individual, no ageing pathologies develop. When 
biological programmes (developmental, reproductive or reparative) are no longer 
needed but remain switched on, they become quasi-programmes. These drive the 
formation of various pathologies (A-D), with pathology A progressing fastest and 
becoming the first to reach the lethal threshold. Thus pathology A causes death. (B) If 
pathology A is treated, then lifespan is extended until pathology B limits life. (C) If an 
intervention suppresses multiple senescent pathologies, the lifespan of these long-lived 
individuals may now be limited by new pathologies (Y,Z). (D) If an intervention treats 
pathology B (e.g uterine tumours in C. elegans), which is currently not lethal, then 
lifespan will be unaltered as it is still limited by pathology A. 
 
To understand more about hyperfunction and its role during ageing in 
both humans and model organisms we need to identify age-related 
pathologies that are the result of hyperfunction. If we can understand how 
these pathologies develop by identifying the quasi-programmes involved, 
we could attempt to intervene to prevent or slow down their progression. 
Often a human will die from a single major senescent pathology; 
therefore this pathology will likely develop faster and become life 
threatening before the others (Figure 1.3A). If this pathology was treated 
before it became lethal the individual would live longer but ultimately die 
from another, slower developing pathology (Figure 1.3B). Therefore to 
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achieve major gains in human health in later life we need to identify 
quasi-programmes that cause multiple pathologies and block the 
programme once it has been completed but before it becomes a quasi-
programme and starts to cause pathologies. Lifespan extending 
interventions may simply cause the development of the same pathologies 
to be delayed or perhaps an entirely new set of pathologies will emerge 
(Figure 1.3C,D). A possibility is that if we treated all hyperfunction related 
pathologies we would be left with a situation where lifespan was now 
limited by the accumulation of molecular damage, such that antioxidants 
would be the answer to an even longer life (Blagosklonny 2008).  
 
1.3 Caenorhabditis elegans as a model organism 
 
In the early 1960s, Sydney Brenner proposed the nematode C. elegans 
as a suitable model for the study of many biological processes, with his 
particular interest at the time being neurobiology (Brenner 1974). Since 
then C. elegans has been extensively studied, resulting in it having its 
entire genome sequenced (Consortium 1998) and the fate of every cell 
during development identified (Sulston & Horvitz 1977). In 2002, 
Brenner’s work with C. elegans contributed to him being one of the 
recipients of the Nobel Prize for Medicine, an acknowledgement of how 
important C. elegans now is within scientific research.  
 
C. elegans is a small nematode worm, found in putrid fruit and soil in the 
wild. When fully grown it is only about 1mm long, thus making storage of 
large populations easy. Worms can be maintained in the laboratory on 
agar plates or within liquid culture. In the wild they feed on a range of 
bacteria (Dirksen et al. 2016), though in standard laboratory conditions 
they are fed the bacterium Escherichia coli OP50, a strain that is an uracil 
auxotroph and so forms thin bacterial lawns, making the worms easier to 
observe. Conveniently on plates, worms can be identified using a low 
power dissecting scope. One major advantage of C. elegans is that they 
are transparent, so under high magnification with Nomarski optics, the 
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cells and internal organs can be examined without the need for 
dissection. This is a particularly useful feature for studies of pathology. 
 
Worms have a compact genome consisting of five autosomal 
chromosomes, ~100 million base pairs and ~21,000 protein coding 
genes, of which nearly 40% are anticipated to have an ortholog in 
humans (Shaye & Greenwald 2011). There are two sexes, 
hermaphrodites and males, which are determined by the number of sex 
chromosomes. Hermaphrodites possess two (XX) and males only have 
one (XO) (Corski et al. 2015). Hermaphrodites generate several hundred 
sperm during development and then irreversibly switch to oocyte 
production during adulthood (Corski et al. 2015). Thus hermaphrodites 
can self-fertilise, with each individual producing up to 300 progeny, which 
are all genetically identical to each other and their mother (Corski et al. 
2015). This allows for large, clonal populations to be easily generated, a 
useful tool when experiments require maintaining large numbers of 
different mutants. In standard laboratory conditions, males occur at a very 
low rate and make up only about 0.1% of the population (Corski et al. 
2015). Stressful conditions, such as high temperature, increase male 
generation due to non-disjunction of the X chromosome (Lints & Hall 
2009a). Therefore in the more stressful conditions experienced in the 
wild, males may be more common. Males can mate with hermaphrodites, 
prolonging the hermaphrodite reproductive output and producing a 
population with equal proportions of both sexes. Mating can be utilised for 
strain constructions, for example of double mutants. For all of these 
reasons, C. elegans is both a convenient and powerful model organism. 
 
For many years researchers employed a forward genetics approach with 
C. elegans, where mutations are generated via exposure to mutagens 
such as ethyl methanesulphonate (Brenner 1974). Mutants with a 
phenotype of interest can then be selected and subsequent analysis 
should reveal the underlying mutated genes. Nowadays, most studies 
instead use reverse genetics approaches, which involve altering levels of 
gene expression and analysing the subsequent effects on the worm 
 34 
phenotype. This approach has been made easier by advances in 
technology and access to the fully sequenced C. elegans genome.  
 
A revolutionary method for reverse genetics was RNA mediated 
interference (RNAi), which was discovered in C. elegans and was the 
subject of the 2008 Nobel Prize for Medicine. It was observed that 
injection (Fire et al. 1998), soaking (Tabara et al. 1998) and ingestion 
(Timmons & Fire 1998) of double stranded RNA (dsRNA) by worms 
caused complementary mRNA levels to be reduced. When dsRNA enters 
a cell it is bound by the Dicer complex, which contains DCR-1, an 
enzyme that cleaves dsRNA into small interfering RNAs (siRNAs). 
siRNAs are then processed into single strands by RDE-1, allowing them 
to bind to complementary mRNAs and initiate their degradation (Zhuang 
& Hunter 2011). C. elegans is particularly suitable for RNAi treatment for 
a couple of reasons. Firstly, ingestion is a very simple method to induce 
RNAi. Worms are fed dsRNA expressing E. coli, generally the HT115 
strain as it has impaired RNA degradation (Timmons et al. 2001). 
Secondly, when worms take up dsRNA, it is automatically disseminated 
throughout much of the body, resulting in systemic knock down of the 
gene of interest (Fire et al. 1998). Perhaps one of the most advantageous 
features of RNAi is the ability to knock down genes at particularly points 
in development, especially useful for when mutations cause embryonic 
lethality. This could also allow for exploration of the hyperfunction theory 
of ageing, as RNAi could be used to switch off a programme before it 
becomes a quasi-programme and thus inhibit the development of age-
related pathology.  
 
Another progressive reverse genetics approach that works well in C. 
elegans is CRISPR. This system utilises the DNA cleavage enzyme Cas9 
to insert sequences specifically into target genes within the genome, 
forever changes the organism’s genotype (Dickinson & Goldstein 2016).  
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1.3.1 C. elegans life cycle 
 
C. elegans has a fast life cycle, developing from an egg to a fertile adult 
in approximately 65hrs at 20°C (Figure 1.4). When conditions are 
agreeable, the worms will pass through four larval stages (L1-L4) before 
becoming a fertile adult, with each transition requiring a moult (Cassada 
& Russell 1975). However when conditions are less favourable, worms 
are able to become dauer larvae, an alternative L3 larval stage (Figure 
1.4). The decision to become dauer begins at the L1 larval stage is 
triggered by a combination of different factors. A high population density 
results in the accumulation of a pheromone that can trigger and maintain 
the dauer stage (Golden & Riddle 1982). Low food and high temperature 
also promote the appearance of dauer larvae (Golden & Riddle 1984). 
Under such conditions, L1 larvae develop into a pre-dauer stage called 
L2d. If the stressful circumstances persist then L2d larvae become 
dauers. Dauers have a number of distinct characteristics amongst the C. 
elegans development stages. They are very thin but have a reinforced 
cuticle, which gives them resistance to external stressors such as acid 
exposure (Cassada & Russell 1975). They have greatly reduced 
movement and their pharynx does not pump (Cassada & Russell 1975). 
In fact, their alimentary canal seals itself, with the mouth closing entirely 
(Cassada & Russell 1975; Riddle et al. 1981). Notably, the dauer stage is 
very long lived and can survive for up to 70 days (Klass & Hirsch 1976). 
Once favourable conditions are restored, the dauer stage is exited and 
worms develop into normal adults. Intriguingly, the length of time spent as 
dauer has no effect on adult lifespan, suggesting that dauers are a non-
ageing stage (Klass & Hirsch 1976). An alternative possibility is that 
dauers do senesce, but rejuvenate upon dauer exit (Houthoofd et al. 
2002). 
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Figure 1.4. The C. elegans life cycle. Eggs are laid and hatch to form L1 larvae. When 
resources are plentiful, L1 larvae can go through several moults and larval stages (L2-
L4) until they become self-fertilising adults. However, if L1 larvae experience stress, 
such as high population density or low food, they can enter a pre-dauer larval stage 
(L2d). If the stressful conditions cease, then normal development can resume. However 
if they persist, then L2d larvae can form dauers, a long-lived stage capable of surviving 
for several months. Once favourable conditions are restored, dauers progress through 
development to form normal, young adults. 
 
1.3.2 C. elegans anatomy 
 
Despite being so small, C. elegans does possess a complex anatomy 
with multiple tissue types and organs. Both the hermaphrodite and the 
smaller male possess an outer tube of body wall, which includes a sturdy 
outer cuticle (Figure 1.5) (Altun & Hall 2009c) and body wall muscle 
which contracts and relaxes to generate a wave-like swimming or 
crawling movement (Altun & Hall 2009c). Neurons also form part of this 
outer tube and are mostly located in the head and tail (Altun & Hall 
2009c).  
Egg 
L1 
L2 
L3 
Dauer 
L4 
Adult L2d (Pre-dauer) 
High population density 
Low food 
 37 
 
Figure 1.5. The C. elegans male and hermaphrodite. (A) The male is smaller and 
thinner than the hermaphrodite. The apparatus for copulation is located in the tail and 
comprises of a fan containing sensory rays, which are used to search for the vulva, and 
spicules, which help to anchor the male to the hermaphrodite during mating. 
Development of these features can distinguish males relatively early in larval 
development. (B) The hermaphrodite has a thinner tail and a vulva located towards the 
center on the ventral side. (Image from (Lints & Hall 2009a). 
 
Within the body cavity are the alimentary canal and gonad. The pharynx 
resides at the anterior end of the alimentary canal and is primarily made 
up of muscle cells, but also contains epithelial, marginal, gland and 
neuronal cells (Figure 1.6) (Altun & Hall 2009b). Bacteria are pumped 
through the anterior portion of the pharynx down into the terminal bulb, 
where they are macerated before entering the intestine. The intestine is 
comprised of 20 polyploid cells arranged mostly into paired rings, though 
with one quadrant at the anterior end (Figure 1.7) (Altun & Hall 2009a). 
Food passes through the lumen of the intestine as the connecting 
muscles contract, before being defecated through the anus at the 
posterior end. 
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Figure 1.6. The structure of the C. elegans’ pharynx. (A) The pharynx contains 
twenty muscle cells that make up eight muscle segments (pm1 – 8) and nine marginal 
cells that make up three marginal cell segments (mc1 – 3). The marginal cells lie in 
between the muscle cells and provide additional structural strength. (B) The pharynx 
also has two classes of gland cells: three g1 cells and two g2 cells. These cells have 
openings into the pharyngeal lumen, with g1 cells having long protrusions that open into 
the lumen in the metacorpus, whereas g2 cells open directly into the lumen within the 
posterior bulb of the pharynx. Bacteria are ground down by the grinder inside the 
posterior bulb, before entering the intestine. (Image from (Altun & Hall 2009b)). 
 
Figure 1.7. Structure of the C. elegans hermaphrodite intestine. (A) The intestine 
(pink) is anchored to the pharynx (green), by the pharyngeal-intestinal valve (dark 
brown), and to the anus. It has to bend around the gonad (blue); therefore one section of 
the intestine will lie on top of the gonad and the other underneath. (B) The intestine is 
made up of 20 large epithelial cells. The majority of these cells form pairs to form 
intestinal rings (int2 – 9). The exception is the most anterior ring, int1, which is 
composed of four cells. (Image from (Altun & Hall 2009a)). 
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The hermaphrodite gonad is composed of two reflexed arms that each 
contain a distal and a proximal region. A somatic sheath encloses the 
germ cells, which develop into oocytes down the proximal arm. At the 
proximal end, oocytes are fertilised by sperm within the spermatheca and 
then enter the uterus. Stimulation of the vulva muscles results in the eggs 
being laid (Lints & Hall 2009d). The male gonad only has one arm, which 
solely creates sperm. Spermatids are stored in the seminal vesicle to 
await copulation (Lints & Hall 2009c). The posterior end of males is not 
just composed of the excretory portion of the intestine, but also contains 
the apparatus needed for mating. This consists of a fan-like structure 
containing sensory rays and additional muscles (Altun & Hall 2009c). 
Males will utilise these to search the hermaphrodite cuticle for the vulva 
and then use spicules within their tail to anchor themselves before 
ejaculation. 
 
1.3.3 C. elegans nomenclature 
 
Working with C. elegans requires adherence to a well defined genetic 
nomenclature, which is described in detail on the website, WormBase. 
When a strain is generated, it should be assigned a unique strain 
number, consisting of a number preceded by two or three uppercases 
letters. The letter code identifies the laboratory where the strain was 
produced. For example CF80 is a strain from Cynthia Kenyon’s group.  
 
Genes are given a three or four letter name, written in lower case italics, 
followed by a number. The name can be derived in a number of different 
ways. Most are named after a phenotype that mutation of the gene 
causes. For example, mutation in glp-4 causes abnormal germline 
proliferation. They can also be named based on the predicted protein 
identity or homologs that have already been named in other model 
organisms, e.g sir-2.1 was named after yeast SIR2. The protein encoded 
by a gene is non-italicised and in capital letters, for example GLP-4. 
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Different alleles also have unique codes. Again they consist of a number 
preceded by a laboratory-specific letter code. This is written in italics and 
in brackets after the gene name. For example glp-4(bn2) tells us this 
allele originates from Susan Strome’s group. A wild-type allele is 
indicated by the + symbol within brackets. A heterozygote has the allele 
code followed by a /+, for example glp-4(bn2)/+. After this there is either a 
roman numeral or X to indicate on which chromosome the gene is found, 
for example glp-4(bn2) I is found on chromosome I. In rare cases the 
allele code may be followed by mtDNA to indicate the gene is expressed 
by the mitochondria.  
 
If a mutation is introduced by genetic engineering techniques, the 
information is enclosed inside square brackets. If a gene encoding a 
fluorescent protein, such as GFP, has been fused to a gene, the gene 
name is followed by two colons and the fluorescent protein gene, e.g 
::gfp.  The transgene also possesses the laboratory-specific allele code 
and additional information to distinguish those that are either 
extrachromosomal arrays or chromosomally inserted by using the codes 
Ex and Is respectively. For example zcIs4[hsp-4::gfp] tells us that this 
transgene is integrated and will produce HSP-4 fused to GFP. This 
nomenclature allows the provenance of C. elegans strains to be clearly 
specified and will be used throughout this thesis.  
 
1.4 Ageing research using C. elegans 
 
For decades C. elegans has been used as a model organism by 
biogerontologists. Aside from all the previously mentioned advantages, C. 
elegans also has a very short lifespan of only 2-3 weeks. This means 
experiments can be completed much faster than in other longer-lived 
model organisms, such as fruit flies, zebrafish or mice. Importantly, they 
also show several of the typical symptoms of human ageing, such as a 
decline in fertility and motility, and increases in tissue degeneration and 
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mortality. Thus, C. elegans has become a convenient and widely used 
tool for exploring the biological mechanisms of ageing. 
 
1.4.1 Pathways involved in ageing in C. elegans 
 
In 1983 Michael Klass published the results of a forward genetic screen, 
where he had discovered a small number of mutants with increased 
lifespans (Klass 1983). Tom Johnson then identified one of these mutants 
as age-1(hx546) (Friedman & Johnson 1988). Another significant 
discovery was that of daf-2 mutants by Donald Riddle (Riddle 1988). The 
daf genes control the formation of dauer larvae and daf-2 mutants are 
dauer constitutive (Daf-c), in that they form dauers even in favourable 
conditions (Riddle 1988). Cynthia Kenyon studied the lifespan of 
temperature sensitive daf-2 mutants. These mutants were moved to the 
non-permissive temperature later in development so that they would not 
arrest as dauers, but instead grow into adulthood. These daf-2 mutants 
had a lifespan approximately double that of wild-type (Kenyon et al. 
1993). Furthermore, the daf-2(e1370) adult appeared virtually normal at 
20°C, in terms of growth, feeding and fecundity (Kenyon et al. 1993). This 
lifespan extension was found to require the activity of the dauer defective 
(Daf-d) gene daf-16, suggesting in wild-type worms DAF-16 activity 
promotes longevity (Kenyon et al. 1993). Later work established that all of 
the previously mentioned proteins have homologs in humans. AGE-1 is a 
homolog of the catalytic subunit of phosphoinositide 3-kinase (PI3K) 
(Morris et al. 1996). DAF-2 is a homolog of the insulin and IGF-1 
receptors (Kimura et al. 1997). DAF-16 is a homolog of a forkhead 
transcription factor (Ogg et al. 1997; Lin et al. 1997). These genes 
encode part of an evolutionarily conserved signalling pathway called the 
insulin/IGF-1 signalling (IIS) pathway (Figure 1.8).  
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Figure 1.8. The insulin/IGF-1 signalling pathway in C. elegans. (A) When the DAF-2 
receptor binds its ligand it initiates a signalling cascade. This starts by DAF-2 activating 
phosphoinositide 3-kinase (PI3K) that phosphorylates phosphatidylinositol 4,5-
bisphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3). PIP3 then 
stimulates 3-phosphoinositide-dependent kinase-1 (PDK-1) that activates several 
serine/threonine kinases including AKT and SGK-1. These kinases then phosphorylate 
the forkhead transcription factor DAF-16. This causes DAF-16 to be retained in the 
cytosol and thus inactivates it. (B) When DAF-2 does not bind its ligand, this kinase 
cascade does not occur so DAF-16 is unphosphorylated. In this state, DAF-16 can enter 
the nucleus and bind its target genes. (Image from (Mukhopadhyay & Tissenbaum 
2007)). 
 
Mutation of genes within the IIS pathway was also found to affect 
longevity in higher organisms. For example mutation of chico, the insulin 
receptor substrate in flies, caused a lifespan extension (Clancy et al. 
2001). Furthermore lifespan was extended in both male and female 
Igf1r/+ (insulin-like growth factor type 1 receptor) mice (Holzenberger et 
al. 2003). This confirms that the control of longevity by this pathway is 
also evolutionarily conserved.  
 
As the importance of IIS in the regulation of ageing became clear, the 
downstream targets of the transcription factor DAF-16 that could directly 
affect ageing were sought, in order to discover the nature of the ageing 
process. However DAF-16 is predicted to control expression of thousands 
A B 
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of genes that are involved in a wide range of activities, from the heat 
shock response to the immune system (Tullet 2015). The search was 
further complicated by the discovery that IIS can also modulate the 
activity of the transcription factors SKN-1 and HSF-1, which widened the 
net of possible downstream targets (Tullet et al. 2008; Chiang et al. 
2012). However many genes that are controlled by IIS and also have a 
role in ageing have now been identified. For example spp-1, which 
encodes an anti-microbial protein, and gst-4, which encodes a protein 
involved in detoxification, are both upregulated and required for longevity 
in daf-2 mutants (Murphy et al. 2003). DAF-16 can activate expression of 
hsp-16, a heat shock protein, which is also required for the lifespan 
extension of daf-2 mutants (Hsu et al. 2003). Therefore a pattern is 
emerging of reduced IIS leading to increased expression of genes 
involved in various stress responses. Thus insights have been gained 
about how IIS may be controlling ageing. 
 
Another evolutionary conserved nutrient sensing pathway that has been 
shown to modulate ageing in C. elegans is the TOR (target of rapamycin) 
pathway. An increase in nutrients activates the TOR pathway and 
subsequently increases protein synthesis and growth (Blagosklonny 
2008). Importantly, a reduction in TOR signalling increases lifespan in C. 
elegans (Vellai et al. 2003; Jia et al. 2004). This effect on longevity is 
conserved, as mice fed the TOR inhibitor rapamycin also had an 
extended lifespan (Harrison et al. 2010). The relationship between the 
effects on ageing of the two main longevity pathways, TOR and IIS, is not 
completely understood but it seems that they can operate together or 
independently to modulate longevity. For example, the extended lifespan 
of the daf-2(e1370) mutant was not lengthened by a reduction of TOR 
signalling (Vellai et al. 2003). This suggests the two pathways act 
together to regulate ageing. On the other hand, the increased longevity 
induced by a reduction in TOR signalling does not require DAF-16 activity 
(Vellai et al. 2003). This implies the two pathways can also operate 
separately to control longevity. 
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Dietary restriction, defined as a reduction of food without starvation, has 
long been known to extend lifespan in a wide range of animals including 
rats and C. elegans (McCay et al. 1935; Klass 1977). In C. elegans, the 
longevity induced by DR does not require DAF-16 activity, suggesting DR 
does not utilise the IIS pathway (Lakowski & Hekimi 1998). So how does 
DR cause an increase in lifespan? An increase in nutrients triggers the 
TOR pathway, while a decrease inhibits it. Thus the TOR pathway 
seemed a likely candidate for the mediator of DR-induced longevity in C. 
elegans (Walker et al. 2005). In support of this, reducing TOR signalling 
did not increase the longevity of a C. elegans DR mutant (Hansen et al. 
2007). Due to its ability to respond robustly to nutrient signals to stimulate 
growth, Blagosklonny proposes that TOR has a pivotal role in ageing 
driven by hyperfunction (Blagosklonny 2008). He proposes TOR 
signalling continues after development, when it may no longer be needed, 
resulting in hyperfunction and age-related pathology (Figure 1.9) 
(Blagosklonny 2008). Thus inhibitors of the TOR pathway, such as 
rapamycin, may be critical anti-ageing drugs in the future.  
 
 
 
 
 
 
 
 
 
Figure 1.9. TOR-centric model for the hyperfunction theory of ageing. The TOR 
pathway is stimulated by food uptake, growth factors and hormones. It can cause 
various effects that activate biosynthesis including activating protein translation and 
inhibiting autophagy. During ageing, the biomass will increase, resulting in a 
hypertrophic phenotype. This will eventually cause damage and the development of 
lethal age-related pathology. (Image adapted from (Blagosklonny 2008; Gems & de la 
Guardia 2013)). 
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1.4.2 Hyperfunction as a possible cause of senescent pathology in 
C. elegans 
 
If the hyperfunction theory of ageing is valid then at least some age-
related pathologies in C. elegans should be the result of quasi-
programmes. Certainly there are a number of pathologies that develop in 
ageing worms that are potentially driven by hyperfunction (Figure 1.10) 
(Gems & de la Guardia 2013). For example, the body wall cuticle 
enlarges during ageing, apparently due to run-on of collagen production 
(Figure 1.10A) (Herndon et al. 2002). Neurons develop additional 
protrusions during ageing (Figure 1.10B) (Tank et al. 2011). Oily yolk 
pools accumulate in the body cavity of old worms (Figure 1.10D) (Garigan 
et al. 2002; Herndon et al. 2002; McGee et al. 2011). Yolk is produced by 
the intestine to nourish developing oocytes. However the occurrence of 
these pools suggests yolk production is not switched off after self sperm 
depletion. This abundance of extracellular yolk may cause the ectopic 
deposition of lipid seen in other areas of the body, such as the muscle, 
which could disrupt tissue function (Figure 1.10C) (Herndon et al. 2002). 
The germline also undergoes extensive changes during ageing. Once 
reproduction ceases, oocyte production continues, causing an 
accumulation of oocytes along the proximal arm of the gonad (Jud et al. 
2007). Unfertilised oocytes also build up in the uterus, where they 
undergo endoreduplication leading to the development of uterine tumours 
(Figure 1.10E) (Golden et al. 2007). The distal gonad arm atrophies and 
disintegrates during ageing (Figure 1.10D) (Garigan et al. 2002; Luo et al. 
2010; Hughes et al. 2011). This appears to be driven by quasi-
programmed apoptosis of germ cells: germline apoptosis contributes to 
oocyte development during the reproductive period but continues to 
operate in late life causing pathology (de la Guardia et al. 2016). 
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Therefore there are an abundance of age-related pathologies in C. 
elegans that either are or could be the result of hyperfunction. 
 
Figure 1.10. Age-related pathology caused by hypertrophy in C. elegans. (A) Day 
18 worm with severe thickening of the body wall cuticle (red line). Muscle, M. (Image 
from (Herndon et al. 2002)). (B) Day 15 worm with evidence of neuronal branching (red 
arrow) (Image from (Tank et al. 2011)). (C) Day 18 worm with ectopic lipid (L) deposition 
(red arrow) in muscle (M) (Image from (Herndon et al. 2002)). (D) Day 11 worm with a 
disintegrated gonad (fragments outlined in white). Also note the yolky pools that fill the 
entire body cavity (Scale bar 20µm). (E) Day 12 worm with a large tumour (outlined in 
black) within the uterus. Vulva, V. (Scale bar 20µm).  
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1.4.3 Lethal pathology in ageing C. elegans 
 
What do worms die of (i.e what age-related disease is lethal)? This is a 
deceptively simple question that surprisingly remains unanswered. To 
solve this mystery, one must identify the organ of the worm most likely to 
develop life-limiting pathology. The intestine is an obvious candidate, as it 
is by far the largest somatic organ in the worm and carries out multiple 
functions, including yolk synthesis (Altun & Hall 2009a). Furthermore it 
shows age-related decline, including atrophy of the intestinal cells, 
degradation of their nuclei and loss of microvilli (McGee et al. 2011). A 
major clue that indicates the intestine could have a key role in C. elegans 
mortality is that it has been shown in daf-16; daf-2 mutants that 
restoration of daf-16 specifically in the intestine is sufficient to extend 
lifespan by 50-60% (Libina et al. 2003), though it does not fully restore 
daf-2 longevity. Furthermore in the long lived sterile mutant mes-1(bn7), 
where longevity is daf-16 dependent, expression of daf-16 specifically in 
the intestine of the daf-16; mes-1 mutant could wholly restore longevity 
(Libina et al. 2003). This demonstrates that DAF-16 activity in the 
intestine is at least partially responsible for daf-2 longevity and could 
completely account for the longevity seen in germ-line deficient mutants. 
 
There is also evidence that intestinal necrosis is involved in the death of 
the worm (Coburn et al. 2013). The intestine contains autofluorescent 
lysosome-related organelles called gut granules that fluoresce blue under 
UV light. It was long assumed that these gut granules contained 
lipofuscin because lipofuscin also emits blue fluorescence when exposed 
to UV light (Jung et al. 2007). Lipofuscin is an aggregate of damaged 
lipids and proteins that accrues during mammalian ageing and its 
presence has been used as evidence for the importance of molecular 
damage during ageing (Jung et al. 2007). However it was discovered in 
C. elegans that blue fluorescence does not increase during ageing, which 
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one would expect if blue fluorescence were caused by a gradual increase 
in lipofuscin. In fact levels stay constant until only a few hours before 
death, where there is a sudden and large increase in blue fluorescence 
(Figure 1.11) (Coburn et al. 2013). This phenomenon was named death 
fluorescence and was seen in worms that died from both stress and old 
age, showing it to be a general feature of death, whatever the cause. 
Death fluorescence also developed in a clear pattern, where it starts at 
the anterior end of the intestine and moves all the way along until it 
reaches the posterior end. This blue fluorescence was then identified as 
being produced by anthranilic acid derivatives (Coburn et al. 2013). 
Levels of anthranilic acid derivatives do not suddenly increase at death 
but their fluorescence is quenched while they are inside the acidic 
environment of the gut granule. When the membrane of the gut granule is 
compromised, the anthranilic acid derivatives are dequenched as the pH 
increases. Therefore death fluorescence is a marker of necrotic death, 
which is stimulated by a wave of Ca2+ influx. This wave of death then 
spreads along the intestine from anterior to posterior. Ca2+ is able to 
activate various enzymes, including phospholipases and proteases, 
which promote necrosis. Thus necrotic cell death within the intestine 
occurs during death in C. elegans, presumably contributing to it. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11. Death fluorescence in C. elegans. A wave of blue fluorescence spreads 
from the anterior (A) to the posterior (P) end of the intestine in a worm that has died from 
old age. This phenomenon is closely associated with death (0 hrs). (Scale bar 50µm). 
(Image from (Coburn et al. 2013)). 
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While there is substantial evidence that the intestine is a site of life 
limiting pathology, it seems unlikely to be the only organ that can develop 
a pathology that contributes to death in the worm. Firstly intestinal daf-16 
expression does not fully restore daf-2 longevity in a daf-16; daf-2 mutant 
(Libina et al. 2003). Therefore daf-16 expression in another tissue could 
be required for full reestablishment of daf-2 lifespan. Secondly, the 
necrotic wave in the intestine implies that necrosis contributes to death, 
however when necrosis is inhibited in C. elegans this does not result in a 
lifespan extension (Coburn et al. 2013). This suggests ageing causes 
other life limiting pathologies that develop alongside intestinal pathology.  
 
Another possible site of lethal pathology is the pharynx, which has also 
been observed to undergo major age-related deterioration, losing both 
structural integrity and functional capacity during ageing (Chow et al. 
2006; Huang et al. 2004). Furthermore bacteria accumulate in the 
pharyngeal lumen and can invade into the pharyngeal tissue of aged 
worms (Garigan et al. 2002; McGee et al. 2011). Perhaps the most 
compelling evidence that the pharynx may harbour a life-limiting 
pathology is that the period of pharyngeal function was found to be a 
predictor of lifespan, with the longest lived worms sustaining pharyngeal 
function for longer (Huang et al. 2004). Additionally the necrotic wave in 
the intestine often begins at the anterior end, close to the pharynx 
(Coburn et al. 2013). This could suggest that in old worms, an age-related 
pathology in the pharynx somehow initiates necrosis in the intestine. 
Overall it seems likely that, as in humans, there are multiple causes of 
death in ageing C. elegans. 
 
1.5 Consolidating ageing theories 
 
Two mechanistic theories of ageing have been introduced in this section: 
the molecular damage theory and the hyperfunction theory. It might seem 
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at first that these two theories are distinct and therefore surely only one 
can be true. However it is possible the two could be interlinked, 
complicating our understanding of the biological mechanisms that drive 
ageing. Ageing results in a wide range of phenotypes. While it is possible 
there is one central process driving the development of all age-related 
pathologies, a more realistic idea is that they are the result of several 
different mechanisms. While these mechanisms could act independently 
there are a number of examples that suggest hypertrophy and molecular 
damage could interact to drive development of pathology. For example 
stimulation of TOR, which has been proposed to have a key role in the 
hyperfunction theory (Blagosklonny 2008), can also cause increased 
levels of ROS (Kim et al. 2005). Therefore while TOR may cause a 
hypertrophic phenotype, it could also be causing increased levels of 
molecular damage in tandem. In addition some hypertrophic pathologies 
are also linked to increased levels of oxidative damage. For example 
myocardial infarction is associated with both hypertrophy of cardiac 
muscle cells but also with an increased amount of lipid peroxidation 
(Blagosklonny 2008; Cracowski et al. 2002). In such scenarios it is 
possible that both hyperfunction and molecular could initiate and/or 
exacerbate the development of the pathology. 
 
For our studies we have chosen to use the model organism C. elegans to 
test the hyperfunction theory of ageing. As listed in section 1.4.2, there 
are several pathologies in C. elegans that could be caused by 
hyperfunction. However as C. elegans has a short growth cycle and a 
huge reproductive output in a small period of time, it is likely to favour a 
state of overgrowth to fuel this production. Furthermore they may not be 
capable of accumulating large levels of molecular damage as they only 
live for a few weeks. In contrast, humans have a very different life history 
and are obviously more complex than C. elegans. The vast array of 
pathologies in ageing humans is likely to be due to a number of different 
causes. Some may be driven predominantly by hyperfunction, for 
example overactivation of osteoblasts can lead to osteoporosis 
(Glantschnig et al. 2003). On the other hand, damage to DNA can cause 
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gene mutations, which in certain cases could lead to excess cellular 
proliferation and subsequently cancer. Therefore molecular damage 
could have a more significant role in human ageing. A challenge for future 
researchers will be to determine how different mechanisms could interact 
to produce age-related pathologies.  
 
1.6 Aims 
 
C. elegans has been used in numerous studies of ageing, but only a very 
small number have analysed pathology in the ageing worm (Herndon et 
al. 2002; McGee et al. 2011; Golden et al. 2007). Therefore there is only 
a limited knowledge about age-related pathology in C. elegans, including 
how senescent pathologies develop and which are the cause of death. 
The primary aims of my PhD were to analyse the pattern of progression 
of various age-related pathologies, explore the possible role of quasi-
programmes as etiology and determine which might be the cause of 
death in ageing C. elegans. 
 
A huge advantage of using the worm for this work is that, due to its 
transparency, Nomarski microscopy can be utilised to examine the 
internal tissues in live or dead animals, without the need to perform 
dissection. To evaluate the level of deterioration in various tissues, 
pathology scores were generated using previously described criteria (de 
la Guardia et al. 2016; Riesen et al. 2014), and ones more recently 
developed by Marina Ezcurra. This revealed that while various 
pathologies develop and worsen during ageing, only two examined during 
this study seem to be lethal: intestinal atrophy and pharyngeal infection.  
 
The C. elegans germline undergoes various age-related changes. The 
uterus swells dramatically as large tumours develop within it (McGee et 
al. 2012; Golden et al. 2007). These tumours appear to develop in all 
wild-type hermaphrodites and are a striking age-related pathology that 
may cause mortality. In chapter 3.1 we show that various interventions, 
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including treatment with the anti-cancer drug 5-fluorodeoxyuridine 
(FUDR), can block uterine tumour development. However we then 
demonstrate that uterine tumours are not life limiting. Furthermore we 
identify a novel age-related pathology, bacterial infection of uterine 
tumours. Previous work in our group by Y. de la Guardia showed that 
gonad disintegration could be the result of quasi-programmed apoptosis 
(de la Guardia et al. 2016). In chapter 3.2, we provide additional evidence 
to support this theory by showing that altering the levels of germline 
apoptosis can change the extent of gonad disintegration. 
 
It is clear the hermaphrodite intestine deteriorates dramatically during 
ageing, in particular it experiences major atrophy (McGee et al. 2011; 
Herndon et al. 2002; Garigan et al. 2002). In chapter 4 we collect 
morphometric data to obtain a better understanding of the dynamics and 
pattern of age-related intestinal atrophy. Furthermore, we provide 
evidence intestinal atrophy is the result of the intestine metabolising its 
own biomass to fuel quasi-programmed yolk production. The pharynx 
was the final tissue I examined during this project. In chapter 5 we used 
necropsy analysis to show that a subpopulation of C. elegans die early 
with an enlarged pharynx, which is caused by bacterial infection. We also 
provide evidence that this infection may be promoted by mechanical 
senescence (Zhao et al., 2017).  
 
Throughout this project I have been fortunate to collaborate with many 
individuals. The work in chapter 3.1 contributed to the published work of 
Riesen et al., 2014, while chapter 3.2 was done in cooperation with Y. de 
la Guardia and much of it is now published in de la Guardia et al., 2016 
(See papers in Appendix 2).  The underlying mechanisms of intestinal 
atrophy, discussed in chapter 4, would not have been known without the 
insights gained by M. Ezcurra, T. Sornda and A. Benedetto (Ezcurra et 
al., 2017, unpublished). The study of pharyngeal infection in chapter 5 
became a truly collaborative work, requiring contributions from a number 
of colleagues. I would like in particular to acknowledge and thank Y. 
Zhao, with whom I worked in partnership with on this project, leading us 
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to co-author the paper Zhao et al., 2017 (See paper in Appendix 2). In 
some places throughout this thesis, I have presented work performed by 
others to allow for a complete narrative. Whenever this is the case, full 
acknowledgement is given and I thank them for their involvement.   
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Chapter 2  Materials and Methods 
 
2.1 C. elegans maintenance and methods 
 
2.1.1 Stock maintenance 
 
For normal maintenance worms were generally kept at 20°C on 60mm 
Petri plates containing nematode growth medium (NGM). These had 
been seeded with 100µl of E. coli OP50 to provide a food supply. To 
ensure the population did not starve, several adult hermaphrodites were 
regularly transferred to fresh plates to initiate a new population. Worms 
were transferred using a worm pick made with a platinum wire. The pick 
was heated in a Bunsen burner flame briefly to sterilise it, before it was 
used to transfer worms. A population of worms can also be maintained by 
chunking. This is where a flame-sterilised scalpel is used to cut out a 
piece of agar that is then placed on a fresh plate.  
 
The male C. elegans is not usually abundant in populations but 
hermaphrodites can be induced to produce more males by heat shock. L4 
hermaphrodites were placed at 30°C for 5-6hrs and then maintained at 
20°C. Their progeny should contain some males. These can then be 
selected and used to create a male stock for experiments, with around 
10-15 males for every 4 hermaphrodites, to ensure copious mating 
occurs. For experiments on plates, males were kept at a low population 
density of 5 per plate, due to the lifespan lowering effect of large numbers 
of males (Gems & Riddle 2000; Maures et al. 2014). 
 
For long-term storage, populations from several starved plates were 
collected into a solution of 1:1 freezing medium and M9 buffer.  Aliquots 
can then be kept at -80°C, for many years if need be. When strains are 
required, they can be thawed and pipetted onto fresh NGM plates. If the 
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original freeze was successful, a large number of L1 larvae should have 
survived and in a few days, grow into fertile adults.  
 
2.1.2 List of C. elegans strains 
 
The vast majority of strains were obtained from Caenorhabditis Genetics 
Center (CGC), at the University of Minnesota. Some strains were kindly 
supplied to us from individual laboratories, and are indicated as such. The 
wild-type strain used was the N2 male stock from the CGC, except for 
chapter 5 where the CGC N2 hermaphrodite stock was used. 
 
Strain name Genotype 
AH102 lip-1(zh15) IV 
BC12677 dpy-5(e907) I; sIs11111[rCesC32F10.8::GFP + pCeh361] 
BC12754 dpy-5(e907) I; sIs12567[rCesC07H6.3::GFP + pCeh361] 
BC16329 dpy-5(e907) I; sEx16329[rCesF20B10.1::GFP + pCeh361] 
CB3168 him-1(e879) I; mab-3(e1240) II 
CF80 mab-3(mu15) II; him-5(e1490) V 
DA464 eat-5(ad464) I 
DA493 phm-3(ad493) III 
DA521 egl-4(ad450) IV (previously eat-7) 
DA522 eat-13(ad522) X 
DA591 unc-10(ad591) X 
DA597 phm-2(ad597) I 
DA606 eat-10(ad606) III 
DA698 unc-36(ad698) III 
DA1110 eat-18(ad1110) I 
DA1116 eat-2(ad1116) II 
DR466 him-5(e1490) V 
EG3234 oxIs144[inx-16::GFP, lin-15+] 
GA1200 mdl-1(tm311) X 
GA1801* lip-1(gt448) IV 
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GA1802* ced-9(n1653ts) III 
GA1803+ gld-1(op236) I; ced-3(n717) IV 
JK560 fog-1(q253) I 
JK4563 gld-1(q126sd) I/hT2 [bli-4(e937) let-?(q782) qIs48] (I;III) 
MT1522 ced-3(n717) IV 
NQ828& qnEx446[Pabu-1:mCherry; Pabu-1:abu-1::sfGFP; rol-6(d); 
unc-119(+)] 
NQ829& qnEx447[Ppqn-2:mCherry; Ppqn-2:pqn-2::sfGFP; rol-6(d); 
unc-119(+)] 
SS104 glp-4(bn2) I 
TG34 gld-1(op236) I 
*Provided by Anton Gartner 
+Provided by Björn Schumacher 
&Provided by David Raizen 
 
2.1.3 Elimination of contamination 
 
To reduce the chances of contamination on plates, plates were only 
opened near the presence of a flame. Regardless, plates can sometimes 
become contaminated with either fungus or non-E. coli bacteria. To 
remove fungus, worms were transferred to a non-contaminated plate and 
allowed to crawl around so they moved away from any spores that had 
been transferred with them. Worms were then transferred again to a fresh 
plate.  To remove bacterial contamination a solution of 1:1 1M NaOH and 
5% bleach was made. A drop of this was added to a fresh NGM plate and 
several adult hermaphrodites were placed in the drop. This kills 
everything except the eggs, which are protected by their eggshell. The 
majority of L1 larvae will not emerge until the bleach solution has soaked 
into the plate and hence escape death. 
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2.1.4 Synchronizing populations 
 
Individuals that were at the L4 larva stage were selected from a mixed 
population of worms to obtain an age-synchronized group. When large 
numbers of individuals were needed, an egg lay or large scale bleaching 
was performed. The latter method was also used when eggs needed to 
be sterile. For an egg lay, 8 adult hermaphrodites were left on a plate to 
lay eggs for approximately 6 hours at 20°C. The adults were then 
removed and the eggs kept at 20°C to hatch. L4 larvae were then 
selected for experiments. For a large scale bleaching, a substantial 
number of adult hermaphrodites were rinsed into a 15ml falcon tube using 
M9 buffer. The tube was centrifuged at 3000rpm for 2 minutes. The 
majority of the supernatant was removed, leaving only 1ml. 300µl of 1:1 
solution 10% bleach and 4M NaOH was added. The tube was agitated 
vigorously and examined regularly under a dissecting scope. Once the 
cuticle of the adults had dissolved and the eggs had been released, the 
tube was filled with M9 buffer to terminate the reaction. The eggs were 
then centrifuged at 3000rpm for 2 minutes and the supernatant removed. 
The pellet was resuspended in fresh M9. This was performed three times 
to remove any remnants of the bleach solution. Eggs were then pipetted 
onto plates and allowed to hatch and grow at 20°C. L4 larvae were then 
selected for experiments. 
 
2.1.5 Survival and necropsy analysis 
 
For survival assays worms were kept at around 25-35 per plate. If the 
DNA and RNA synthesis inhibitor 5-fluorodeoxyuridine (FUDR) was used 
to block progeny production, it was added to the plates the day before the 
L4 worms were picked. This was to allow it to diffuse throughout the 
plate. Most survival assays were then scored three times a week for dead 
worms. For necropsy assays, scoring was performed more regularly to 
reduce corpse decomposition. Corpses were then collected and prepared 
for microscopy. A dead worm was one that did not respond to a poke by a 
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worm pick to the head, body or tail. Sometimes worms had to be 
censored if they had crawled up the wall and desiccated; if eggs had 
hatched internally; if the intestine had ruptured through the vulva; or if the 
plate had become contaminated. 
 
For worms exposed to glass powder for necropsy analysis, glass plates 
were prepared as follows. Glass frit was obtained from www.warm-
glass.co.uk. To purify smaller glass particles, the powder was separated 
by gravity for 1 minute in 40ml 30% glycerol in a 50ml falcon tube. Only 
the top third of the solution was retained and again separated by gravity 
in glycerol. This was done 4 times to obtain a solution of micro glass 
particles. This was then centrifuged for 5 minutes at 3000rpm, the 
supernatant removed and the pellet resuspended in M9. This was done 
three times to wash away the glycerol. The solution was then autoclaved 
and allowed to cool before 300µl of it was added to a plate with a well-
established bacterial lawn. Plates were then allowed to dry overnight 
before worms were introduced. 
 
2.1.6 Individual liquid culture 
 
To study male ageing in C. elegans in the absence of male-male 
interactions that reduce lifespan, males can be cultured individually using 
the following liquid culture method developed by D. McCulloch 
(McCulloch & Gems 2003). OP50 was grown in 200ml OP50 medium 
overnight at 37°C in a shaker. This solution was then centrifuged at 
4100rpm for 15 minutes and resuspended in 150ml S medium, that had 
been kept at 4°C. The bacterial count of the solution was determined by 
doing serial dilutions plated onto LB plates. The required range was 1-5 x 
109 cells ml-1 to ensure there was sufficient food for optimum lifespan and 
progeny production. This liquid medium was then divided into 20ml 
aliquots and stored at 4°C. Aliquots were streaked on agar plates and if a 
contaminant grew the aliquot was disposed of. 50µl of this culture was 
then added to each well in a 96 U-well plate, except for the outer wells 
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that contained milliQ water to act as an evaporation buffer. Males and 
hermaphrodites were then removed from agar plates at the L4 stage and 
placed individually into the wells. The plates were wrapped in parafilm 
and placed in sealed boxes with a cup of water to prevent the wells from 
drying out. Worms were could be transferred out of wells for microscopy 
using a hook shaped pick.  
 
2.1.7 RNA-mediated interference 
 
HT115 is the E. coli strain used for RNAi experiments in C. elegans. RNAi 
clones were collected from the Ahringer library (owned by Richard Poole, 
UCL) and then stored at -80°C. Clones were streaked onto LB plates 
containing the antibiotics ampicillin (50µg/ml) and tetracycline (10µg/ml) 
and grown up overnight at 37°C. A single colony was then selected and 
grown in LB broth with only ampicillin in a 37°C shaker overnight. The 
bacteria were pelleted in a centrifuge at 4100rpm for 15 minutes and then 
the supernatant was removed before the pellet was resuspended in a 
solution of LB devoid of antibiotic. Cultures were then stored at 4°C. 
 
IPTG plates were made by adding 1ml of 1M IPTG for every 1L of NGM 
media. These plates were then seeded with 200µl of the appropriate 
HT115 clone. The bacteria were grown on the plates for a couple of days 
before being used immediately.  
 
2.2 Bacterial methods 
 
2.2.1 Preparation of bacterial cultures 
 
E. coli OP50 was streaked on a LB plate from a frozen stock provided by 
the CGC. A single colony was selected with a sterile loop and used to 
inoculate 100ml OP50 culture solution. This was left overnight in a 37°C 
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shaker and then stored at 4°C. Bacterial stocks were replenished 
approximately every two weeks. 
 
A strain of E. coli OP50 that emitted red fluorescence (OP50-RFP) was 
kindly generated for me by M. Ezcurra. She transformed E. coli with the 
pRZT3 plasmid, kindly sent to us by J.F Rawls of Duke University, 
Durham. This plasmid contained genes for tetracycline resistance and 
DsRed, whose expression was regulated by a constitutive lac promoter. 
OP50-RFP for streaked onto a LB plate containing 10µg/ml tetracycline. 
A single colony was selected and grown in LB solution, also containing 
tetracycline. This was allowed to grow overnight in a 37°C shaker. The 
stock was then centrifuged at 4100rpm for 15 minutes and the 
supernatant removed. The bacterial pellet was then resuspended in fresh, 
antibiotic-free LB solution and stored at 4°C. 
 
2.2.2 Inhibition of bacterial growth 
 
Bacterial growth was inhibited using either antibiotic treatment or UV 
exposure, as previously described (Garigan et al. 2002; Gems & Riddle 
2000). For antibiotic treatment, NGM plates were seeded with 100µl 
OP50 and left to grow at room temperature for two days. A 500mM 
solution of carbenicillin was made up fresh for each experiment in MilliQ 
water and then 80µl of it was added to each plate to give a final 
concentration of 4mM carbenicillin. Plates were allowed to dry overnight 
and then worms were transferred onto plates at the L4 stage, unless 
otherwise specified. Carbenicillin-treated plates not immediately used for 
experiments were stored at 4°C until required.  
 
For UV-killing, NGM plates were seeded with 80µl OP50, which was 
allowed to grow overnight at 20°C. In the morning, a Stratagene UV 
stratalinker 2400 was sterilised by running it empty for 10 minutes. Plates 
and their upturned lids were then placed inside for 30 minutes. UV-killed 
bacteria were then streaked onto a LB plate. If no colonies grew, this 
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affirmed the protocol had been successful. Sterile eggs, obtained from 
large scale bleaching, were pipetted onto the plates and allowed to grow 
until L4 stage, when they were selected for experiments.  
 
2.3 Staining methods 
 
2.3.1 DAPI staining 
 
DAPI (4’,6-diamidino-2-phenylindole) emits blue fluorescence and 
associates with DNA. It has been used extensively to stain C. elegans 
and the following method is based on previous work (Francis et al. 1995). 
Worms were picked into M9 in a 1.5ml tube and centrifuged at 3000rpm 
for 2 minutes. The supernatant was removed and 200µl methanol, which 
was cooled at -20°C, was added. Tubes were kept on ice for 5 minutes, 
but agitated at regular intervals. The methanol was removed and worms 
were washed in M9 before being centrifuged again. 200µl DAPI 
(500ng/ml) was added and the tube was placed in darkness for 30 
minutes. M9 was added before worms were centrifuged again and the 
supernatant removed. Worms were then pipetted onto a NGM plate and 
prepared for microscopy.  
 
2.3.2 SYTO 12/13 staining 
 
SYTO12 is a vital dye previously used to stain apoptotic cells in C. 
elegans (Gumienny et al. 1999), while SYTO13 has been previously 
shown to stain Microbacterium nematophilum in the worm, where it 
causes an infection in the rectum (Nicholas & Hodgkin 2004). Both emit a 
green fluorescence that can be seen using a GFP filter cube. The 
following method is based off this previous work, but was adapted by A. 
Benedetto. A square of parafilm was adhered to a microscopy slide and 
an imprint was formed on it by using the round end of a pencil. A drop of 
15µM SYTO13 or 33µM SYTO12 was pipetted into this impression. 
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Around 10 worms were placed in the droplet, along with some bacteria 
that had been scraped from the plate, to ensure the worms did not starve. 
Slides were placed in a covered container that had been partially filled 
with water. This was to prevent the dye from bleaching and to ensure the 
worms were protected from desiccation.  The container was then placed 
at 25°C for 4 hours. Worms were then picked out of the drop and placed 
onto a seeded NGM plate. This had to be done quickly, before the drop 
dries out. Thus it is recommended to only have one drop per slide. For 
SYTO12 staining, worms were left for around 30 minutes before they 
were imaged to allow any dye taken up by the intestine to be flushed out. 
For SYTO13 experiments, worms were imaged immediately. 
 
2.4 Microscopy 
 
2.5 Preparation for imaging 
 
For both Nomarski and confocal microscopy, live adult worms were 
placed on 2% agar pads inside a 5µl drop of 0.2% levamisole, an 
anaesthetic. A cover slip was then gently placed onto the pad and worms 
were imaged immediately. In some cases, nail varnish was wiped around 
the coverslip to seal the slides.  
 
2.5.1 Microscope systems 
 
Nomarski images of worms were collected on a Zeiss Axioskop2 plus 
microscope with a Hamamatsu ORCA-ER digital camera C4742-95 using 
Volocity 6.3 (Mac version) software to take the images.  For fluorescence 
images the following filter cubes were used: DAPI cube (excitation range 
350 – 380nm, emission >420nm), FITC/GFP cube (excitation range 450 – 
490nm, emission 515 – 565nm) and Rhodamine cube (excitation range 
540 – 552nm, emission >590nm). The default setting for gain in Volocity 
is 0 and this was unchanged throughout experiments. Exposure time was 
 63 
altered as it was optimised for each animal, however the following ranges 
were generally used: RFP 20-50ms, GFP 250 – 500ms and for DAPI (for 
C. elegans autofluorescence) 100-200ms. 
 
To collect image stacks, a Zeiss Axio Observer microscope was used that 
was connected to a LSM-710 confocal system. Images were obtained 
using Zen 2009 software (Windows version) and then exported into 
Volocity 6.3 (Mac version) for further analysis.  
 
2.5.2 Electron microscopy 
 
We used protocol 8 developed by Dave Hall from WormBook to prepare 
our worms for electron microscopy (Shaham 2006), with assistance from 
M. Turmaine. Worms were grown on OP50-RFP until day 8 at 20°C and 
then sorted into groups based on pharyngeal pathology. Worms were 
picked onto unseeded plates, into a drop of M9, in an attempt to wash off 
excess bacteria. A small hole was then cut out of an agar pad on a 
microscope slide using a scalpel. A drop of fixing solution (2.5% 
glutaraldehyde, 1% paraformaldehyde in 0.1M sucrose and 0.05M 
cacodylate) was added to the hole and a worm picked into it. The worm 
was then decapitated using a 30g needle and the heads were collected 
into a tube of fixing solution, where they remained for at least 2 hours. 
The heads then went through several steps of washes and fixes before 
being mounted into agarose blocks, which are used for sectioning. 
Sections were collected and examined under low magnification until the 
posterior bulb of the pharynx was reached. At this point, a diamond blade 
was used to collect 70nm sections, which were transferred to a copper 
mesh and stained with lead citrate. The sections were examined using a 
Joel 1010 transition electron microscope and images were collected by 
Gatan Imaging Software in TIFF format.  
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2.5.3 Measuring the pathology state of C. elegans tissues 
 
Images used for these pathology screens were Nomarski images 
obtained at either x400 or x630 magnification, unless otherwise stated. 
Image J or Volocity 6.3 software (Mac versions) were used to perform 
any necessary measurements. To prevent bias when qualitative scores 
were generated, images were randomly sorted and blinded using 
scrambling software developed by Peter Rennert (de la Guardia et al. 
2016). I would like to thank M. Riesen, Y. de la Guardia, Y. Zhao, C. 
Yang and M. Ezcurra who developed the majority of the following 
protocols that I adopted for my studies.  
 
2.5.4 Uterine tumours 
 
The following qualitative scoring system was used to determine the 
pathology state of the uterus (Riesen et al. 2014). A class 1 worm shows 
no tumours and the eggs are well organised within the uterus. In class 2 
there is some disorder and unfertilised oocytes have started to 
accumulate within the uterus. Class 3 worms have developed small 
tumours while class 4 worms have larger tumours. Class 5 worms have 
huge tumours that have filled the entire body cavity. The cross-sectional 
area of the tumours could also be measured from images collected at 
x100 magnification. 
 
2.5.5 Gonad atrophy 
 
The following qualitative scoring system was used to determine the extent 
of gonad atrophy (de la Guardia et al. 2016). A class 1 worm has a 
healthy gonad, with both gonad arms filling the body cavity. In class 2, the 
gonad arms have started to thin. In class 3 the thinning has worsened to 
such an extent a breakage appears unavoidable. In class 4, gonad 
fragmentation has occurred, while in class 5 the gonad has deteriorated 
to the point it can no longer be identified.  
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2.5.6 Intestinal atrophy and lumen distension 
 
Initially I tried to measure the entire cross-sectional area of the intestine 
and the lumen. To do this I collected three images of each worm taken at 
x100 magnification; a brightfield image, a gut auto-fluorescence image 
and a RFP image. Images were then overlaid in Volocity 6.3 software and 
the cross-sectional area of the entire intestine was measured using both 
the brightfield and gut auto-fluoresence image as a guide. Next the area 
of the RFP was measured which, as these worms had been fed OP50-
RFP, was hoped to represent the intestinal lumen area. To obtain the 
cross-sectional area of the intestine, the lumen value was subtracted from 
the overall area.  
 
We found there to be some problems using this method. Firstly, when the 
lumen was very narrow, it was virtually impossible to draw around it to 
measure the area accurately. Secondly, the fluorescent bacteria 
produced a strong signal in young worms but at older ages the 
fluorescence sometimes disappeared. Even if the bacteria were still 
fluorescing in these older worms, the red fluorescence from the intestinal 
cytoplasm was often of a similar brightness to the luminal fluorescence. 
This made it difficult to distinguish between the intestinal cytoplasm and 
lumen.  
 
Therefore I decided to adopt the method that had been developed by M. 
Ezcurra to get a score for the level of intestinal atrophy and lumen 
distension. At a point in the posterior intestine, the lumen, intestine and 
worm body diameter was measured. A lumen score was obtained using 
the following formula: (lumen diameter/body diameter) x 100. An intestine 
score was obtained using the following formula: ((intestine diameter – 
lumen diameter)/body diameter) x 100.  
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2.5.7 Yolky/lipid pools 
 
The yolky/lipid pool area within the body cavity and the total body cavity 
area in the field of view were both measured. A lipid/yolky pool score was 
obtained using the following formula: (yolk area/body area) x 100. 
 
2.5.8 Pharyngeal pathology 
 
Due to our heightened interest in pharyngeal pathology, we used a 
number of different methods to analyse the ageing pharynx.  
 
Qualitative scoring system 
Class 1 pharynxes have a smooth outline and the radial muscle lines are 
clearly visible. In class 2, the outline of the pharynx becomes uneven, the 
radial muscle lines are starting to fade and small cavities or blisters 
appear. By class 3 the pharynx starts to show clear signs of ageing. It will 
have one of the following features: bacterial accumulation in the lumen, 
complete loss of radial muscle lines, or large cavities or blisters. Class 4 
worms will show at least two of these features. Class 5 worms contain a 
posterior pharyngeal bulb that is barely recognisable or grossly swollen.  
 
Tracking pharyngeal size in individual worms 
11 – 15 worms were placed individually onto plates at the L4 stage. 
Worms were then imaged three times a week at x200 magnification until 
their death. As we wanted to track these worms into very old age, the 
worms had to be imaged in situ on agar plates without anaesthetic. This 
was because the trauma of being mounted onto an agar pad or being 
exposed to anaesthetic could easily cause the death of a fragile, old 
worm. Instead worms were immobilised by placing them on ice for around 
10-15 minutes until they stopped moving. A Nomarski image was taken of 
the pharynx and the area of the posterior bulb measured. A control set of 
worms was kept to ensure the imaging process did not have an effect on 
lifespan. 
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Necropsy analysis 
Corpses of worms from a survival assay were collected onto an 
unseeded NGM plate. They could then be examined for evidence of 
pharyngeal swelling using a Nikon SMZ645 microscope. If further 
analysis was required or measurements needed to be taken, corpses 
were mounted onto agar pads and high magnification Nomarski images 
collected.  
 
Bacterial load 
Extracted pharynxes from day 10 or 11 worms, which has been grown at 
20°C, were washed in M9 buffer and then pulverised until the entire 
tissue had broken apart. A serial dilution was performed and plated onto 
LB plates to allow the colony forming units to be counted.  
 
2.5.9 Tracking pathology in individual worms 
 
Marina Ezcurra developed the following method to obtain high 
magnification images of worms throughout their life span. Worms were 
placed onto individual NGM plates. At various time points, up until day 18 
at 20°C, the worms were prepared for Nomarski microscopy. Images of a 
range of tissues were collected. Each worm was mounted onto an agar 
pad, under a slightly raised cover slip, which was supported on each side 
by a stack of two cover slips. This was to prevent the coverslip crushing a 
fragile, elderly worm. A PE120 Peltier stage was set to 4°C before the 
slide was placed onto it. At this temperature worms were immobile, which 
made it easier to obtain higher quality images. To retrieve worms, M9 
was pipetted under the cover slip. The cover slip was then removed and 
the worm hooked out of the solution and returned to its NGM plate. A 
control set of worms was kept to ensure the imaging process did not have 
an effect on lifespan. 
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2.6 Measuring pharyngeal function 
 
2.6.1 Pharyngeal pumping rate 
 
Worms that were dwelling on the bacterial lawn were tracked with a Nikon 
SMZ645 microscope. The total pharyngeal pumps within 15 seconds 
were recorded using a clicker counter. This was then done twice more to 
obtain three values from which a mean was calculated. Pharyngeal 
pumps per minute was then determined. 
 
2.6.2 Serotonin assay 
 
Serotonin hydrochloride was dissolved in a solution of 0.1M HCl, to give a 
concentration of 250mg/ml serotonin. 100µl of this was then added 
topically to a NGM plate with an established bacterial lawn, to give a final 
concentration of 12mM serotonin. Control plates had 100µl of 0.1M HCl 
added topically to give a final concentration of 1mM HCl. The plates were 
allowed to dry overnight before worms were transferred onto them. 
Pharyngeal pumping rate was calculated as above and measured both in 
worms on the bacterial lawn and those residing away from it. 
 
2.7 Statistics 
 
To compare qualitative pathology scores (e.g gonad atrophy, uterine 
tumours, pharyngeal pathology), the non-parametric Wilcoxon-Mann-
Whitney test was used in JMP 11 and then corrected for multiple 
comparisons. 
 
For single comparisons, a two-tailed Student’s t test was performed using 
Microsoft Excel. If analysis required multiple comparisons the data was 
analysed in either JMP 11 or Graphpad Prism 6.  A one-way ANOVA was 
performed to analyse a single factor to determine if there were any 
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statistically significant differences in the data. If the ANOVA result was 
significant, a Tukey HSD was carried out to obtain the statistical 
comparisons between all the groups. For two factors a two-way ANOVA 
was used, followed by a Tukey HSD or Sidak’s test if the two-way 
ANOVA indicated a significant interaction.  
 
Significant correlations between pathology state on a certain day and 
eventual life span were obtained using linear regression in GraphPad 
Prism.  
 
Data from survival assays were analysed using the log-rank test in either 
JMP 11 or Graphpad Prism. To deconvolve lifespan graphs into P and p 
deaths, each was plotted by censoring the other form of death and the 
entire standard censors from the whole population. The same was done 
when calculating mortality rate, which was performed in GraphPad Prism. 
To determine if there was a significant slope change in mortality rate, two 
separate linear regressions were performed on data before and after day 
11. Graphpad Prism was then used to determine if there was a significant 
difference between these two slopes. 
 
2.8 Reagents 
 
Name Recipe (per 1 litre of reagent) 
Freezing medium  6.8g KH2PO4, 5.85g NaCl, 300ml 100% glycerol 
in total of 1L water. 
Autoclave to sterilise, then add 300µl of sterile 
1M MgSO4.  
IPTG plates 3g NaCl, 17g agar, 2.5g bactopeptone in total of 
1L of water. Autoclave to sterilise.  
Cool to approximately 55°C then add the 
following sterile solution: 25ml 1M KH2PO4, 1ml 
1M CaCl2, 1ml 1M MgSO4, 1ml 5mg/ml 
cholesterol (in 100% ethanol), 1ml 1M IPTG.  
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LB broth/plates 
 
 
+ antibiotics 
25g LB broth powder (Fisher Scientific)/17g agar 
in total of 1L water. Autoclave to sterilise.  
 
Cool to approximately 55°C then add 1ml 
50mg/ml ampicillin and/or 2ml 10mg/ml 
tetracycline. 
M9 buffer 5g NaCl, 7g Na2HPO4.2H2O, 3g KH2PO4, 0.25g 
MgSO4.7H2O in total of 1L water. Autoclave. 
NGM plates 3g NaCl, 17g agar, 2.5g bactopeptone in total of 
1L of water. Autoclave to sterilise.  
Cool to approximately 55°C then add the 
following sterile solutions: 25ml 1M KH2PO4, 1ml 
1M CaCl2, 1ml 1M MgSO4, 1ml 5mg/ml 
cholesterol (in 100% ethanol). 
OP50 broth 5g tryptone, 2.5g yeast extract in total of 1L 
water. Autoclave to sterilise. 
S basal 5.85g NaCl, 1g K2HPO4, 6g KH2PO4, 1ml 5mg/ml 
cholesterol (in 100% ethanol) in total of 1L water. 
Autoclave to sterilise. 
S medium 3ml 1M CaCl2, 3ml 1M MgSO4, 10ml 1M 
potassium citrate, 10ml trace metals solution in 
1L S basal. All solutions should be sterilised 
before mixing. 
Trace metals solution 0.69g FeSO4.7H2O, 0.2g MnCl2.4H2O, 0.26g 
ZnSO4.7H2O, 0.025g CuSO4.5H2O, 1.86g 
disodium EDTA in total of 1L water. Autoclave to 
sterilise. 
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Chapter 3 The development and impact of 
pathologies in the C. elegans germ line 
 
3.1 Part 1: Investigating the effect of C. elegans’ uterine tumours 
on mortality 
 
 
3.2 Introduction  
 
During the first 3-4 days of adulthood the C. elegans hermaphrodite can 
produce approximately 300 progeny through self-fertilisation. During this 
time healthy, viable oocytes develop and move down each proximal arm 
of the gonad and are fertilised in the spermatheca. Once all the sperm 
have been depleted unfertilised oocytes will continue to be expelled via 
the vulva for several more days, with reproduction still possible if 
additional sperm are supplied via mating. Eventually ovulation ceases 
and oocytes stack up along the proximal arm of the gonad (Jud et al. 
2007) before the gonad undergoes atrophy and disintegration (de la 
Guardia et al. 2016). Unfertilised oocytes that remain in either the uterus 
or distal to the spermatheca then start to degenerate; they can shrink 
(Luo et al. 2010) or become hypertrophic (de la Guardia et al. 2016) with 
cavities forming between cells (Luo et al. 2010). They also start to 
undergo nuclear endoreduplication (McGee et al. 2012) and eventually 
develop into large uterine tumours that contain large quantities of DNA 
(Golden et al. 2007) (Figure 3.1). Earlier studies have refrained from 
calling them tumours, preferring instead to describe them as clusters (Luo 
et al. 2010), masses (Golden et al. 2007) or growths (McGee et al. 2012). 
However we propose that calling them tumours is the most precise 
definition, where tumour refers to an accumulation of cells. Therefore I 
shall use the term tumour in regards to this pathology throughout this 
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thesis.  Note this is in contrast with mammalian tumours that occur due to 
cell proliferation rather than accumulation. 
 
The first appearance of these tumours coincides with the end of 
reproduction (day 4 at 20°C) and they ultimately develop in all ageing 
wild-type hermaphrodites. While the tumours are primarily made of 
polyploid oocytes there is also evidence they contain other components, 
including yolk (McGee et al. 2012), various secreted proteins 
(Zimmerman et al. 2015) and lipids within the oocytes (Wang et al. 2017, 
unpublished). 
 
 
 
Figure 3.1. Ageing of the C. elegans hermaphrodite reproductive system. In young 
worms, the gonad is healthy with oocytes being fertilized within the spermatheca. 
Fertilized oocytes go on to form eggs that are eventually expelled through the vulva. In 
older animals, the sperm supply is exhausted and unfertilized oocytes begin to stack up 
along the proximal arm. This means unfertilized oocytes start to undergo nuclear 
endoreduplication, with those within the uterus ultimately forming uterine tumours. 
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3.2.1 C. elegans uterine tumours as a model for mammalian 
tumours 
 
In mammals both malignant and benign tumours are major age-related 
pathologies, with cancer being a significant cause of late life mortality. C. 
elegans’ uterine tumours are quite different from malignant mammalian 
tumours. The latter are caused by mutations that result in uncontrolled 
cell proliferation, leading to the formation of a tumour. These tumours can 
eventually become metastatic, where cancerous cells spread throughout 
the body. In contrast, C. elegans’ tumours are formed by increases in 
size, apparently unrelated to mutations, and there is no evidence that 
they can invade other tissues. However they could be viewed as a good 
model for benign tumours. For example there are parallels to mammalian 
ovarian teratomas, which are usually benign and are also derived from 
unfertilised oocytes (Ulbright 2005). 
 
It is unclear whether the uterine tumours impair worm health. However 
their substantial size does result in compression of the intestine that 
might cause disruption to nutrient absorption and metabolism. 
Furthermore in the long-lived mutants daf-2 and sma-2 uterine tumours 
are suppressed (Luo et al. 2009; Luo et al. 2010), though in daf-2 
mutants the uterine tumours can develop later in life (McGee et al. 2012). 
This raises the possibility that uterine tumours could limit lifespan in wild-
type worms. Given the major impact tumours can have on late-life health 
in mammals, we set out to establish if uterine tumours contribute to 
mortality in C. elegans. 
 
3.2.2 Manipulating uterine tumour growth 
 
The mdl-1 gene in C. elegans encodes a protein homologous to 
mammalian MAD transcription factors (Yuan et al. 1998). In mammals, 
these act as growth inhibitors by antagonising the MYC transcription 
factors, which are often upregulated in cancerous tumours (Yuan 1998). 
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MAD acts as a tumour suppressor, competing with MYC to form 
heterodimers with the MAX transcription factors, which can then bind to 
DNA (Yuan et al. 1998). MYC/MAX heterodimers generally turn on gene 
expression and promote cell proliferation and growth. In contrast, 
MAD/MAX heterodimers generally turn off gene expression and are 
upregulated in terminally different cells (Yuan et al. 1998). C. elegans 
also has a homolog for MAX, which is encoded by mxl-1 and can form 
heterodimers with MDL-1. However the C. elegans genome does not 
possess any myc-like genes (Yuan et al. 1998; Riesen et al. 2014), 
perhaps because the somatic tissue is post-mitotic so there is no need for 
extensive control of cell proliferation. 
 
mdl-1 was identified as a potential direct target of DAF-16 (Schuster et al. 
2010), and this was then confirmed (Riesen et al. 2014). As DAF-16 is 
the transcription factor required for longevity in daf-2 mutants, this 
suggests that MDL-1 activity could promote daf-2 mutant longevity. In 
agreement with this hypothesis, mutation of mdl-1 decreased lifespan in 
both a wild-type and daf-2(m577) background (Riesen et al. 2014) and 
mdl-1 RNAi was able to reduce daf-2(mu150) lifespan (Murphy et al. 
2003). 
 
The mdl-1(tm311) C. elegans mutant contains a putative null deletion 
allele and is the strain we decided to use for our experiments. It does not 
have detectable abnormal somatic growth but shows abnormalities in 
germline proliferation (Riesen et al. 2014). It lays an increased number of 
unfertilised oocytes, referred to as the Uno-o (unfertilised oocyte 
overproducer) phenotype, and also has increased oocyte stacking in the 
proximal arm of the gonad (Riesen et al. 2014). As endoreduplicating, 
unfertilised oocytes that persist inside the uterus result in tumour 
development it was not surprising that mdl-1, with its increased oocyte 
production, also had accelerated tumour development (Riesen et al. 
2014). Interestingly, it has also been shown that MDL-1 can act 
downstream of DAF-16 in the germline. gld-1 mutants develop lethal, 
hyperproliferative germline tumours that are distinct from uterine tumours 
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(Francis et al. 1995). Knockdown of daf-2 can suppress these tumours, 
but mdl-1 RNAi in these worms causes an increase in germ cell number 
(Pinkston-Gosse & Kenyon 2007). Thus, MDL-1 can suppress growth of 
the germline and delay uterine tumour development in C. elegans.  
 
This all fits with a familiar pattern, that many genes that affect ageing also 
affect growth, in this case in the germline. Therefore we hypothesised 
that the mdl-1 mutant could be shortening lifespan by accelerating tumour 
development that causes mortality. We decided to test whether reduction 
or total inhibition of tumour development could increase lifespan in wild-
type or mdl-1 worms. We used 5-fluorodeoxyuridine (FUDR), an anti-
cancer drug used in humans, to see if it could block tumour development 
and extend lifespan. FUDR works by inhibiting DNA and RNA synthesis. 
FUDR is metabolised into FdUMP that can inhibit thymidylate synthase, 
an enzyme crucial for DNA synthesis (Bijnsdorp et al. 2007). Other FUDR 
metabolites can also become incorporated into DNA and RNA, impairing 
normal synthesis and function (Longley et al. 2003).  Therefore FUDR 
should be able to block endoreduplication in unfertilised oocytes and thus 
prevent tumour formation. Consistent with this, high doses of FUDR 
prevent both the development of DNA masses and the dramatic increase 
in genome copy number seen in ageing C. elegans (Golden et al. 2007). 
In regards to longevity, it has been reported that FUDR does not increase 
wild-type lifespan (Gandhi et al. 1980; Hosono 1978; Hosono et al. 1982; 
Van Raamsdonk & Hekimi 2011). However, it is not known whether the 
FUDR concentrations used were sufficient to block tumour formation. 
Moreover, one study did report an extension of lifespan at a high 
concentration of FUDR (400µM) (Angeli et al. 2013), which suggests that 
in certain conditions uterine tumours could be lethal. 
 
To study uterine tumour development we created a qualitative uterine 
pathology scoring system that ranked the status of the uterus from class 
1-5. Score 1-2 denotes no tumour while scores 3-5 indicate a tumour is 
present, with higher scores representing larger tumours (Figure 3.2). 
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Using this scoring system we set out to establish whether FUDR could 
inhibit tumour development and if so, whether it could also extend 
lifespan. Some of the data and discussion from this section were 
published in Riesen et al., 2014. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. The uterus pathology scoring system. All images were taken at x400 
magnification and are of wild-type worms. Class 1 denotes a healthy uterus, containing 
well-organised eggs. Class 2 denotes a mildly abnormal uterus, with unfertilised oocytes 
present. Classes 3 – 5 indicate that tumours have developed. Class 3 denotes small 
sized tumours and class 4 medium sized tumours. In class 5 the tumour has become so 
large it fills the mid-section of the worm. (Scale bar = 40µm). 
  
Class 1 Class 2 
Class 3 Class 4 
Class 5 
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3.3 Results 
 
3.3.1 Mating delays development of uterine tumours in wild-type 
hermaphrodites 
 
Hermaphrodites generate a finite amount of sperm during the L4 larval 
stage (L’Hernault 1997). We hypothesised that uterine tumour 
development is triggered by sperm depletion, which occurs around day 4 
of adulthood. Oocyte production then shifts from being a programme to a 
quasi-programme in the post-reproductive hermaphrodite. Unfertilised 
oocytes then accumulate in the uterus and undergo endoreduplication, 
resulting in uterine tumours. Mated hermaphrodites have additional 
sperm, allowing more oocytes to be fertilised (Ward & Carrel 1979). 
Therefore mating could delay uterine tumour growth in hermaphrodites. 
 
To test this hypothesis we placed individual L4 hermaphrodites on plates 
with three L4 males and allowed them to mate for several days. On day 4 
of adulthood, plates were screened for successful mating. Only 
hermaphrodites that produced approximately 50% male progeny were 
retained. These worms were transferred away from the males and kept in 
hermaphrodite-only groups for the remainder of the experiment. On day 
1, 4, 7, 11 and 14 Nomarski images of the uteri were taken and scored. 
These were then compared to the scores from unmated hermaphrodites. 
Mating caused a significant reduction in uterine tumour development on 
days 4 and 7 (Figure 3.3). However by day 11, tumour growth in mated 
worms had reached the same levels as in unmated worms. Presumably 
this reflects male sperm depletion. At this point unfertilised oocytes will 
start to accumulate in the uterus, eventually resulting in uterine tumours. 
There is also an apparent catch-up effect, with more rapid tumour growth 
between days 7 and 11 in mated hermaphrodites. This pattern was 
observed in both trials. Perhaps male sperm stimulates hermaphrodites 
to produce more oocytes. Thus, once male sperm is depleted, oocytes 
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accumulate more rapidly in the uterus, causing accelerated uterine 
tumour development.   
 
This demonstrates mating hermaphrodites in early life can delay the 
formation of uterine tumours, seemingly by allowing fertilization to 
continue for longer. However once sperm is depleted, subsequent tumour 
growth occurs more rapidly and reaches the same level as in unmated 
hermaphrodites. Additionally, mating is not a suitable intervention to see 
how tumour growth contributes to mortality for several reasons. Most 
importantly, mating hermaphrodites drastically reduces their lifespan (Shi 
& Murphy 2014; Gems & Riddle 1996). This could be because in mated 
hermaphrodites eggs often hatch within the mother, resulting in matricide. 
(Luo et al. 2009; Pickett & Kornfeld 2013). Mating also causes severe 
damage to the cuticle around the vulva, which could compromise its 
protection against the external environment (Woodruff et al. 2014). Finally 
it has also been shown that males release pheromones that shorten life 
span (Maures et al. 2014). What is needed is a means to reduce uterine 
tumour development, which does not reduce life span.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. The effect of mating on uterine tumour growth in C. elegans 
hermaphrodites. Hermaphrodites were exposed to males at 20°C from L4 until day 4 of 
adulthood. Mating delayed uterine tumour development until day 11. Data mean±s.e.m, 
combined from two trials.  (p<0.01 **, p<0.001*** Wilcoxon-Mann-Whitney test versus 
unmated hermaphrodites of the same age. n=20 per time point per condition). 
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3.3.2 FUDR can decrease uterine tumour size in wild-type and in 
the mdl-1 mutant 
 
We attempted to block tumour development using 5-fluorodeoxyuridine 
(FUDR), an inhibitor of DNA and RNA synthesis that is used in the 
treatment of colorectal cancers (Aitlhadj & Stürzenbaum 2010).  It has 
been used in work with C. elegans for many years to inhibit progeny 
production to make it easier to maintain synchronised populations of 
adults (Gandhi et al. 1980; Mitchell & Stiles 1979). When worms are 
placed onto FUDR at a young age it can cause developmental defects, 
such as a protruding vulva phenotype (Pvl) (Gandhi et al. 1980). If worms 
were not exposed to FUDR until L4 the majority do not develop Pvl and 
have a normal appearance. A previous study found that FUDR could 
inhibit the development of DNA masses found in uterine tumours (Golden 
et al. 2007). Therefore we decided to determine whether this drug could 
reduce overall uterine tumour growth in both wild-type and mdl-1 worms 
and whether this could cause an increase in lifespan.  
 
FUDR was added topically to NGM plates with an established E. coli lawn 
and left to diffuse into the plate overnight. Wild-type L4 worms were 
transferred to FUDR plates and maintained at 20°C for the rest of their 
lifespan. We selected the following range of FUDR concentrations to 
study initially: 10µM, 25µM and 50µM. On days 1, 4, 8 and 12 of 
adulthood Nomarski images of the uteri from 10 worms were collected 
and then scored (Figure 3.4). On day 4 some worms grown without 
FUDR had already started to develop small tumours. By day 8, worms 
grown on 10µM and 25µM were also starting to develop tumours, 
whereas tumour development was still blocked in worms on 50µM (Table 
3.1). By day 12 all worms grown without FUDR had large tumours but 
both 25µM and 50µM were able to significantly reduce tumour 
development, though 50µM was more effective than 25µM (p<0.001). 
Throughout the experiment 10µM FUDR did not have a significant impact 
on tumour development but the higher concentrations of FUDR were able 
to reduce tumour size in a dose-dependent manner. Therefore 50µM 
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FUDR was the most effective dose in this trial because it blocked the 
appearance of uterine tumours in 90% of day 12 worms, whereas 90% of 
worms on 25µM FUDR still developed tumours at that age.   
 
 
Figure 3.4. The effect of FUDR on tumour formation in wild-type C. elegans. Worms 
were placed on FUDR plates from L4 stage onwards and maintained at 20°C. FUDR 
decreases uterine tumour formation in a dose-dependent manner in wild-type worms. 
Data mean±s.e.m (p<0.01 **, p<0.001*** Wilcoxon-Mann-Whitney test versus 0µM 
FUDR of the same age. To adjust for multiple comparisons p<0.01 was considered to be 
significant. See table below for sample sizes.).  
 
Table 3.1. The distribution of uterine status scores in wild-type worms aged on 
various FUDR concentrations. Scores of 3 and above indicate the presence of a 
tumour 
 
Next we tested another range of FUDR concentrations, which included a 
higher dose, to see if this could completely eliminate tumour development 
in day 12 wild-type adults. We also decided to include mdl-1 in this trial to 
see if the same concentration of FUDR could reduce tumour development 
in both strains. FUDR plates and worms were prepared as described 
above. Nomarski images were gathered on days 1, 4, 8 and 12 of 
adulthood and images of the uteri then scored. The results for wild-type 
were similar to those of the previous experiment (Figure 3.5, Table 3.2A). 
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In this experiment we were not able to show that mdl-1 significantly 
increases the rate of uterine tumour development (Figure 3.6). It is 
possible that larger sample sizes or perhaps looking at a time point 
between day 4 and day 8 could have recreated the significant effect of 
mdl-1. For mdl-1, 25µM and 50µM FUDR were capable of significantly 
reducing uterine tumour development on day 8 (p<0.004 for both). 50µM 
was also more effective than 25µM at reducing tumour development 
consistently on day 12 (p<0.004) (Figure 3.5). 75µM was not significantly 
more effective than 50µM on any of the time points in either strain. In fact, 
on day 8, 50µM was more effective than 75µM in mdl-1 (p<0.004). 
However it should be noted that in mdl-1, 50% of worms still developed 
tumours by day 12 on 50µM FUDR. Though the majority of these tumours 
were small, 50µM FUDR was no longer able to significantly reduce 
tumour development in mdl-1 on day 12 (Table 3.2B, Figure 3.6). This 
implies the effect of FUDR may start to diminish in later life, allowing 
tumour growth to occur. This could be due either to the breakdown or 
metabolism of FUDR or because the tumours develop resistance to it.  
Finally on 50µM FUDR, there was no significant difference between wild-
type and mdl-1 on any of the days examined (Figure 3.6), meaning as 
well as tumour development being reduced, any differences in the rate of 
tumour development between the two genotypes had been removed. 
Thus, FUDR is an effective drug to block uterine tumour development in 
C. elegans, with 50µM being the minimum concentration in this study to 
get a major inhibition of tumour development in later life. 
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Figure 3.5. The effect of FUDR on tumour formation in wild-type and mdl-1(tm311) 
mutant C. elegans. Worms were placed on FUDR plates from L4 stage onwards and 
maintained at 20°C. FUDR decreases uterine tumour formation in both wild-type and 
mdl-1 worms. 50µM FUDR was the optimum dose for reducing tumour development in 
both strains. Data mean±s.e.m. (Day 12 data can be found in Riesen et al., 2014). 
(Wilcoxon-Mann-Whitney test. To adjust for multiple comparisons p<0.004 was 
considered to be significant. For sample sizes see table below). 
 
 
Table 3.2. Uterine status scores in wild-type and mdl-1(tm311) aged on various 
FUDR concentrations. (A) Wild-type (B) mdl-1(tm311). Scores of 3 and above indicate 
the presence of a tumour (Day 12 data can be found in Riesen et al., 2014). 
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Figure 3.6. The effect of 50µM FUDR on tumour formation in wild-type and mdl-
1(tm311). (A) Day 8 (B) Day 12. Each dot represents a single worm. Scores of 3 and 
above indicate the presence of a tumour. (p<0.004 **, p<0.001*** Wilcoxon-Mann-
Whitney test. To adjust for multiple comparisons p<0.004 was considered to be 
significant. For sample sizes see table 3.2). (Day 12 data can be found in Riesen et al., 
2014). 
 
3.3.3 Uterine tumours do not affect lifespan 
 
As described in the introduction to this section, the majority of published 
data shows FUDR does not affect lifespan even at relatively high 
concentrations (Hosono et al. 1982), suggesting uterine tumours are 
unlikely to limit life span in wild-type worms. However it remains possible 
that accelerated tumour development, as seen in the short-lived mdl-1 
mutant (Riesen et al. 2014), reduces lifespan.  
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To address this, we transferred wild-type and mdl-1 L4 stage worms onto 
50µM FUDR plates and recorded survival at 20°C. We found that mdl-1 
shortened lifespan, as previously shown at 25°C (Riesen et al. 2014). 
However in two trials, 50µM FUDR did not extend lifespan in either strain 
(Figure 3.7, Table A.1). It was possible that FUDR may not be able to 
inhibit tumour development in later life as we have shown uterine tumour 
development is suppressed on day 8 on 50µM FUDR in mdl-1 but not by 
day 12. As the mean lifespan of mdl-1, with or without FUDR was ~12 
days, its possible that tumour growth in both conditions could start to limit 
life (Table A.1). Nevertheless this demonstrates that uterine tumours do 
not limit lifespan under standard culture conditions in wild-type worms. 
Additionally, uterine tumours are unlikely to be limiting lifespan in mdl-1 
worms where their formation is accelerated. This implies uterine tumours 
do not contribute to age-related mortality in worms, at least under the 
conditions tested here. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. No effect on lifespan by 50µM FUDR in wild-type and mdl-1(tm311) C. 
elegans. Data from one representative trial. For survival statistics and sample sizes see 
Appendix table A.1. (Data can be found in Riesen et al., 2014). 
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3.3.4 Uterine tumours become infected with E. coli in aged C. 
elegans  
 
During the course of investigation of intestinal pathology, I serendipitously 
discovered a new element of the pathology of uterine tumours: their 
infection with bacteria. To study bacterial accumulation in the lumen of 
the C. elegans’ intestine by E. coli (Garigan et al. 2002) we used E. coli 
OP50 that contained a plasmid that expressed the red fluorescent protein 
DsRed (OP50-RFP) (kindly provided by J.F. Rawls, Duke University, 
originally from W. Bitter, Vrije University) (van der Sar et al. 2003). The 
plasmid also contained a gene for tetracycline resistance, thus bacteria 
had to be grown in the presence of antibiotics. However as our objective 
was to study bacterial pathogenicity, bacteria raised on tetracycline was 
then resuspended in broth containing no antibiotic. This was to ensure 
that when the bacteria were growing on NGM plates, their growth was not 
impeded by the presence of antibiotics.  
 
NGM plates inoculated with OP50-RFP were confirmed to be fluorescent 
before worms were transferred onto them. Worms for experiments were 
grown on OP50-RFP from egg. During pilot studies we noticed that the 
uterine tumours of aged worms often exhibited strong red fluorescence 
(Figure 3.8A). 45% of wild-type worms had red fluorescence in their 
tumours by day 9 when grown at 25°C (Figure 3.9A) and in some cases 
this fluorescence was seen throughout the entire tumour (Figure 3.8A). 
While weak red autofluorescence has been observed in the uterine 
tumours of aged worms grown on standard OP50 (Wang et al. 2017, 
unpublished), the red fluorescence we observed in worms grown on 
OP50-RFP was of a much higher intensity. This suggested that E. coli 
invades and proliferates within uterine tumours.  
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Figure 3.8. Invasion of the C. elegans uterus by E. coli OP50. (A) x100 brightfield 
and fluorescent images of day 9 wild-type and glp-4(bn2) worms grown at 25°C. Top: 
tumours in wild-type are outlined in white and emit red fluorescence. Bottom: in glp-
4(bn2) worms, the uterus emits red fluorescence (green arrow) and E. coli accumulation 
is seen in the anterior intestine (white arrow). (Scale bar 20µm). (B) x400 brightfield and 
fluorescent images of a day 14 wild-type worm grown at 20°C. The tumour is outlined in 
white with an area emitting red fluorescence and resembling densely packed is bacteria 
indicated (black arrow). (Scale bar 20µm). 
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We wanted to confirm that bacteria were actually present within the 
tumours. It was a possibility that RFP from digested OP50-RFP could be 
transported out of the intestine and become incorporated into the 
tumours. Brightfield and fluorescent images of the uterine tumours taken 
at high magnification were examined. This revealed that regions that 
exhibited strong red fluorescence also showed a grainy appearance 
resembling packed bacteria (Figure 3.8B). This provides further evidence 
that bacterial cells are the cause of the red fluorescence in the uterus.  
 
To see if bacterial proliferation was necessary for this apparent infection, 
we tested whether antibiotic treatment of OP50-RFP could protect the 
worms from uteri invasion. The antibiotic carbenicillin was added topically 
to NGM plates as previously described (Garigan et al. 2002). Worms 
were grown on OP50-RFP with or without carbenicillin from egg. Worms 
were grown to L4 at 15°C and then shifted to 25°C. Both a brightfield and 
a fluorescence image was taken of ~10 worms on days 1, 3, 6 and 9. 
Images were then scored for the presence of red fluorescence within the 
uterus. Our results show that the uteri of all wild-type worms on day 1 and 
3 remained un-invaded. On day 6 and 9 ~45% of control worms had red 
fluorescence in their tumours and this was completely suppressed by 
carbenicillin treatment (Figure 3.9A).  
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Figure 3.9. The effect of different conditions on bacterial invasion of the uterus in 
C. elegans. (A) Uteri invasion in wild-type and glp-4(bn2) worms, grown with and 
without the antibiotic carbenicillin at 25°C. (B) Uteri invasion in wild-type worms grown at 
20°C. (C) Cross-sectional uterine tumour area in day 9 wild-type worms, grown with and 
without the antibiotic carbenicillin at 25°C. (p<0.001*** Student’s t test versus control). 
(Sample sizes on graphs). 
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To confirm this invasion also occurred under more standard culture 
conditions and to see if there was any temperature dependence, I 
examined worms grown at 20°C. Worms were examined on days 1, 10, 
14 and 18 of adulthood. While red fluorescence was seen in the uteri of 
these worms, it developed at a much slower rate than at 25°C (Figure 
3.9B). For example by day 10 only ~12% of worms had invaded uteri 
compared to ~45% at 25°C on day 6. In fact, not until day 18 at 20°C did 
the fraction of worms with invaded uteri reach ~45%. These data show 
that development of this pathology is closely linked to temperature. This 
could be because at higher temperatures the bacteria are able to 
proliferate faster and thus colonise the uterus more rapidly. On the other 
hand, it has been shown that worms grown at higher temperatures age 
faster and have a shorter life span (Klass 1977). Potentially the 
mechanisms that protect young worms from bacterial invasion of the 
uterus could undergo age-related deterioration faster at 25°C, resulting in 
more rapid bacterial infection. 
 
I tested whether the presence of tumours was necessary for uterine 
infection. We used glp-4 worms which do not develop tumours at 25°C 
(Riesen et al. 2014). If glp-4 worms are raised from egg at 25°C they are 
long lived (Riesen et al. 2014). Therefore we raised worms on OP50-RFP 
with or without carbenicillin at 15°C and then switched them to 25°C at L4 
because glp-4 worms raised in these conditions do not develop tumours 
but are not long lived (McElwee et al. 2004). This was because we 
wanted to ensure we were only examining how the absence of tumours 
affected this apparent infection; long lived glp-4 could have longevity 
mechanisms activated that protect them from bacterial invasion, factors 
that are independent of the inhibition of tumour development. On day 6 
and 9 a proportion of both wild-type and glp-4 worms had red fluorescent 
uteri and this was largely prevented by carbenicillin treatment (Figure 
3.9A). However 10% of glp-4 worms on plates with carbenicillin also 
started to show uterine red fluorescence by day 9. This could be because 
as glp-4 worms are sterile they were not transferred as frequently as wild-
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type. Therefore as they remained on the same carbenicillin plates for 
longer it is possible the carbenicillin had started to degrade, allowing 
some bacterial proliferation to occur. 
 
Finally I explored whether bacterial growth within uterine tumours 
contributes to their growth. Tumour size was measured in aged wild-type 
worms grown with or without carbenicillin present. Tumour area was 
measured instead of using the uterine scoring system so that more subtle 
differences in tumour size could be detected. This was because it was 
anticipated that bacterial growth might have a relatively minor effect on 
uterine tumour size. Wild-type worms grown on carbenicillin did show a 
significant reduction in tumour size, with a decrease of ~27% (Figure 
3.9C), suggesting that bacterial infection does indeed contribute to 
tumour growth. Subsequent work showed that antibiotics slow 
development of a wide range of senescent pathologies (Ezcurra, 
unpublished). Therefore it is unclear if this protection against tumour 
growth is due to an inhibition of bacterial proliferation within the tumours 
or whether it is the result of a general protection against a range of 
pathologies. 
 
These results show that proliferating E. coli is capable of invading both 
the uteri and tumours of aged worms. It is likely that E. coli first invades 
through the vulva of old worms, as this is the nearest opening to the 
external environment. In support of this, we often saw red fluorescence in 
worms only in the area just within the vulva (Figure 3.10). Furthermore 
there is evidence that the vulva undergoes an age-related decline (Leiser 
et al. 2016; Pickett & Kornfeld 2013), which could result in it no longer 
being an effective barrier to the external environment. 
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Figure 3.10. Initial invasion of E. coli into the uterus near the vulva. Representative 
x400 brightfield and fluorescent images of a day 18 wild-type worm grown at 20°C with 
uterine tumours outlined in white. Red fluorescence is strongest near the vulva (white 
arrow). Fluorescence intensity decreases with distance from the vulva. (Scale bar 
20µm).  
 
Uterine tumours present a rich source of nutrients for bacterial 
proliferation. Unfertilised oocytes take up yolk during their development. 
Vitellogenins are the protein portion of yolk and when VIT-2 is tagged with 
GFP, strong green fluorescence is seen within the tumours (Wang et al. 
2017, unpublished). Tumours are also lipid rich, perhaps reflecting 
deposition of yolk lipid (Wang et al. 2017, unpublished). Thus uterine 
tumours appear to be full of yolk, which likely provides a rich food source 
for E. coli. 
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3.4 Discussion 
 
3.4.1 Uterine tumours are not a life-limiting pathology in C. elegans 
 
We have shown in this study that the anti-cancer drug FUDR can 
suppress uterine tumour development in C. elegans in both wild-type, and 
mdl-1 mutants where their development is accelerated. FUDR worked in 
a dose-dependent manner in both cases up to 50µM, which was sufficient 
to largely prevent tumour growth in both wild-type and mdl-1. However 
this concentration did not extend lifespan in either genotype. It remains 
possible that 50µM FUDR is mildly toxic to the worms; in one trial it did 
slightly reduce wild-type lifespan (Table A.1). Such toxicity could cause a 
reduction in life span that masks the beneficial effects of tumour 
suppression. However given that it is widely reported FUDR has no effect 
on wild-type lifespan (Gandhi et al. 1980; Hosono 1978; Hosono et al. 
1982; Van Raamsdonk & Hekimi 2011), even at higher doses than we 
tested here, it seems unlikely that 50µM FUDR is life-shorteningly toxic. 
Furthermore as FUDR primarily works through blocking DNA synthesis, 
the post-mitotic somatic cells of C. elegans should be largely unaffected 
by FUDR, with the drug exerting most of its influence on the mitotic germ 
line. However FUDR can also disrupt RNA synthesis (Longley et al. 2003) 
so it remains possible it could impede transcription in somatic tissue 
resulting in a toxic effect.  
 
However our data is consistent with other studies that show that removal 
of uterine tumours do not have an affect on life span. The temperature 
sensitive mutant glp-4(bn2) is sterile at 25°C because germ cell 
proliferation is blocked and thus it does not produce any oocytes. When it 
is grown until L4 at 15°C and then switched to 25°C it still becomes a 
sterile adult (Beanan & Strome 1992) but its lifespan remains similar to 
wild-type (McElwee et al. 2004). Furthermore it was shown that this 
temperature shift was sufficient to totally block uterine tumour formation in 
glp-4, in both a wild-type and mdl-1 background (Riesen et al. 2014). 
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Despite this tumour suppression, glp-4; mdl-1 mutants raised until L4 at 
15°C and then switched to 25°C still had a lifespan that was much the 
same as mdl-1 (Riesen et al. 2014). Furthermore removing the whole 
gonad via laser ablation, which should completely prevent uterine 
tumours from forming, did not increase lifespan in wild-type worms (Hsin 
& Kenyon 1999).  This demonstrates that in C. elegans, uterine tumours 
are not a life-limiting pathology, even when their growth is accelerated, as 
in mdl-1 mutants.  
 
Uterine tumours develop in all ageing wild-type hermaphrodites. Yet 
surprisingly in the conditions we tested, we have demonstrated they are a 
bystander pathology and do not limit lifespan, much like skin wrinkling 
and greying hair in humans. Given that they are not lethal to worms, 
further study of them could be seen as unnecessary. However tumours, 
particularly cancerous ones, are major causes of death during ageing in 
humans. Therefore by understanding the origins of senescent tumours in 
C. elegans, new insights may be gained into the development of 
cancerous tumours in humans, paving the way for future treatments.  
 
Even if they are not lethal in C. elegans, it remains unclear how they 
affect worm health, something that is harder to measure than changes to 
life span but could be considered more important. They are a gross, 
abnormal pathology so it seems unlikely they are not detrimental in some 
way to worm health. It remains possible in conditions that we have not yet 
studied that tumours are life-limiting. For example, removal of only the 
germline via laser ablation caused an increase in wild-type lifespan (Hsin 
& Kenyon 1999). It is also still uncertain what long-lived daf-2 mutants die 
of. They also develop uterine tumours as they age (M. Ezcurra, 
unpublished) and removal of either the whole gonad or just the germline 
via laser ablation in daf-2(e1370) mutants caused further increases to 
lifespan (Hsin & Kenyon 1999). This raises the possibility that uterine 
tumours may be a life-limiting pathology in daf-2 mutants and in wild-type 
grown in certain conditions. If yes, then 50µM FUDR should increase daf-
2 mutant lifespan. 
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In this study we have shown that conditions predicted to block 
endoreduplication in unfertilised oocytes in the uterus reduced tumour 
growth. Yet it is possible that the endoreduplication in oocytes is not the 
only cause of uterine tumour growth. The tumours also incorporate 
various other components, including yolk (McGee et al. 2012), which is 
secreted from the intestine, and other proteins such as ULE-2,-3,-4,-5, 
which are secreted from the toroidal cells of the uterus (Zimmerman et al. 
2015). Interestingly RNAi of vitellogenins, the protein portion of yolk, 
extends lifespan (Murphy et al. 2003). Furthermore RNAi of ule-2,-3,-4,-5 
simultaneously also increases lifespan (Zimmerman et al. 2015). This 
shows that these proteins are detrimental to life span. One possibility is 
that uterine tumours do actually shorten life, but it is the yolk or ULE 
proteins in them that cause this; hence suppressing tumour growth does 
not extend lifespan.   
 
In the case of males, uterine tumours clearly do no limit life, since males 
do not develop them, nor any other form of germline tumour (Golden et 
al. 2007). Therefore everything studied in this section is sex-specific in 
regards to the hermaphrodite. What C. elegans males die from is also still 
unknown. 
 
3.4.2 Uterine tumours of aged worms become infected with E. coli 
 
In approximately half of aged, wild-type C. elegans grown on E. coli 
expressing RFP, red fluorescence was seen within the uterine tumours. 
Possibly RFP from E. coli in the lumen of the gut is somehow transported 
out of the intestine and incorporated into the uterine tumours. However 
this seems unlikely as antibiotic treatment prevented this tumour 
fluorescence, despite fluorescent bacteria still being observed in the 
intestine of these worms. This suggests bacteria are present in the 
uterine tumours and that bacterial proliferation needs to take place for this 
invasion to occur. Transmission electron microscopy (TEM) of red 
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fluorescent tumours would confirm unequivocally that there are bacteria 
present. 
 
The red fluorescence in the tumours was often brightest near the vulva 
and becomes weaker more distally in the tumour (Figure 3.10). Given the 
vulva is an opening into the external environment, this suggests that 
bacteria invade through the vulva. In support of this, bacteria were 
observed in the uterus of elderly worms near the vulva using TEM 
(McGee et al. 2011). Presumably in younger worms, where no bacteria 
are seen within the uterus, the vulva acts as an effective barrier, but 
some worms lose this ability during ageing. One study defined a 
phenotype called Avid (age-associated vulva integrity defects), where the 
intestine protrudes out of the vulva (Leiser et al. 2016). This condition 
primarily starts to occur during middle age, which is when bacterial 
invasion of the uterus is observed. Additionally, it has been shown that 
the vulval muscles in aged worms no longer respond robustly to 
serotonin, which would normally make them contract (Pickett & Kornfeld 
2013). This is thought to be due to a loss of vulval muscle integrity. One 
way to test whether a defective vulva is the route of bacterial invasion 
would be to mate hermaphrodites. Mating damages the vulva (Woodruff 
et al. 2014) and should therefore increase the percentage of infected uteri 
or at least cause earlier appearance of infection. Using sterile males 
would be ideal as additional egg laying may force invading E. coli out of 
the vulva. On the other hand, in young worms bacterial invasion could be 
prevented by an immune response within the uterus. In aged worms this 
response could undergo decline and may no longer be able to inhibit 
bacterial growth. 
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Figure 3.11. Progression of bacterial infection of uterine tumours. Unfertilised 
oocytes accumulate in the uterus and take up yolk from the body cavity. 
Endoreduplication in the oocytes drives the formation of uterine tumours, which are rich 
in yolk. During ageing the vulva weakens and is no longer an effective barrier against 
the external environment. This allows bacteria to invade into the uterine tumours. A 
possibility is that the bacteria are nourished by yolk, allowing them to proliferate 
throughout the tumours. E. coli proliferation within tumours may cause them to increase 
in size. 
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Presumably once bacteria have entered the uterus they can utilise 
nutrients within the tumour to proliferate and colonise the tumours (Figure 
3.11). Yolk in particular would provide a rich source of nourishment for 
the bacteria. It is possible that bulk growth of E. coli within tumours 
increases tumour size. This would require bacterial biomass to 
accommodate more space than the yolk biomass it metabolised. As yolk 
is an energy rich storage material, this is plausible. Therefore E. coli 
proliferation should increase tumour size. However it is unclear whether 
this is actually the case. To attempt to answer this question, I compared 
the size of tumours with and without red fluorescence. While I did not see 
a difference in size (data not shown), this trial had a small sample size 
and did not differentiate between levels of infection. Antibiotic treatment 
prevented uterus invasion and reduced tumour size by around a quarter 
(Figure 3.9A,C). Furthermore axenic culture conditions, where worms are 
grown without any bacteria present, also reduced uterine tumour growth 
(McGee et al. 2012). This suggests bacteria could contribute to tumour 
growth. However both conditions extend life span and this could reflect in 
an overall reduction in pathology development in several tissues. In 
addition, axenic conditions also cause a general slowing of growth that 
could affect uterine tumours (Szewczyk et al. 2003). Nevertheless it 
remains possible bacterial proliferation within uterine tumours does 
contribute to their growth. 
 
In humans the relationship between bacteria and cancer progression has 
been studied for decades. In some instances, bacteria appear to initiate 
or drive malignant alterations. For example, colorectal cancer is often 
associated with an abundance of Streptococcous bovis/gallolyticus and 
Fusobacterium sp, which are thought to trigger and drive cancer 
progression by causing persistent inflammation (Cummins & Tangney 
2013; Kostic et al. 2012).  As in C. elegans, the initial infection of tumours 
is sometimes thought to be opportunistic, as the anaerobic conditions and 
excess nutrients within tumours provide an optimum environment for the 
growth of certain bacteria (Cummins & Tangney 2013). Interestingly, 
bacterial infection of tumours is not necessarily detrimental to the host. 
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Post-operative infection in lung cancer actually improved patient survival 
(Ruckdeschel et al. 1972), perhaps because bacteria compete for 
nutrients, secrete toxic proteins or help to initiate immune responses 
against tumour cells. Given that certain bacterial species have an affinity 
for particular cancers (Cummins & Tangney 2013), genetically 
engineered bacteria are now being created as future anti-cancer 
therapies (Baban et al. 2010).  These bacteria can either secrete tumour-
suppressor proteins or act as vectors to deliver therapeutic genes via 
plasmids to cancerous cells (Baban et al. 2010). As C. elegans tumours 
have now been shown to be susceptible to bacterial invasion, they could 
be used as a model to study this pathology or to test new bacteria-based 
anti-cancer therapies. However caution should be adopted, as C. elegans 
tumours are fundamentally different from mammalian tumours. For 
example they are the result of cell accumulation rather than proliferation 
and there is no metastasis or angiogenesis. In addition we are unaware 
whether C. elegans tumours are hypoxic like many mammalian tumours. 
Thus further investigation of the composition and environment of C. 
elegans tumours is required before they can be used as model for 
bacterial invasion of mammalian tumours.  
3.4.3 C. elegans as a model for benign mammalian tumours 
 
The ability of somatic cells to undergo mitotic division is a major 
evolutionary advantage in youth as it allows for tissues to be renewed or 
repaired. However a disadvantage is that an organism becomes more 
vulnerable to developing cancer in later life. Malignant tumours often 
have a number of the following characteristics: loss of cell cycle control; 
apoptosis resistance; invasion of nearby tissue; activation of 
angiogenesis and metastasis. All of these attributes mean these tumours 
can significantly disrupt normal tissue function. While it is still uncertain 
exactly why we become more susceptible to cancer as we become older, 
there is no doubt cancer is a major cause of death in the elderly. This 
means there is a huge amount of research focused on developing cancer 
treatments and cures, leading to the need for suitable model organisms. 
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In adult C. elegans all somatic cells are post-mitotic and are therefore 
incapable of dividing. Consequently, C. elegans does not appear to be a 
viable cancer model. However the germline does undergo division during 
adulthood. Germ cells at the distal end of the gonad undergo mitosis, 
before eventually undergoing meiosis as they move towards the proximal 
end. Therefore while the somatic tissue in C. elegans may not be a good 
model for the study of tumour development, the germline potentially is 
(Kyriakakis et al. 2016).  
 
 
Figure 3.12. Germline tumours in C. elegans hermaphrodites. (A) Healthy gonad in 
a day 1 wild-type hermaphrodite. Oocytes develop along the entire proximal arm until 
they are fertilized in the spermatheca (spth). (Scale bar 20µM) (B) gld-1(q268) 
hermaphrodite with a germline tumour. Oocytes are not seen in the proximal arm, 
instead it fills entirely with mitotic germ cells (Francis et al. 1995). (Scale bar 10µM) (C) 
Wild-type hermaphrodite where certain cells of the somatic gonad were removed using 
laser ablation. This results in the formation of a proximal tumour (Pro) (Seydoux et al. 
1990). (Scale bar 20µM). 
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There have been several studies detailing the generation of germline 
tumours in C. elegans. In certain gld-1 mutants, germ cells exit meiosis 
and re-enter mitosis, resulting in a huge accumulation of germ cells 
(Francis et al. 1995). This generates a large tumour within the gonad 
(Figure 3.12B). The sheer volume of cells can result in cells bursting 
through the spermatheca and into the uterus. The increasing pressure 
can eventually cause protrusion of the vulva, which correlates with death. 
daf-2 mutation reduced germ cell number and increased lifespan in a gld-
1 mutant background, suggesting these tumours may be lethal (Pinkston 
et al. 2006). In another study, the proximal gonad sheath was shown to 
be a latent tumour niche, as under normal circumstances it is not a niche 
but is capable of becoming one when it interacts with cells it would not 
usually come into contact with. In this case when mitotic germ cells 
interact with the proximal sheath, proximal tumours form in the gonad 
resulting in a Pro phenotype (McGovern et al. 2009). The Pro phenotype 
has also been observed in lin-12 mutants and in wild-type 
hermaphrodites when certain cells in the somatic gonad were removed by 
laser ablation (Seydoux et al. 1990) (Figure 3.12C).  These are some 
examples of studies that have been able to generate tumours in the C. 
elegans germline. Their formation was driven by mutation, much like the 
majority of malignant mammalian tumours, or by changes to morphology 
allowing improper cell interactions. Furthermore like mammalian tumours 
their growth is impelled by cell proliferation.  
  
The uterine tumours we have focused on in this study directly correlate 
with the ageing process and form in all aged, wild-type hermaphrodites. 
Moreover they do not appear to be initiated by mutational changes nor is 
their growth due to cell division. Rather their expansion is caused by 
unfertilized oocytes entering the uterus and undergoing 
endoreduplication. In many ways these uterine tumours are different to 
most types of mammalian tumours: their growth is not due to cell 
proliferation; there is no evidence they invade nearby tissues and they 
cannot metastasise. Nevertheless these uterine tumours do seem 
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capable of affecting the activity of other tissues. For example, they can 
grow so large that they fill the entire body cavity of the worm, completely 
compressing the midsection of the intestine and potentially disrupting its 
function. This means uterine tumours more closely resemble benign 
tumours in humans. Firstly benign tumours do not invade nearby tissues, 
nor do they metastasise. Secondly like uterine tumours, large benign 
tumours can have a mass effect on nearby tissues. This is a term used to 
describe a tumour that squashes or moves nearby tissue to such an 
extent that the tissue’s normal function is disrupted. Ovarian teratomas 
are benign tumours that develop in pre-menopausal women and 
potentially bear a striking resemblance to C. elegans’ uterine tumours, 
particularly in that they are both derived from unfertilised, immature 
oocytes and both express genes usually associated with later embryonic 
growth (Wang et al. 2017, unpublished). This comparison will be explored 
in more detail in an upcoming publication from David Gems’ group. 
 
While C. elegans does not initially seem to be the most suitable cancer 
model, the convenience of maintaining worm populations makes them 
appealing to work with. They would be particular useful for drug screens. 
In this study we have demonstrated C. elegans’ suitability for this 
because the cancer drug, FUDR, used to treat human tumours also 
reduces growth of C. elegans’ uterine tumours. A major advantage of C. 
elegans is the ability to see tumour growth easily in vivo because the 
worms are transparent. We propose C. elegans’ uterine tumours to be a 
useful model for some types of benign tumours found in humans, 
particularly those associated with ageing but not mutation accumulation. 
However the main goal of this project was to identify life-limiting 
pathology in wild-type C. elegans and we have shown uterine tumours 
are not associated with age-related mortality. Therefore we must now turn 
out attention to another organ in the worm that seems to be a likely 
source of a lethal pathology: the intestine.  
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3.5 Part 2: Altering apoptosis levels changes the rate of gonad 
disintegration in C. elegans hermaphrodites 
 
3.6 Introduction to the structure of the C. elegans gonad 
 
A focus of our group is to identify age-related pathologies in C. elegans 
and to determine whether they are the result of developmental run-on. 
Yila de la Guardia began studying a previously observed age-related 
phenomenon in the germline, the disintegration of the gonad (Hughes et 
al. 2011; Luo et al. 2010; Garigan et al. 2002). She analysed this 
pathology quantitatively during ageing and set out to determine whether it 
could be caused by a quasi-programme. Due to my previous interest in 
studying how developmental run-on could lead to uterine tumours in the 
germline, I decided to collaborate with her in this endeavour.  
 
The C. elegans hermaphrodite gonad is made of two arched gonad arms, 
which converge on a central uterus (Figure 3.13A). During the L4 larval 
stage it generates sperm, which are stored in the spermatheca, but then 
shifts to making oocytes during adulthood. At the distal end of each arm 
is a distal tip cell (DTC), which preserves a stem cell population within the 
nearby germ cells (Lints & Hall 2009d). This means the distal end of the 
gonad contains proliferative germ cells and is known as the mitotic zone. 
As germ cells progress along the gonad, away from the influence of the 
DTC, they begin meiosis in the transition zone. They enter the pachytene 
stage, which continues around the bend of the gonad arm (Hirsch et al. 
1976). During this stage the germ cells start to grow in volume. Within the 
distal arm, germ cells form a syncytium, where cells are not completely 
enclosed. Instead, a central cytoplasmic cylinder called a rachis connects 
them (Hirsch et al. 1976). Along the proximal arm, gametogenesis occurs 
and oocytes are formed. Oocytes progress along the proximal arm, 
continuing to grow in size and advance into diakinesis (Hirsch et al. 
1976). They arrest in this state until they are ovulated into the 
spermatheca and fertilised.  
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Unlike the hermaphrodite, the male gonad consists of only one gonad 
arm that exclusively creates spermatids (Figure 3.13B). Similar to the 
hermaphrodite, the distal end is a mitotic zone and all germ cells are 
connected via a rachis. Germ cells enter meiosis in the transition zone 
before reaching the pachytene stage. In males, the pachytene stage 
continues around the loop of the gonad and along the proximal arm. 
Further down, spermatogenesis takes place and spermatids are formed, 
which accumulate within the somatic gonad to await ejaculation (Lints & 
Hall 2009b). 
 
Figure 3.13. The structure of the C. elegans’ gonad. (A) The hermaphrodite gonad 
(Lints & Hall 2009d). Germ cells proliferate in the mitotic zone (MZ), progress into 
meiosis in the transition zone (TZ) and then into pachytene (Pyt). They then form 
oocytes and arrest in diakinesis (DK) until fertilization in the spermatheca (Sp). (B) The 
male gonad (Lints & Hall 2009b). Germ cells proliferate in the mitotic zone (MZ), 
progress into meiosis in the transition zone (TZ) and then into pachytene (Pyt). 
Spermatogenesis then occurs and spermatids are formed. Distal arm (DG), proximal 
arm (PG), distal tip cell (DTC). 
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3.6.1 Apoptosis in C. elegans germline 
 
During normal development in C. elegans, 131 of the somatic cells 
undergo programmed cell death via apoptosis (Sulston & Horvitz 1977). 
In adulthood, the somatic tissue is post-mitotic and no apoptosis occurs. 
However in the hermaphrodite germline, the only proliferative tissue in the 
adult, apoptosis does take place and occurs primarily in cells that are 
about to exit the pachytene region of the gonad (Gumienny et al. 1999; 
Gartner et al. 2000). Apoptotic cells are then quickly removed from the 
germline by the cells of the gonad sheath (Gumienny et al. 1999).  
 
Two main forms of apoptosis can occur in the germline. The first form is 
known as stress-induced apoptosis (SIA) and happens as a reaction to 
DNA damage or environmental stresses such as UV exposure (Gartner et 
al. 2000). This allows for the removal of germ cells that may have 
accumulated harmful mutations that could be detrimental to the next 
generation. The second form is called physiological apoptosis (PA) and 
involves apparently healthy, viable germ cells undergoing apoptosis, 
despite the lack of any obvious external stresses (Gumienny et al. 1999). 
Therefore PA appears to function as a necessary programme for normal 
development within the germline. 
 
Physiological apoptosis in the somatic tissue occurs via a tightly 
controlled apparatus. The core pathway contains CED-4 (cell death 
abnormal), the homologue of Apaf-1 (apoptotic peptidase activator 1) 
found in humans (Zou et al. 1997), and CED-3, the homologue of 
mammalian interleukin-1β- converting enzyme/caspase-1 that produces a 
cytokine (Yuan et al. 1993). CED-4 cleaves and activates CED-3, 
resulting in programmed cell death via apoptosis (Metzstein et al. 1998). 
CED-3 and CED-4 are essential for apoptosis because loss of them 
blocks apoptosis completely (Ellis & Horvitz 1986). CED-9, a homologue 
of the Bcl-2 protein that inhibits apoptosis in humans (Hengartner & 
Horvitz 1994a), operates in cells that are to be protected from apoptosis. 
It does this by binding to CED-4 and inactivating it (Chinnaiyan et al. 
 105 
1997). The EGL-1 (egg-laying defective) protein possesses a region 
analogous to the BH3 domain (Bcl-2 homology region 3) that is found in 
mammalian Bcl-2 proteins that are activators of apoptosis (Condradt & 
Horivitz 1998). EGL-1 binds to CED-9 and sequesters it (Condradt & 
Horivitz 1998), allowing CED-4 to be free to initiate apoptosis.  
 
Germline apoptosis is also dependent on the activity of CED-3 and CED-
4, though in SIA and PA they are induced via different mechanisms. SIA 
can be initiated by CEP-1, a homolog to mammalian p53 that prevents 
tumour formation via apoptosis (Schumacher et al. 2001). CEP-1 acts in 
response to DNA damage to activate EGL-1 or CED-13 (Hofmann et al. 
2002; Schumacher et al. 2005), which act upon CED-9 to allow apoptosis 
to be triggered (Gartner et al. 2000). In contrast, PA is cep-1 independent 
(Schumacher et al. 2001); EGL-1 is not required for it to take place and 
over-activation of CED-9 does not prevent it (Gumienny et al. 1999). The 
upstream activators of PA continue to be a mystery (Figure 3.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14. The apoptotic pathway in C. elegans. In stress-induced apoptosis, CEP-
1 activates EGL-1 or CED-13 to inhibit CED-9. This allows CED-4 to activate CED-3 to 
initiate apoptosis. In physiological apoptosis, CED-4 and CED-4 are also required but 
the upstream activators are unknown. Mammalian homologs are in red. 
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Apoptosis of the germline is a hermaphrodite specific event. PA was 
never observed in the wild-type male germline (Gumienny et al. 1999). 
Even in the presence of stress, germ cells in wild-type males did not 
undergo SIA (Gartner et al. 2000). 
 
3.6.2 The role of apoptosis in the germline of the C. elegans 
hermaphrodite 
 
It was originally estimated that the destiny of approximately half of all 
germ cells in the hermaphrodite germline was to undergo apoptosis 
(Gumienny et al. 1999). A more recent study estimates this proportion to 
actually be greater than 90% (Jaramillo-Lambert et al. 2007). It is feasible 
these germ cells are removed because they have accumulated 
deleterious mutations. However it seems highly unlikely that this would be 
the case in such a high proportion of cells. In support of this, germs cells 
that would usually undergo apoptosis can develop into viable eggs, as 
seen in ced-3 and ced-4 mutants where apoptosis is blocked (Ellis & 
Horvitz 1986). Furthermore study of germ cells using electron microscopy 
did not reveal a substantial proportion to appear defective (Gumienny et 
al. 1999). Therefore an alternative theory about the purpose of PA has 
been proposed. It suggests PA contributes to reproductive fitness by 
sacrificing germ cells to act as nurse cells (Gumienny et al. 1999). In 
mammals, nurse cells provide growing oocytes with all the nutrients 
needed to form viable embryos upon fertilization. C. elegans do not have 
separate nurse cells, instead the nurse cell theory suggests other germ 
cells substitute for this role by undergoing apoptosis and donating their 
cytoplasm to the rachis. The rachis then uses this surplus cytoplasm to 
grow developing oocytes. In support of this idea, mature oocytes are very 
much larger than germ cells (Figure 3.13A). Oocytes will then be primed 
to form healthy embryos once they have been fertilised.  
 
There is a large amount of evidence to support the nurse cell theory. For 
example, PA and oogenesis appear to be tightly linked. Germline 
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apoptosis occurs exclusively during hermaphrodite adulthood only once 
oogenesis has begun and is not seen during the larval stages (Gumienny 
et al. 1999). Germline apoptosis is also not seen in males (Gumienny et 
al. 1999). Presumably this is because there is no adaptive value for this 
to occur, as sperm are small and only require sufficient nutrients to 
complete fertilisation. The location of germline apoptosis, at the end of 
the pachytene region of the gonad, is also the location where germ cells 
start to swell (Gumienny et al. 1999). When apoptotic germ cells are 
removed from the syncytium by cells of the gonad sheath, the majority of 
their cytoplasm remains in the rachis (Gumienny et al. 1999). 
Cytoplasmic particles were also seen to flow along the rachis towards 
developing oocytes, presumably to provide them with a continuous supply 
of cytoplasm (Wolke et al. 2007). If the nurse cell theory were correct, this 
would mean PA is a programmed mechanism in young adulthood that 
improves the reproductive fitness of the C. elegans hermaphrodite. 
 
3.6.3 Degeneration of the C. elegans gonad due to apoptotic run-on 
 
The hermaphrodite gonad has been previously observed to undergo 
major degeneration during ageing, with the gonad shrivelling and 
eventually disintegrating (Garigan et al. 2002; Luo et al. 2010; Hughes et 
al. 2011). Work from de la Guardia explored the pattern of gonad 
degeneration in more detail (de la Guardia et al. 2016). A qualitative 
scoring system was created, inspired by a similar approach in a previous 
study (Garigan et al. 2002). Score 1 is a healthy gonad in a young adult 
while scores 2 and 3 indicate minor and major degeneration respectively. 
A score of 4 or above means disintegration has occurred (Figure 3.15). 
The purpose of this scoring system was to allow for the comparison of the 
dynamics of gonad pathology with those of other pathologies. It would 
also allow us to quantify the effects of various interventions on gonad 
pathology. The scoring system revealed that virtually all wild-type, 
hermaphrodite gonads disintegrated by day 12 (Figure 3.16A) (de la 
Guardia et al. 2016). I also showed that gonad disintegration continues 
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up until day 11, with no further increases seen after this age (Figure 
3.16B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15. The C. elegans gonad scoring system. All images were taken at x400 
magnification and are of wild-type hermaphrodites. Class 1 is a healthy gonad, where 
the distal gonad (DG) and proximal gonad (PG) fill the body cavity (Day 1, 25°C). Class 
2 is where gonad degeneration begins and slight shrinkage is seen (black arrow) (day 6, 
25°C). Class 3 is where major shrinkage is observed (black arrow) and disintegration is 
impending (day 12, 20°C). Class 4 is where the gonad has disintegrated into fragments 
(black arrows) (day 9, 25°C). Class 5 is where the gonad can no longer be identified. 
(Scale bar = 20µm). 
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Figure 3.16. Gonad degeneration in ageing wild-type C. elegans hermaphrodites at 
20°C. (A) Each dot represents a single worm. By day 12 virtually all gonads have 
undergone disintegration (Sample sizes day 1 n=35, day 8 n=66, day 12 n=60. Data 
from (de la Guardia et al. 2016). To adjust for multiple comparisons p<0.02 was was 
considered to be significant). (B) Gonad degeneration increases significantly up until 
day 14. Data mean±s.e.m, combined from three trials. (n=30 up until day 14, n=10 for 
remaining days) (p<0.001*** Wilcoxon-Mann-Whitney test; for (B), versus day 1 (black 
stars) or previous day (red stars) To adjust for multiple comparisons p<0.004 was 
considered to be significant). 
 
A hypothesis for the cause of gonad atrophy was proposed. It was 
suggested that PA continued in post-reproductive worms, when it was no 
longer required (de la Guardia et al. 2016). This would fit with the 
hyperfunction theory of ageing, which was explained in more detail 
previously (Introduction section 1.2.3) (Blagosklonny 2008; Blagosklonny 
2006). In young animals, PA contributes to reproductive fitness by 
nourishing developing oocytes (Gumienny et al. 1999). The gonad does 
not disintegrate because germ cell proliferation occurs at a high enough 
rate to ensure the total cell number remains stable. However once 
reproduction ceases there is no evolutionary pressure to terminate the 
apoptotic programme, so it continues to function when it is no longer 
needed and becomes a quasi-programme. PA is not operating 
incorrectly; it is simply not switched off at the appropriate time. As the 
germ cell mitotic population falls during ageing (Luo et al. 2010), run-on of 
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PA would lead to a decrease in total germ cell number, resulting in gonad 
atrophy. 
 
Supporting this theory, de la Guardia showed that germline apoptosis 
continues until at least day 8, many days after self-reproduction ceases in 
hermaphrodites (de la Guardia et al. 2016). Furthermore blocking 
apoptosis using ced-3 and ced-4 mutants delayed gonad disintegration 
(de la Guardia et al. 2016). In the male germline, where no apoptosis 
occurs, gonad disintegration was not seen (de la Guardia et al. 2016). All 
these data so far agree with the hypothesis that run-on of PA is at least 
partly responsible for gonad atrophy. The aim of my work was to see how 
altering apoptosis levels in both the male and hermaphrodite germline 
affected the rate of gonad degeneration. In the following account, any 
work conducted by others is indicated as such (as in Figures 3.17A, 
3.18A, 3.20). Some data and theories from this section are described in 
the paper by de la Guardia et al., 2016. 
 
3.7 Results 
 
3.7.1 Increasing apoptosis in hermaphrodites accelerates gonad 
disintegration 
 
If run-on of apoptosis causes gonad atrophy in later life, then increasing 
germline apoptosis should accelerate gonad disintegration. GLD-1 
(defective in germline development) is required for normal development 
of the germline. It is upregulated in the early stages of germline meiosis 
where it binds to various mRNA targets, including cep-1 mRNA where it 
acts to block translation (Schumacher et al. 2005). By preventing 
synthesis of CEP-1, GLD-1 helps to prevent germline apoptosis at this 
stage of meiosis. In the final stages of pachytene, GLD-1 levels decrease, 
which permits germline apoptosis to proceed (Schumacher et al. 2005). 
In the gld-1(op236) mutant, cep-1-dependent apoptosis or SIA is 
increased and at 25°C PA is also increased (Schumacher et al. 2005). In 
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support of the apoptotic run-on theory for gonad degeneration, Y. de la 
Guardia showed that gld-1(op236) has accelerated gonad disintegration 
from early adulthood at 25°C (Figure 3.17A) (de la Guardia et al. 2016).  
 
 
 
 
Figure 3.17. Accelerated gonad degeneration in C. elegans mutants with elevated 
apoptosis levels at 25°C. (A) gld-1(op236) accelerated gonad disintegration (n=17-18 
per condition per timepoint). Data from (de la Guardia et al. 2016)) (B) lip-1(zh15), lip-
1(gt448) and ced-9(n1653) all accelerated gonad degeneration. (p<0.01 **, p<0.001*** 
Wilcoxon-Mann-Whitney test vs wild-type hermaphrodites of the same age. To adjust for 
multiple comparisons p<0.017 was considered significant. n=30 per condition per time 
point). (All data can be seen in de la Guardia et al., 2016).  
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which supress Ras/mitogen-activated protein kinase (MAPK) (Berset et 
al. 2001). lip-1 loss of function mutations cause an increase in Ras/MAPK 
signalling and also cause a rise in PA at 25°C (Rutkowski et al. 2011; 
Kritikou et al. 2006). How exactly increased Ras/MAPK signalling results 
in increased PA is unclear. It could initiate a signalling cascade that 
triggers apoptosis. On the other hand, Ras/MAPK signalling is required 
for cells to progress out of pachytene (Church et al. 1995). Apoptosis 
occurs to cells that are leaving the pachytene stage (Gumienny et al. 
1999). Therefore increased Ras/MAPK signalling may simply push cells 
into a position where they are more vulnerable to apoptosis (Gumienny et 
al. 1999). I observed accelerated gonad disintegration in two loss of 
function alleles of lip-1, lip-1(zh15) and lip-1(gt448), at 25°C on all days 
examined, even in early adulthood (Figure 3.17B). 
 
As previously described in this chapter, CED-9 protects cells from 
apoptosis by inhibiting CED-4 and thus preventing it from activating the 
caspase CED-3, which initiates apoptosis (Hengartner & Horvitz 1994b). 
The loss of function mutation ced-9(n1653) was shown to have increased 
levels of germline apoptosis (Gumienny et al. 1999). ced-9(n1653) did 
have increased gonad degeneration in early and mid life, but not in late 
life (Figure 3.17B). 
 
These data demonstrate that increased germline apoptosis is associated 
with accelerated gonad degeneration. This provides further evidence that 
run on of PA in wild-type contributes to age-related gonad atrophy.  
 
3.7.2 Decreasing physiological apoptosis reduces accelerated 
gonad disintegration 
 
We wanted to confirm that the effect of gld-1(op236) on gonad 
disintegration was due to an increase in PA and not due to other effects 
of this mutation. Firstly we wanted to demonstrate that gld-1(op236) was 
increasing PA under our conditions. We stained day 1 hermaphrodites 
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with the vital dye SYTO 12, which specifically stains apoptotic cells 
(Gumienny et al. 1999). We then counted the number of fluorescent 
apoptotic cells in the germline of each worm and found gld-1(op236) had 
significantly more than wild-type (Figure 3.19A). Next I examined the gld-
1(op236);ced-3(n717) double mutant, which has been previously shown 
to have no apoptosis (Schumacher et al. 2005). As expected ced-3(n717) 
was able to reduce gonad degeneration in the gld-1(op236) background 
(Figure 3.18). However gonad degeneration in the double mutant was still 
higher than in both ced-3(n717) and WT on day 6 (day 6 p<0.01 vs WT, 
p<0.001 vs ced-3). This implies that other additional factors in gld-
1(op236) mutants can contribute to gonad degeneration, independent of 
apoptosis.  
 
 
Figure 3.18. Suppression of accelerated gonad degeneration in gld-1(op236) 
mutants. ced-3(n717) can reduce gonad degeneration in a gld-1(op236) background. 
However it cannot entirely suppress it to the same extent as it can in a wild-type 
background (day 6 p<0.01 vs WT, p<0.001 vs ced-3). All trials performed at 25°C.  
(p<0.01 **, p<0.001*** Wilcoxon-Mann-Whitney test vs wild-type hermaphrodites of the 
same age. To adjust for multiple comparisons p<0.01 was considered significant. n=30 
per condition per timepoint). (All data can be found in de la Guardia et al., 2016). 
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Figure 3.19. Accelerated gonad degeneration in gld-1(op236) does not require 
cep-1-dependent apoptosis. (A) cep-1 RNAi can moderately reduce germline 
apoptosis in day 1 gld-1(op236) mutants. (p<0.05 *, p<0.01 **, p<0.001*** Tukey HSD 
test vs wild-type on control RNAi. n=29-33 per condition per time point)  (1 trial 
performed by de la Guardia, 1 trial performed by Gilliat) (B) cep-1 RNAi cannot reduce 
gonad degeneration in gld-1(op236). All trials performed at 25°C. (p<0.01 **, p<0.001*** 
Wilcoxon-Mann-Whitney test vs wild-type on control RNAi. To adjust for multiple 
comparisons p<0.01 was considered to be significant. n=29-34 per condition per 
timepoint) (1 trial performed by de la Guardia, 1 trial performed by Gilliat. All data can be 
found in de la Guardia et al., 2016). 
 
gld-1(op236) also increases SIA in the germline, which is cep-1 
dependent (Schumacher et al. 2005). We grew animals on cep-1 RNAi 
from egg at 20°C and then shifted them to 25°C at the L4 stage. This is 
because at 25°C, PA is also increased in glp-1(op236) mutants 
(Schumacher et al. 2005). We then stained day 1 hermaphrodites with 
SYTO 12 to count apoptotic cells in the germline. A two-way ANOVA 
revealed a significant effect of both genotype and cep-1 RNAi 
(comparison for genotype F(1,119)=142.4 p<0.0001, comparison for 
RNAi F(1,119)=60.41 p<0.0001). This is to be expected as apoptosis 
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levels are altered by both mutation of gld-1 and cep-1 RNAi. We then 
found cep-1 RNAi had no effect on WT apoptotic levels (Figure 3.19A), as 
expected. In gld-1(op236), cep-1 RNAi was able to significantly reduce 
the number of germline apoptotic cells (Figure 3.19A). However it was not 
able to bring apoptosis down to a wild-type level, consistent with prior 
work (Schumacher et al. 2005). This could be because the RNAi did not 
cause a complete knockdown of cep-1 activity. However it could also 
imply that a proportion of the increased apoptosis seen in gld-1(op236) is 
cep-1-independent. Furthermore, despite cep-1 RNAi dramatically 
reducing apoptosis in gld-1(op236), it was not able to reduce gonad 
degeneration in this mutant (Figure 3.19B). This suggests that cep-1-
independent apoptosis is the cause of the accelerated gonad 
degeneration in gld-1(op236). 
 
These data show the increase in PA, which is cep-1-independent, in gld-
1(op236) mutants does augment age-related gonad decay. However gld-
1(op236) can induce gonad degeneration in ced-3(n717) mutants, where 
apoptosis is completely blocked. This suggests gld-1(op236) can cause 
gonad degeneration through other mechanisms that are independent of 
apoptosis.  
 
3.7.3 Inhibition of apoptosis in post-reproductive hermaphrodites 
suppresses gonad degeneration 
 
The nurse cell theory proposes in young animals the apoptotic 
programme contributes to reproductive fitness by improving oocyte 
quality (Gumienny et al. 1999). However germline apoptosis continues to 
operate once reproduction has ended because there is no evolutionary 
pressure to switch it off (de la Guardia et al. 2016). We propose quasi-
programmed apoptosis in post-reproductive hermaphrodites contributes 
to gonad degeneration. If this were true, switching off apoptosis only after 
reproduction has ceased should still prevent gonad degeneration.  
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To achieve this, I grew worms on control RNAi and ced-3 RNAi from L4 at 
20°C. On day 4 of adulthood, when reproduction is mostly complete, I 
transferred half of the worms from the control RNAi to ced-3 RNAi and 
then examined the worms on day 8 and day 12. ced-3 RNAi from L4 was 
able to significantly reduce gonad degeneration throughout (Figure 
3.20A). Worms shifted onto ced-3 RNAi on day 4 did not show a 
suppression of gonad degeneration on day 8 (Figure 3.20A). Perhaps this 
is due to a delay in the RNAi exerting its effect or because up to day 8 
other factors, apart from apoptosis, cause minor gonad degeneration. 
However by day 12, ced-3 RNAi from day 4 blocked any further gonad 
degeneration (Figure 3.20A) and completely prevented any gonad 
fragmentation (Figure 3.20B). This supports the idea that quasi-
programmed apoptosis is the main driver of age-related gonad 
degeneration in wild-type hermaphrodites. 
 
Figure 3.20. Blocking apoptosis in post-reproductive hermaphrodites prevents 
further gonad degeneration. (A) Exposure to ced-3 RNAi on day 4 inhibits further 
gonad degeneration after day 8 in wild-type hermaphrodites. (B) By day 12, ced-3 RNAi 
from both L4 larval stage and day 4 causes a significant reduction in gonad 
degeneration. All trials performed at 20°C. (p<0.01 **, p<0.001*** Wilcoxon-Mann-
Whitney test; for (A) vs control RNAi at same age (blue stars); vs ced-3 RNAi from L4 
(red stars). To adjust for multiple comparisons p<0.017 was considered to be significant. 
n=10 per condition on day 1, n=15-17 per condition on day 8 and day 12) (Day 12 data 
can be found in de la Guardia et al., 2016). 
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3.7.4 Feminization does not induce gonad disintegration in males 
 
The germ cells in male C. elegans never undergo apoptosis (Gumienny 
et al. 1999). While the male gonad does show slight atrophy during 
ageing, it was never seen to disintegrate (de la Guardia et al. 2016). We 
wanted to determine whether this was because of an absence of 
apoptosis or due to other protective mechanisms specific to the male.  If 
germline apoptosis causes gonad disintegration, then switching it on in 
males should result in major degeneration of the male gonad.  
 
FOG-1 (ferminization of germline) is required for spermatogenesis to 
occur in both males and hermaphrodites (Barton & Kimble 1990). In 
males, fog-1 loss of function mutations result in a feminized germline 
while the somatic tissues remain male. Male fog-1(q253)/+ heterozygotes 
initially generate sperm but then switch to oocyte production, whereas the 
homozygotes always generate oocytes (Barton & Kimble 1990). The 
germline of the fog-1(q253) homozygous males has also been shown to 
have similar levels of apoptosis as the wild-type hermaphrodite 
(Gumienny et al. 1999). Therefore we set out to determine whether fog-
1(q253) males exhibit gonad disintegration.  
 
Firstly, given that male fog-1(q253)/+ can produce oocytes we decided to 
examine whether these worms have germline apoptosis. We generated 
fog-1(q253)/+ males by mating fog-1(q253) hermaphrodites with wild-type 
males at 20°C. I then collected L4 males and shifted them to 25°C due to 
the temperature sensitivity of the mutation. Males were kept in small 
groups because large groups of males have strongly reduced life spans 
(Gems & Riddle 2000). Day 1 fog-1(q236)/+ males were examined  with 
Nomarski microscopy to confirm the presence of oocytes. I then stained 
day 1 wild-type hermaphrodites, wild-type males and fog-1(q236)/+ males 
with SYTO12 and counted fluorescent apoptotic cells in the germline. As 
expected we saw no apoptosis in the wild-type male germline (Figure 
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3.21A). However, fog-1(q253)/+ males had similar levels of apoptosis to 
wild-type hermaphrodites (Figure 3.21A). Despite this, fog-1(q253)/+ 
males did not show any age-related gonad disintegration, nor was there a 
significant increase in age-related gonad degeneration compared to wild-
type males (Figure 3.21B). I then examined fog-1(q253) homozygotes 
and another germline feminized male, gld-1(q126) homozygotes, 
however due to severe abnormalities of the gonad in both cases 
quantitative analysis was not possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21. Partial feminization of males induces germline apoptosis but not 
gonad atrophy. (A) fog-1(q253)/+ males have germline apoptosis at similar levels to 
wild-type hermaphrodites. Data mean±s.e.m. (p<0.01 **, Student’s t test. To adjust for 
multiple comparisons p<0.025 was considered significant. n=11-13 per genotype.). (B) 
fog-1(q253)/+ males do not undergo age-related gonad disintegration. All experiments 
performed at 25°C (p<0.017 *, p<0.01 **, p<0.001*** Wilcoxon-Mann-Whitney test. To 
adjust for multiple comparisons p<0.017 was considered to be significant. Day 1 WT 
hermaphrodite n=15, fog-1/+ n=18, WT male n=15. Day 4 WT hermaphrodite n=10, fog-
1/+ n=16, WT male n=13. Day 8 WT hermaphrodite n=8, fog-1/+ n=11, WT male n=6).  
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These data suggest germline apoptosis on its own cannot instigate gonad 
atrophy in feminized males. Other areas of the male, such as the somatic 
gonad sheath that engulfs apoptotic germ cells (Gumienny et al. 1999), 
may also need to be feminized. Alternatively as males generate large 
quantities of sperm, it may be that high levels of germ cell proliferation, 
even in older males, can offset the loss of germ cells via apoptosis (de la 
Guardia et al. 2016). 
 
3.7.5 Endoreduplication contributes to oocyte hypertrophy 
 
While studying age-related gonad degeneration, another phenomenon 
was observed by de la Guardia. In some aged worms the terminal oocyte, 
which is the oocyte closest to the spermatheca, had become enlarged (de 
la Guardia et al. 2016). While the rest of the gonad is decrepit, these 
oocytes are hypertrophic and healthy and appear robust. Hypertrophic 
oocytes were defined as those that are more than one standard deviation 
above the mean area of the terminal oocyte on day 1 (>945µm2). Their 
occurrence was then confirmed to increase with age (de la Guardia et al. 
2016). 
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Figure 3.22. The effect of FUDR on percentage of hypertrophic oocytes. (A) Worms 
shifted onto 10-50µM FUDR on day 3 of adulthood had reduced prevalence of 
hypertrophic oocytes during ageing. (Sample sizes: Day 4 0µM 7/13, 10µM 7/13, 25µM 
6/12, 50µM 5/10. Day 8 0µM 6/11, 10µM 2/10, 25µM 2/11, 50µM 2/9) (B) 25µM FUDR 
was most effective when worms were shifted on day 1 of adulthood. (Sample sizes: Day 
4 control 3/11, day 1 shift 5/13, day 2 shift 3/11, day 3 shift 4/11. Day 8 control 7/18, day 
1 shift 1/18, day 2 shift 4/15, day 3 shift 2/15)  (Day 8 data can be found in de la Guardia 
et al., 2016). 
 
One possibility as to why these cells grow so substantially is that, like 
unfertilised oocytes in the uterus, they are undergoing endoreduplication 
(McGee et al. 2012).  Due to the previous success of using the DNA 
synthesis inhibitor FUDR to reduce tumour development (Riesen et al. 
2014), I decided to test its effect on hypertrophic oocytes. Worms were 
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allowed to grow at 20°C without FUDR present until day 3 of adulthood. 
This was to allow full development of the germline. On day 3, worms were 
placed on 10µM, 25µM and 50µM FUDR and then imaged on day 4 and 
day 8. No effect was seen after only one day of exposure to FUDR, but 
by day 8 all three concentrations caused a major decrease in the 
percentage of hypertrophic oocytes (Figure 3.22A). To discover the 
optimum time that worms needed to be shifted onto FUDR, I shifted 
worms to 25µM FUDR on days 1, 2 and 3 of adulthood and then imaged 
them on day 4 and day 8. To have a strong reduction in the prevalence of 
hypertrophic oocytes, worms needed to be shifted onto 25µM FUDR on 
the first day of adulthood (Figure 3.22B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23. The effect of FUDR on percentage of hypertrophic nuclei in terminal 
oocytes. Surprisingly, hypertrophic nuclei were seen in terminal oocytes even on day 1. 
Worms were then shifted onto 25µM FUDR on day 1. This reduced the percentage of 
hypertrophic nuclei by day 8 (Sample sizes: Day 1 control 5/21. Day 8 control 10/17, 
25µM 3/12).  
 
Endoreduplicating oocytes in Emo mutants have enlarged nuclei (Iwasaki 
et al. 1996). To explore whether hypertrophic oocytes are 
endoreduplicating, I stained day 1 and day 8 worms with DAPI and then 
measured their nuclei area. I defined hypertrophic nuclei as being one 
standard deviation above the mean area of day 1 nuclei in terminal 
oocytes (>27.2 µm2). This revealed that the percentage of terminal 
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oocytes with hypertrophic nuclei increased with age by 35% (Figure 
3.23). Furthermore this increase was suppressed by exposure to 25µM 
FUDR from day 1 of adulthood (Figure 3.23). This suggests that 
continuous endoreduplication in the terminal oocytes promotes age-
related hypertrophy, though other mechanisms, such as the uptake of 
yolk from the body cavity, may also contribute. 
 
3.8 Discussion 
 
3.8.1 Run-on of physiological apoptosis contributes to gonad 
disintegration 
 
During ageing, the gonad of C. elegans hermaphrodites undergoes major 
atrophy. I have provided evidence that this atrophy is linked to the run-on 
of PA in post-reproductive animals. For example, gonad disintegration 
can be accelerated if PA levels are increased, such as in gld-1(op236), 
lip-1(zh15) and lip-1(gt448) mutants. When PA is blocked in a ced-
3(n717) mutant background, the acceleration of gonad degeneration 
caused by gld-1(op236) was reduced. 
 
Continued apoptosis in the post-reproductive germline does not seem to 
serve any purpose. The hyperfunction theory proposes PA becomes a 
quasi-programme at this point and continues to function simply because 
there is no evolutionary advantage to switching it off once reproduction 
has ceased. We artificially turned the apoptotic programme off at the 
“appropriate” time by exposing post-reproductive hermaphrodites to ced-3 
RNAi, which prevented gonad disintegration.  
 
Apoptosis can also occur in the germline in response to DNA damage or 
other stresses (Gartner et al. 2000). This process is dependent on CEP-
1. However we showed that cep-1-dependent apoptosis does not 
contribute significantly to the rate of gonad disintegration in 
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hermaphrodites. This argues against SIA having a major role in the 
development of this gonadal pathology.  
 
This fits with the hyperfunction theory of ageing, as PA switches from 
being a programme contributing to reproductive fitness in young animals 
to a quasi-programme that promotes age-related pathology post-
reproduction. Apoptosis may also have a role in the development of 
pathology in ageing mammalian tissues. For example, sarcopenia of 
mammalian muscle during ageing has also potentially been linked to 
apoptosis (Tower 2015). This shows that controlling apoptosis during 
ageing could have benefits to human health in later life.  	
3.8.2 The balance with germ cell proliferation 
 
At the distal end of the gonad is the mitotic zone, where proliferation 
occurs to provide a continuous stream of germ cells. We propose that in a 
young animal this constant supply of germ cells replenishes the 
population within the gonad and counteracts the loss of cells via PA. Thus 
apoptosis does not cause gonad disintegration in young hermaphrodites. 
In older hermaphrodites, the number of germ cells in the mitotic region 
decreases, implying a loss of proliferative capacity (Luo et al. 2010). In 
these circumstances we suggest that even if apoptotic levels do not 
increase during ageing, there will be an overall loss of germ cell number 
that could eventually lead to gonad disintegration. 
 
This model implies that mutants that are able to maintain or increase 
germ cell proliferation during ageing should be able to protect against 
gonad disintegration. For example, in feminized males, apoptosis is 
induced in the germline but no disintegration was observed (Figure 3.21). 
This could be due to males being able to better maintain germ cell 
proliferation rate during ageing and thus replenish any cells lost via 
apoptosis. To see disintegration in the feminized males could therefore 
require apoptosis levels to be increased dramatically to tip the balance 
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towards an overall decrease in germ cell population. Furthermore, daf-
2(m577) can suppress age-related gonad disintegration without affecting 
PA (de la Guardia et al. 2016). It is possible it does this by protecting 
germ cell proliferation levels during ageing. In support of this it has been 
shown that daf-2 mutants have a much smaller decline with age in the 
number of germ cells in the mitotic zone than wild-type (Luo et al. 2010). 
The lip-1(zh15) and lip-1(gt448) mutants used in this study are loss of 
function alleles. Previous work has shown that lip-1(0) mutants, in 
addition to their effect on PA, have reduced germ cell proliferation (Lee et 
al. 2006). Therefore both reducing germ cell proliferation and increasing 
PA concurrently may be the cause of the severe gonad atrophy that 
occurs in these mutants. To explore this further we wanted to study germ 
cell proliferation rate using 5-ethynyl-2’-deoxyuridine (EdU) labelling, 
which identifies the nuclei of S-phase cells (Michaelson et al. 2010). 
However attempts to use this method in our lab were unsuccessful 
(Marina Ezcurra, correspondence). 
 
Therefore we hypothesise that while run-on of PA is required for gonad 
disintegration, it can only cause atrophy when its rate is higher than that 
of germ cell proliferation. One may view this system as being like a sink; 
the water from the tap (germ cell proliferation) fills the basin (germ cell 
population) but water is steadily lost via an open plughole (physiological 
apoptosis) (Figure 3.24). During ageing in wild-type hermaphrodites the 
tap is slowly closed causing the basin to gradually empty (gonad 
disintegration). In mutants such as gld-1(op236), the plughole is opened 
more and this causes the basin to empty faster (accelerated gonad 
disintegration). According to this model it is the balance between PA and 
germ cell proliferation that ultimately decides the rate of gonad 
disintegration. 
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Figure 3.24. Quasi-programmed physiological apoptosis and declining germ cell 
proliferation lead to gonad disintegration. A faucet and sink model to explain how the 
balance of germ cell proliferation (GP) and physiological apoptosis (PA) during ageing 
results in gonad disintegration. In a young animal, GP and PA occur at the same rate so 
the germ cell population remains steady and the gonad remains healthy. In mid-life, GP 
rate starts to fall while PA levels are unchanged. Minor degeneration of the gonad 
begins. In old animals, the downturn in GP rate has caused the germ cell population (i.e 
the water in the sink) to fall as cells are lost via PA. This results in disintegration of the 
gonad. (Adapted from de la Guardia et al., 2016).  
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Chapter 4  Intestinal biomass conversion to yolk 
causes age-related intestinal atrophy in C. 
elegans 
 
4.1 Introduction to the C. elegans intestine 
 
Our hypothesis is that worm lifespan is restricted by life-limiting 
pathologies. Despite decades of work using C. elegans as a model 
organism for the study of ageing, their cause of death is still unclear. 
Previous work from David Gems’ laboratory eliminated the germline as a 
possible site of life-limiting pathology in wild-type hermaphrodites (Riesen 
et al. 2014; de la Guardia et al. 2016). Therefore we focused on another 
candidate organ that could be the site of fatal pathology: the intestine. 
 
The intestine is the major somatic organ in the worm. Unlike the 
mammalian intestine, it carries out many different functions beyond 
simply food digestion and absorption. It is the site of innate immune 
defence against external pathogens (Schulenburg et al. 2004). It can 
absorb and store important nutrients, such a lipids, which means it also 
functions as the adipose tissue (McGhee 2007). It is essential for 
reproductive fitness as it synthesises and exports yolk, a mixture of 
protein and associated lipids, which are eventually taken up by oocytes to 
provide nutrition for developing embryos (Kimble & Sharrock 1983). All of 
these functions are important and age-related degeneration of the 
intestine could conceivably impact any number of them, with lethal 
consequences.  
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4.1.1 The intestine as a site of life-limiting pathology 
 
Our aim is to identify pathologies in the intestine and to understand how 
and why they develop. Specifically we wanted to see if any could be 
attributed to run-on of wild-type gene action or quasi-programmes, like 
pathologies in other tissues of the worm (Gems & de la Guardia 2013; de 
la Guardia et al. 2016). We also wanted to establish if any intestinal 
pathologies we identify could be life-limiting. 
 
Aside from the intestine simply being the largest somatic organ in the 
worm there are several reasons we chose to study it. Firstly intestinal daf-
16 is partially responsible for daf-2 mutant longevity (Libina et al. 2003), 
implying the importance of intestinal function in long-lived mutants. It has 
also been observed that the intestine does undergo age-related 
deterioration (Figure 4.1). The intestinal epithelium experiences 
significant age-related shrinkage or atrophy with intestinal cells appearing 
to lose a large proportion of their cytoplasmic mass (Herndon et al. 2002; 
Garigan et al. 2002; McGee et al. 2011). The intestinal lumen becomes 
variable in width, with both narrow and bloated regions (Garigan et al. 
2002; McGee et al. 2011). The capacity for digestion also diminishes as 
undigested, potentially alive bacteria were observed in the lumen 
(Garigan et al. 2002; McGee et al. 2011). The microvilli also degrade, 
which could hamper effective nutrient absorption in later life (McGee et al. 
2011). Intestinal nuclei also breakdown and sometimes completely 
vanish, which presumably prohibits the synthesis of new mRNA, which 
could impair control of cell metabolism (McGee et al. 2011). Importantly 
some of these age-related deteriorations are suppressed in long-lived 
mutants (McGee et al. 2011). Necrotic intestinal cells were also 
occasionally observed, potentially contributing to worm mortality 
(Herndon et al. 2002). Indeed, intestinal necrosis occurs during worm 
death (Coburn et al. 2013). The so-called smurf assay, first used in 
Drosophila (Rera et al. 2011) and recently shown to work in C. elegans 
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as well (Dambroise et al. 2016; Gelino et al. 2016), can test intestinal 
permeability. Here a dye is fed to animals, which permeates out of the 
intestine into the body cavity if there is a failure of intestinal barrier 
function, leading to the smurf (extensively coloured) state. Loss of such 
function could result in uncontrolled flow of material (e.g bacteria) into the 
pseudocoelom, likely with adverse effects. It was observed that with 
increasing chronological age there is a greater proportion of worm 
smurfs. Furthermore worm smurfs died sooner than non-smurfs 
(Dambroise et al. 2016). 
 
 
Figure 4.1. Age-related degeneration in the C. elegans intestine. The intestine of a 
young worm appears healthy: the lumen is narrow and regular in width; microvilli are in 
good condition; intestinal cells and nuclei can be identified and appear normal. After 
ageing the intestine undergoes many age-related changes. The lumen dilates in places 
and fills with bacteria (Garigan et al. 2002; McGee et al. 2011). The intestinal cells 
undergo atrophy (Garigan et al. 2002; Herndon et al. 2002; McGee et al. 2011). The 
mid-section of the intestine is squashed by uterine tumours (McGee et al. 2011). The 
microvilli degenerate, where many are shortened or lost (McGee et al. 2011). Finally, 
intestinal nuclei start to deteriorate or disappear entirely (McGee et al. 2011). 
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Intestinal atrophy is a striking age-related pathology and could be linked 
to loss of intestinal barrier function and necrosis, both of which are 
associated with death (Coburn et al. 2013; Dambroise et al. 2016). 
However such changes in intestinal size during ageing have not been 
analysed quantitatively, nor how intestinal atrophy is correlated with other 
pathologies. Therefore we set out to better characterise intestinal atrophy, 
to determine the cause of the atrophy and establish whether it contributes 
towards age-related mortality.  
 
4.1.2 Obstacles to analysing intestinal atrophy 
 
I decided to conduct a thorough description of intestinal atrophy, to try to 
understand its underlying causes. One reason quantitative analysis of 
intestinal atrophy has not yet been performed it that it is somewhat 
difficult to study the ageing intestine with Nomarski microscopy. The 
intestinal cytoplasm can often be difficult to identify when it has lost much 
of its mass and develops an irregular morphology. In older worms, the 
middle portion of the intestine can become squashed by uterine tumours, 
thus making it difficult to locate, though electron microscopy confirmed 
there are no breaks and that the intact intestine is still present in this 
section of the worm (McGee et al. 2011). 
 
I initially attempted to circumvent some of these obstacles by blocking 
uterine tumour development and using various fluorescent reporters. 
Later I adopted a semi-quantitative method developed in our lab by 
Marina Ezcurra (Ezcurra et al., 2017, unpublished). This involved 
measuring the diameter of the intestine, lumen and body to create an 
intestinal score (Figure 4.2). This score revealed what percentage of the 
worm was occupied by intestinal cytoplasm at the point of measurement. 
Utilisation of all of these methods helped us to describe the atrophy of the 
intestine more accurately.  
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Figure 4.2. Scoring intestinal atrophy. (A) A young, healthy intestine from a day 1, 
wild-type hermaphrodite. (B) An old, atrophied intestine from a day 9, wild-type 
hermaphrodite. Body width (B) (green), intestinal width (I) (blue) and lumen (L) width 
(red) are all measured and used to generate an intestine (((I-L)/B)x100) or lumen score 
((L/B)x100). A decreasing intestine score indicates atrophy has occurred. An increasing 
lumen score indicates dilation has occurred. (Scale bar = 20µm). 
 
4.1.3 Bacterial proliferation as a possible cause of intestinal 
atrophy 
 
In our search for a possible cause of intestinal atrophy one suspect was 
the worms’ food source under standard laboratory conditions, E. coli 
OP50. There is evidence that OP50, though considered non-pathogenic, 
can cause infection and limit life in elderly worms (Garigan et al. 2002; 
Gems & Riddle 2000). Large quantities of E. coli accumulate in the 
intestine of ageing worms (McGee et al. 2011; Garigan et al. 2002). In 
young worms the pharyngeal grinder ensures all E. coli are macerated 
before entering the intestine. But during ageing, the grinder appears to 
lose efficiency as intact, live bacteria appear in the intestine (Garigan et 
al. 2002; Portal-Celhay et al. 2012). E. coli  then proliferate and colonise 
the intestine. This could damage intestinal cells; indeed, degenerated 
microvilli are often associated with clusters of E. coli (McGee et al. 2011). 
Furthermore E. coli cells were occasionally observed within the intestinal 
tissue of aged worms (Herndon et al. 2002). This suggests E. coli is 
eventually harmful to the intestine. For example, the bacterial 
accumulation was described by one study as possibly causing 
Score 58%  Score 23%  
A B 
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constipation of the intestine (Garigan et al. 2002). Constipation occurs 
when there is a blockage in the gastrointestinal tract resulting in a build 
up of material. Yet there is no evidence that the large bacterial load in the 
intestine actually impedes movement of material through the lumen. 
Therefore it remains to be determined to what extent the bacterial 
accumulation contributes to a decline in intestinal function. 
 
In the wild, C. elegans feed on many different types of bacteria (Dirksen 
et al. 2016). When worms are grown on the soil microbe B. subtilis, their 
lifespan is extended (Garsin 2003). Furthermore if worms are fed on 
antibiotic-treated or UV-killed E. coli the accumulation of bacteria is 
largely prevented (Garigan et al. 2002), suggesting proliferating bacteria 
in the intestine is responsible for the build up. Notably, antibiotic and UV 
treatment of E. coli can also extend lifespan (Garigan et al. 2002; Gems & 
Riddle 2000). This all suggests E. coli is pathogenic in ageing C. elegans. 
Therefore it would be interesting to see how E. coli might contribute to 
intestinal atrophy.  
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4.2 Results 
4.2.1 The C. elegans hermaphrodite intestine undergoes rapid 
atrophy during early ageing 
 
To assess anecdotally for potentially interesting features of the ageing 
intestine that could warrant further study, the following simple screen was 
performed. I examined the ageing intestine of glp-4(bn2) worms. Worms 
were shifted to 25°C at L4 stage, to block uterine tumour growth without 
affecting lifespan. This was to ensure that the ageing of the intestine was 
not affected by any longevity mechanisms that could be switched on in 
glp-4 mutants when they are long-lived when grown at 25°C from egg. 
Worms were also grown with or without the antibiotic carbenicillin. These 
two interventions allowed us to observe age-related changes in the 
intestine in the absence of E. coli accumulation and squashing by uterine 
tumours.  
 
As previously observed, worms grown without antibiotics had E. coli 
accumulate in their intestine, especially in the most anterior portion 
(Figure 4.3A,B) (Garigan et al. 2002). Worms grown with antibiotics did 
appear to have a lower incidence of E. coli accumulation, as previously 
observed (Garigan et al. 2002).  Nevertheless I noted that some still had 
a distended lumen, but that such lumens appeared to be devoid of 
densely packed bacteria (Figure 4.3E). This suggests that lumen dilation 
may occur independently of bacterial accumulation and instead happens 
due to intrinsic age-related mechanisms within the intestine. I also 
observed large fat droplets within glp-4 intestinal cells (Figure 4.3C), 
something not usually seen in the ageing wild-type gut. As glp-4 worms 
produce more yolk than wild-type (Riesen et al. 2014), these fat droplets 
may be due to ectopic deposition of lipid. Atrophy of the intestine 
occurred along its entire length and in the absence or presence of 
antibiotic. Extensive atrophy still occurred in the mid-section of the worm, 
despite the absence of uterine tumours (Figure 4.3A). Therefore while 
uterine tumours could slightly worsen atrophy, they are not its primary 
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cause. I also noted marked irregularity in the extent of atrophy along the 
intestine, with some regions more atrophy than others, in an apparently 
random fashion (Figure 4.3D).  
 
Figure 4.3. Age-related changes to the C. elegans intestine in glp-4 mutants. All 
images were captured at x400 magnification. A-C were grown on proliferating E. coli. 
D,E were grown on carbenicillin-treated E. coli. The intestine (blue line) and the lumen 
(red line) are indicated. (A) The intestinal lumen is filled with E. coli and intestinal cells 
undergo severe atrophy. Vulva (V). (B) E. coli accumulation (arrow) is usually most 
severe in the most anterior portion of the intestine near the pharynx (Ph). (C) Fat 
droplets (arrows) appear in the cytoplasm of atrophied intestinal cells. These were also 
seen in worms grown with carbenicillin. (D) Certain points of the intestine show more 
atrophy (arrows), resulting in irregularity in intestinal width. (E) Worms grown on 
carbenicillin sometimes had a distended lumen that appeared devoid of E. coli (arrow). 
Atrophy of the intestinal cells was still observed on carbenicillin. In all panels, oily yolk 
pools can also be seen to be filling the body cavity (Scale bars = 40µm). 
 
This preliminary study of the ageing intestine emphasised to us that 
intestinal atrophy is a severe age-related pathology and warrants further 
study, as outlined in the rest of this chapter. It also implied that uterine 
tumours and proliferating E. coli are not significant contributors to the 
development of this pathology, given that atrophy still occurred when both 
are removed. Furthermore, the lumen still distended in the absence of 
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proliferative bacteria, which suggests that bacteria accumulate within the 
intestine, not because of constipation, but merely to fill the space made 
available by age-related changes to the intestine. Therefore I set out to 
examine intestinal atrophy using quantitative analysis of this pathology.  
 
To quantify overall intestinal atrophy, I measured the cross-sectional area 
of the intestine during ageing. To investigate lumenal dilation, I measured 
lumenal cross-sectional area at the same time. To view the entire length 
of the worm intestine in a single image, images were taken at x100 
magnification. Given that this resulted in a lower resolution image, I 
employed a number of markers to assist with the identification of the 
intestine. The intestinal cytoplasm emits blue autofluorescence, which 
was used to help identify the intestinal biomass. A strain bearing 
oxIs144[INX-16::GFP, lin-15+] was used to mark the intestinal cell 
boundaries with GFP. INX-16 is a transmembrane protein found at gap 
junctions that connect the intestinal cells together (Peters et al. 2007). 
Finally I also grew worms on E. coli OP50 expressing a RFP protein 
(OP50-RFP) to help to visualise the lumen and gain a greater 
understanding of the pattern of E. coli accumulation in the intestine. The 
bacteria were also grown either with or without the antibiotic carbenicillin 
present to help to determine how proliferating bacteria might affect 
intestinal atrophy. 
 
Worms were imaged on days 1, 4, 8 and 11 (20°C). To calculate the 
cross-sectional area of the intestinal biomass, lumenal area was 
subtracted from the total intestinal area. In some worms, especially on 
day 1 of adulthood, the lumen was too narrow to measure accurately so it 
was estimated as 1% of the total intestinal area. A two-way ANOVA 
indicated there was a significant effect of age on intestinal area 
(F(2,52)=15.5), p<0.0001). Intestinal area significantly decreased 
between day 4 and day 8 (Figure 4.4). In worms on antibiotic-treated 
bacteria, intestinal area also declined between days 4 and 8. Furthermore 
the two-way ANOVA revealed there is no overall significant effect of 
carbenicillin on intestinal atrophy (F(1, 52)=0.64, p=0.43). Therefore while 
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proliferating bacteria may contribute to atrophy, as growth on UV-treated 
bacteria could delay it (Marina Ezcurra, unpublished), this pathology is at 
least partly independent of E. coli accumulation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Intestinal atrophy in oxls144[INX-16::GFP, lin-15+] C. elegans. (A) Age-
related changes in intestinal cross-sectional area in worms grown with and without 
carbenicillin. Intestinal atrophy occurs in both conditions between day 4 and day 8. 
Data±s.e.m (n=10 per time point, per condition except day 8 control n=8). (Black stars 
vs day 1 of same condition, blue stars vs previous day. p<0.05 *, p<0.01 **, p<0.001 *** 
Sidak’s test)  
 
A two-way ANOVA revealed the mean luminal area does change 
significantly with age (F(2,52)=17.87, p<0.0001) and carbenicillin also has 
a significant effect on lumen size (F(1,52)=8.09, p=0.0064). The mean 
lumenal area increased dramatically on proliferative bacteria between day 
1 and day 4, from 265µm2 to 7,931µm2, a 30-fold increase (Figure 4.5). 
On antibiotic-treated bacteria there was also an increase in the mean 
lumenal area between day 1 and day 4, from 211µm2 to 4,013µm2. 
However in both cases lumen size appeared to plateau after day 4 
(Figure 4.5). This supports a previous study that showed the bacterial 
load in the C. elegans’ intestine increases until day 4 and then remains 
constant until day 14 (Portal-Celhay et al. 2012). This suggests dilation 
may be partly due to proliferating bacteria but other mechanisms also 
appear to contribute to this phenomenon. Collectively these data show 
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that endogenous changes in the intestine could cause both lumenal 
dilation and intestinal atrophy. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Intestinal lumen distension in oxls144[INX-16::GFP, lin-15+]. Age-
related changes in intestinal lumen cross-sectional area in worms grown with and 
without carbenicillin. Lumen dilation shows a trend for being reduced on carbenicillin. 
Data±s.e.m (n=10 per time point, per condition except day 8 control n=8).  
 
The INX-16::GFP marker revealed another characteristic of intestinal 
atrophy, that it is greater at the cell boundaries (Figure 4.6). This explains 
the variable diameter I previously observed in the ageing intestine. This 
could be due to a loosening of the connections between the intestinal 
cells or because atrophy occurs more rapidly at the transverse cell 
membranes. In contrast this could be due to mislocalisation of gap 
junctions and therefore a defect specific to gap junctions rather than the 
plasma membrane as a whole. 
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Figure 4.6. Accelerated atrophy at intestinal cell boundaries. Images were taken at 
x100 magnification and are of a day 4 worm. Cell boundaries in oxls144[INX-16:GFP, 
lin-15+] have been tagged with GFP (arrows). A pinching at the boundaries can be 
observed indicating more atrophy at these points. (Scale bar = 40µm). 
 
Another observation was that OP50-RFP fluorescence was absent from 
the lumen of some of the older worms, even though the lumen appeared 
to be full of densely packed bacteria (Figure 4.7). Moreover, the 
intestine’s red autofluorescence increased in older worms, as had been 
observed previously (Coburn et al. 2013), making it difficult to distinguish 
the intestinal cytoplasm from the fluorescent bacteria in the lumen. This 
was especially a problem in areas of the intestine where the lumen was 
narrower. This is why I was unable to obtain data for day 11 worms on 
carbenicillin-treated plates because a combination of background 
int1 int2 
int3 
int4 
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fluorescence from the intestine and the small amount of red fluorescence 
in the lumen made it difficult to measure lumenal area. Furthermore, 
close inspection of the images taken of worms grown on OP50-RFP 
showed that sometimes only OP50-RFP in the centre of the lumen was 
fluorescing (Figure 4.7). This was seen in some worms as early as day 4. 
Perhaps this is a transitional stage before all OP50-RFP in the lumen 
stops fluorescing. It could be that the bacteria closest to the intestinal 
cells are exposed to something that stops them fluorescing first. It could 
also imply an intermediate stage of E. coli accumulation, where bacteria 
line the gut and there is a lime scale-type effect (e.g as occurs in water 
pipes) as a biofilm is produced. Biofilms are created when bacteria 
adhere to both a surface and to each other. They then produce an 
extracellular polymeric matrix to enclose themselves. Biofilms are 
resistant to various biocides including acid exposure and antibiotics (Hall-
Stoodley et al. 2004), so may protect the bacteria in the acidic 
environment of the C. elegans intestine (Allman et al. 2009).  
 
Together these results demonstrate that the hermaphrodite intestine 
undergoes rapid atrophy during ageing, particular at the cell boundaries, 
along with lumenal dilation. While both of these appear to be partly 
dependent on proliferating bacteria, it appears that other endogenous 
mechanisms contribute to their formation. Therefore we set out to 
discover what these mechanisms could be.  
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Figure 4.7. Loss of fluorescence of E. coli OP50-RFP in the intestinal lumen during 
ageing. Images were taken at x100 magnification and are of a day 4 worm. The blue 
autofluorescence is from the intestinal cytoplasm while the red fluorescence marks 
OP50-RFP in the lumen. At certain points OP50-RFP has either stopped fluorescing at 
the outer edges of the lumen (white arrows) or throughout (red arrows). (Scale bar = 
40µm). 
 
4.2.2 The biomass conversion theory 
 
As there is only partial suppression of intestinal atrophy in the presence 
of antibiotics, atrophy is at least partly independent of proliferating E. coli. 
We hypothesised that the remaining atrophy could be the result of a 
quasi-programme. One quasi-programme that could be linked to intestinal 
atrophy is yolk production in ageing C. elegans. 
 
Yolk is made up of protein, produced in C. elegans by the vit genes, and 
lipid (Sharrock et al. 1990). As viewed on protein gels, the three yolk 
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proteins of C. elegans are YP170, YP115 and YP88 and all are 
synthesised in the intestine (Kimble & Sharrock 1983). Yolk is then 
transported out of the intestine into the body cavity where, during the 
reproductive period, it is taken up by maturing oocytes. However once 
reproduction has ceased at around day 4, the body cavity starts to fill with 
yolk, suggesting the worm is incapable of switching off yolk production 
when it is no longer required (DePina et al. 2011; Garigan et al. 2002; 
Herndon et al. 2002; McGee et al. 2011). In fact yolk proteins continue to 
be synthesised until around day 14 of adulthood, with YP170 reaching 7 
times the levels seen in early adulthood (Ezcurra at el., 2017, 
unpublished). Therefore post-reproductive yolk production appears to be 
a quasi-programme, as it does not result from any sort of malfunction 
during ageing, but rather that it is simply not switched off.  
 
In young worms, the pharynx pumps at a high rate to ingest the resources 
sufficient to fuel yolk production. Therefore in early adulthood, the 
bacterial food source is the primary nutrient supplier for vitellogenesis. 
However in older worms the pharyngeal pumping rate declines until 
pumping completely ceases (Chow et al. 2006; Huang et al. 2004). One 
possibility is that in the absence of an alternative nutrient supply, 
continued yolk production requires the intestine to consume its own 
biomass. Alternatively, as most intestinal atrophy occurs between days 4 
and 8, when pharyngeal pumping is still relatively high, demand for yolk 
production might always outweigh what can be supplied through the 
bacterial food source. Therefore putative intestinal biomass conversion to 
yolk might be required earlier to promote fitness. If this mechanism was 
maintained (i.e runs on) during ageing, it could result in extensive 
intestinal atrophy.  
 
This theory was developed during various discussions in our laboratory 
and was dubbed the biomass conversion hypothesis. Other members of 
David Gems’ group have provided evidence to support this hypothesis. 
Firstly, intestinal atrophy and yolk accumulation occur at similar times, 
mostly between days 3 and 7, though of course this does not prove 
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causation (Figure 4.8) (Ezcurra at el., 2017, unpublished). Various 
interventions that extend lifespan, such as dietary restriction and daf-2 
mutations, all decrease both yolk accumulation and intestinal atrophy 
(Ezcurra at el., 2017, unpublished). Furthermore total protein content in 
worms does not change between days 5 and 7, yet the percentage that is 
yolk protein continues to rise (Ezcurra at el., 2017, unpublished). I 
decided to determine whether there was any sexual dimorphism in this 
pathology, given we had seen this with another pathology we had 
examined previously: gonad atrophy (de la Guardia et al. 2016). Some of 
the work from this section will be published in an upcoming paper from 
our laboratory, Ezcurra at el., 2017. 
 
 
Figure 4.8. The biomass conversion theory. (A) A theoretical graph of how yolk levels 
and intestinal volume might change during ageing in C. elegans. (B) Actual yolky pool 
and intestinal biomass scores from wild-type worms aged at 20°C, showing yolk 
accumulation and intestinal atrophy occur at similar times, mostly between days 3 and 7, 
data from Marina Ezcurra (Ezcurra et al., 2017, unpublished). 
 
4.2.3 Males do not accumulate lipid pools during ageing 
 
In hermaphrodites, run-on of yolk production results in large, shiny fat 
pools or ‘yolky’ pools that contain yolk protein and other constituents 
including lipids (Garigan et al. 2002; Ezcurra et al., 2017 unpublised). The 
male intestine does not synthesise vitellogenin (Kimble & Sharrock 1983), 
therefore males would not be expected to accumulate yolky pools in the 
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body cavity. Upon examination of young males we did observe what 
appeared to be small fat pools, generally in the posterior portion of the 
worm, apparently within the vas deferens (Figure 4.9). These are putative 
lipid pools, as we cannot be certain of their components, though their 
appearance strongly suggests they contain lipids. For simplicity, they 
shall henceforth be designated simply as lipid pools. I set out to examine 
how lipid pools changed during ageing in males. A lipid pool score was 
obtained using a method developed by Marina Ezcurra by calculating the 
percentage of the body cavity area occupied by these pools in one field of 
view (Figure 4.10) (Ezcurra et al., 2017 unpublished).  
 
 
 
 
 
 
 
 
 
Figure 4.9. Lipid pools in wild-type male C. elegans. Image was taken at x630 
magnification and is of a day 1 wild-type male. Lipid pools are found in the posterior 
portion of the worm (black arrows). (Scale bar = 10µm). 
 
 
 
 
 
 
 
 
 
Figure 4.10. Measuring yolky/lipid pools in C. elegans. Yolky pools (Y) in a day 7 
wild-type hermaphrodite are outlined (black). A score is generated by measuring the 
percentage of the body cavity area (B) occupied by the yolky pools ((Y/B)x100)). An 
increasing score indicates yolk accumulation has taken place. (Scale bar = 20µm). 
 
Score: 41% 
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When ageing C. elegans in the laboratory, worms are typically kept in 
large groups on NGM plates and such grouping has no impact on 
hermaphrodite lifespan (Gems & Riddle 2000). However males cultured 
in groups are much shorter lived than individually cultured males, with 
group size negatively correlating with lifespan (Gems & Riddle 2000). 
This could be because males form mating clumps, which could result in 
them physically damaging each other (Gems & Riddle 2000). On the 
other hand, it could be because males secrete compounds that have 
been shown to reduce hermaphrodite lifespan (Maures et al. 2014). 
Therefore to study ageing in C. elegans males, it is ideal to study them 
individually on plates. However individual males often crawl off NGM 
plates and die from desiccation on the sides of the plates. To solve this 
problem a method was developed to culture males individually in liquid 
culture in 96-well plates. The surface tension of the liquid prevents the 
males from escaping (McCulloch & Gems 2003). Therefore I decided to 
adopt this method to study age-related changes to lipid pools in males. 
However as liquid culture is quite different from culturing on NGM plates, 
the culturing method used in the majority of experiments for this project, I 
decided to examine males kept in small groups on plates (5 per plate). 
This would allow me to see if the two conditions produced very different 
results and determine which was more convenient for future experiments.   
 
Wild-type males and hermaphrodites were kept individually in liquid 
culture at 20°C from L4 stage and imaged on days 1, 7, 11, 14 and 18. A 
two-way ANOVA revealed that there was a significant difference with age 
and between the two sexes (F(4,58)=5.744, p=0.0006 and 
F(1,58)=62.75), p<0.0001 respectively). I observed that, as expected, 
hermaphrodites had a dramatic accumulation of yolk pools between days 
1 and 7, though levels did not rise further after day 7 (Figure 4.11A). This 
demonstrates that run-on of yolk synthesis still occurs in hermaphrodites 
grown in liquid culture. However in males, lipid pools did not increase 
above the levels seen on day 1 and were significantly smaller than 
 144 
hermaphrodite yolky pools on days 7, 11, 14 and 18 (Figure 4.11A). On 
NGM plates worms were also grown at 20°C and imaged on days 1, 4, 7, 
11 and 14. Again a two-way ANOVA revealed that there was a significant 
difference with age and between the two sexes (F(4,160)=46.40, 
p<0.0001 and F(1,160)=196.2), p<0.001 respectively). The 
hermaphrodites accumulated large yolk pools, which continually 
increased until day 11 (Figure 4.11B). The lipid pools did not increase 
during ageing in males on plates and were always significantly smaller 
than hermaphrodite yolky pools (Figure 4.11B). Therefore males grown in 
small groups on NGM plates and individually in liquid culture appear very 
similar in terms of this pathology.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. Lipid pool scores in ageing wild-type male and hermaphrodite C. 
elegans (A) Worms were grown individually in liquid culture. While yolk accumulates in 
ageing hermaphrodites, lipid pools do not increase in males. (n=8 per condition per 
timepoint until day 18 where n=2 for hermaphrodites and n=5 for males) (B) Worms 
were grown on plates, with males kept in small groups (5 per plate). While yolk 
accumulates in ageing hermaphrodites, lipid pools do not increase in males. 
Data±s.e.m. (n=18-20 per condition per time point, until day 14 where n=3 for males and 
n=10 for hermaphrodites) (Black stars vs day 1 of same gender; red stars vs 
hermaphrodite of same age; blue stars vs previous day. Tukey HSD p<0.05 *, p<0.01 **, 
p<0.001 ***). 
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4.2.4 The male intestine does not undergo atrophy 
 
If intestinal atrophy is caused by intestinal biomass conversion to yolk 
then intestinal atrophy should not happen in males because males do not 
make yolk (Barton & Kimble 1990) nor do they accumulate lipid pools 
during ageing. I therefore examined the male intestine during ageing, 
measuring atrophy and lumen dilation. For this experiment and all ones 
henceforth where I investigate intestinal atrophy, I adopted a method 
developed by Marina Ezcurra to measure intestinal atrophy and lumen 
dilation by generating a score for each using measurements from high 
magnification (x630) Nomarski images (Figure 4.2) (Ezcurra et al., 2017, 
unpublished). A high intestinal score indicates a large intestinal volume, 
while a decrease in score indicates a decrease in intestinal volume, 
indicating intestinal atrophy has taken place. Here we are assuming that 
a decrease in volume also correlates with a decrease in biomass (i.e 
weight of intestine). For this to be correct a decrease in intestinal volume 
should not result in an increase in density. To support this it has been 
demonstrated that during ageing the C. elegans hermaphrodite intestine 
does have a reduced lipid density, (Ezcurra et al., unpublished) 
suggesting a decrease in intestinal volume may be associated with a 
decrease in intestinal biomass. An increase in lumen score demonstrates 
lumen dilation has occurred. I switched to this method due to the previous 
problems I had encountered when measuring whole cross-sectional area 
of the intestine, particularly the issue of the declining fluorescence of 
lumenal OP50-RFP during ageing. The DIC images taken at higher 
magnification made it much easier to distinguish between the lumen and 
the intestinal cytoplasm. The posterior intestine was selected for 
measurement, since atrophy in the anterior intestine is highly variable, 
and the middle of the intestine gets squashed by uterine tumours. 
 
In individual liquid culture, wild-type males and hermaphrodites were 
imaged on days 1, 7, 11, 14 and 18. It was noted that males have a 
smaller intestine than hermaphrodites in early adulthood, which could 
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theoretically mean they are unable to lose similar proportions of intestinal 
biomass as hermaphrodites. This would mean any small changes to 
intestinal size in the ageing male could be harder to detect. As usual, the 
hermaphrodite intestine appeared to atrophy during ageing (two-way 
ANOVA, comparison for age F(4,58)=3.029 p<0.0245), and there was no 
evidence of intestinal atrophy in the males (Figure 4.12A). A two-way 
ANOVA showed the lumen appeared to dilate in both sexes with 
increasing age (F(4,58)=8.026, p<0.0001), however there was no 
significant difference between the two sexes (F(1,58)=0.9894, p=0.3240) 
(Figure 4.12B). It is important to note that there was a small sample size 
in this trial, particularly on later days. This was because it was difficult to 
maintain a large ageing population using the more labour intensive 
individual liquid culture method.  On plates, intestinal atrophy did occur in 
hermaphrodites (two-way ANOVA, comparison for age F(4,160)=10.73, 
p<0.0001), with the intestine continuously losing volume up until day 11 
(Figure 4.13A). Furthermore I again saw no evidence of intestinal atrophy 
in males (Figure 4.13A). The lumen seems to alter its width with age (two-
way ANOVA, comparison for age F(4,160)=7.723, p<0.0001), first 
increasing and decreasing in both sexes (Figure 4.13B). Additionally 
there appears to be a difference between the two sexes (two-way 
ANOVA, comparison for sex F(1,160)=7.955 p=0.005), which 
demonstrates that males are able to maintain a narrower lumen during 
ageing. 
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Figure 4.12. Intestinal atrophy and lumen dilation in ageing wild-type 
hermaphrodites and males in liquid culture. (A) Males show no intestinal atrophy, 
while hermaphrodites show a trend for intestinal atrophy. (B) Males and hermaphrodites 
show an increase in lumen dilation but there is no significant difference between the two 
sexes. Data±s.e.m. (n=8 per condition per timepoint until day 18 where n=2 for 
hermaphrodites and n=5 for males). 
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Figure 4.13. Intestinal atrophy and lumen dilation in ageing wild-type 
hermaphrodites and males on plates. (A) Males show no intestinal atrophy, while 
hermaphrodites undergo significant intestinal atrophy. (Black stars vs day 1 of same 
gender, Tukey HSD p<0.05 *, p<0.01 **, p<0.001 ***) (B) Lumen size varies throughout 
age, first increasing and peaking on day 7 before then decreasing. Additionally males 
appear to be able to maintain a narrower lumen throughout life. (n=18-20 per condition 
per time point, until day 14 where n=3 for males and n=10 for hermaphrodites)  
Data±s.e.m. 
 
Thus these data show that on both plates in small groups and in 
individual liquid culture, the male intestine does not undergo atrophy 
during ageing. This is consistent with the biomass conversion hypothesis. 
Given the similarity between the results from the two culturing conditions, 
I opted to perform future experiments with males on plates at low 
population density.  
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4.2.5 Feminised males undergo intestinal atrophy 
 
To test the biomass conversion hypothesis further, I decided to see 
whether turning on yolk production in the male intestine could induce 
intestinal atrophy. The MAB-3 transcription factor acts downstream of 
TRA-1, which controls many pathways involved in sex determination in C. 
elegans (Shen & Hodgkin 1988; Yi et al. 2000; Hodgkin 1987). mab-3(-) 
mutant males were identified in a screen for mutations that caused an 
impairment of male mating behaviour due to the defects in their tails 
(Hodgkin 1983). MAB-3 acts in the intestine of wild-type males to prevent 
transcription of the vitellogenin genes (Shen & Hodgkin 1988). Therefore 
mab-3 mutant males have a feminized intestine, which produces yolk as 
indicated by the presence of yolk protein bands on protein gels and the 
appearance of yolky pools in the body cavity (Shen & Hodgkin 1988). 
MAB-3 appears to exert its effects in the male only, as mab-3 mutant 
hermaphrodites appear normal (Shen & Hodgkin 1988). If the biomass 
conversion theory were true, it would be expected that mab-3 mutant 
males would undergo intestinal atrophy. 
 
I examined mab-3(mu15) males, which are maintained in a him-5(e1490) 
background to give a high incidence of males. I first tested whether mab-
3 males accumulate yolky pools during ageing, and this proved to be so 
(Figure 4.17). Yolky pools increased up until day 7 in mab-3 males where 
they appeared to reach a threshold  (Figure 4.14). Furthermore on day 7, 
mab-3 males had significantly larger yolky pool levels than their 
hermaphrodite counterpart (day 7 p<0.0001 vs mab-3 hermaphrodite, 
Student’s t test). This may be because mab-3 males do not produce 
oocytes, which would normally take up yolk from the body cavity, and 
reduce yolk accumulation. Immunofluorescent staining of yolk proteins 
also revealed that the yolk mab-3 mutant males produce does not enter 
the gonad (Shen & Hodgkin 1988). As before, lipid pools did not 
accumulate in wild-type or him-5 males (Figure 4.14). I also examined 
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another mab-3 allele, mab-3(e1240) and, again, these males 
accumulated yolky pools in the body cavity (Figure 4.16A). These data 
provide further evidence the yolky pools are the result of vitellogenic run-
on. 
 
 
Figure 4.14. Lipid pool accumulation in feminized mab-3(mu15) males. Experiment 
was performed on plates. mab-3(mu15) males accumulate yolky pools during ageing at 
an even greater rate than hermaphrodites. Data±s.e.m. (n=20 per timepoint per 
condition) (+ for males, * for hermaphrodite. Colours match the line. Dark colours vs day 
1, light colours vs previous day. Tukey HSD p<0.05 */+, p<0.001 ***/+++) 
 
I next asked whether loss of MAB-3 activity could induce age-related 
intestinal atrophy in males. The intestine of mab-3(mu15) males was 
larger on day 1 than the intestine of wild-type males. This is consistent 
with feminisation of the intestine as the intestine of the wild-type 
hermaphrodite is greater in size relative to the wild-type male intestine. 
As before, the intestines of all the hermaphrodite strains underwent 
atrophy by day 7 (Figure 4.15A) and the intestine of wild-type males and 
him-5 mutant males did not undergo atrophy (Figure 4.15A). However the 
mab-3 mutant male intestine underwent continuous atrophy until day 7, 
like the hermaphrodites (Figure 4.15A, Figure 4.17). Furthermore, the 
intestinal atrophy was more severe, with mab-3 males losing a greater 
percentage of their intestinal biomass than any of the hermaphrodite 
strains (Figure 4.15B). Similar atrophy was seen in the intestine of mab-
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3(e1240) mutant males, where most atrophy occurred by day 4 (Figure 
4.16B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. Intestinal atrophy in feminized mab-3(mu15) males. Experiment was 
performed on plates. (A) mab-3(mu15) males undergo intestinal atrophy during ageing. 
Data±s.e.m. (n=20 per timepoint per condition) (+ for males, * for herm. Colours match 
the line. Dark colours vs day 1, light colours vs previous day. Tukey HSD p<0.001 
***/+++). (B) mab-3(mu15) males undergo atrophy at a greater rate than hermaphrodites 
and lose a greater percentage of their original biomass.  
 
 
 
 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
Day 1 Day 4 Day 7 Day 11 
In
te
st
in
e 
sc
or
e 
Age 
mab-3(mu15) male 
him-5(e1490) male 
WT male 
mab-3(mu15) hermaphrodite 
him-5(e1490) hermaphrodite 
WT hermaphrodite 
0 
20 
40 
60 
80 
100 
Day 1 Day 4 Day 7 Day 11 
In
te
st
in
e 
sc
or
e 
(%
 o
f d
ay
 1
) 
Age 
mab-3(mu15) male 
him-5(e1490) male 
WT male 
mab-3(mu15) hermaphrodite 
him-5(e1490) hermaphrodite 
WT hermaphrodite 
A 
B 
*** 
*** *** *** 
*** *** 
*** 
*** *** 
+++ 
+++ 
+++ 
+++ 
- ( ) 
i - ( ) 
- ( ) 
i - ( ) 
i - ( ) 
- ( ) 
i - ( ) 
 152 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16. Lipid pool accumulation and intestinal atrophy in mab-3(e1240) 
males. (A) mab-3(e1240) males accumulate yolky pools during ageing. (B) mab-
3(e1240) males undergo intestinal atrophy during ageing. Data±s.e.m. (n=8-11 per 
timepoint per condition, except on day 14 where WT hermaphrodite n=10, WT male n=3, 
mab-3 male n=2) (Colours match the line. Dark colours vs day 1, light colours vs 
previous day. Tukey HSD p<0.05 *, p<0.01 **, p<0.001 ***). 
 
These results provide further evidence to support the biomass conversion 
theory. It appears that induction of vitellogenin synthesis in the feminised 
male intestine results in intestinal atrophy because of the conversion of 
intestinal biomass into yolk. However it is also possible that the feminised 
intestine undergoes atrophy due to other mechanisms unrelated to yolk 
synthesis that do not usually occur in a wild-type male intestine. One 
such mechanism could be aberrant E. coli accumulation in the intestine. 
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Figure 4.17. Intestinal atrophy and lumen dilation in mab-3(e1240) males. Images 
at x630 magnification of day 7 worms at 20°C. Intestinal width (blue), lumenal width 
(red) and yolky pools (black) are indicated. (Scale bar = 20µm). 
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4.2.6 Intestinal atrophy in feminised males is not due to 
proliferative E. coli 
 
While examining the mab-3 mutant males, I noticed the intestinal lumen 
became greatly distended and filled with bacteria during ageing (Figure 
4.17). In fact, by day 11 the mab-3(mu15) male lumen score was 
significantly higher than all the other groups tested (two-way ANOVA, 
comparison of mutants F(2,114)=19.30, p<0.0001 and comparison of sex 
F(1,114)=12.09, p=0.0007. p<0.0001 for mab-3 male vs each other group 
(Tukey HSD)) (Figure 4.18). Given that E. coli accumulation has been 
suggested to cause lumen dilation (putative constipation) (Garigan et al. 
2002), I wondered whether abnormally profuse E. coli proliferation in the 
intestine of mab-3 mutant males might contribute to the marked intestinal 
atrophy. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18. Lumen dilation in mab-3(mu15) males during ageing. The male mab-
3(mu15) intestinal lumen undergoes a dramatic distension during ageing, that is 
significantly higher than all other strains by day 11 (p<0.0001 vs all strains). Data±s.e.m 
(n=20 per timepoint per condition)  (Colours match the line. Dark colours vs day 1, light 
colours vs previous day. Tukey HSD p<0.05 *, p<0.01 **, p<0.001 ***). 
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Figure 4.19. Yolky pool accumulation and intestinal atrophy is not affected by 
antibiotic treatment in mab-3(mu15) mutant males. (A) mab-3(mu15) mutant males 
accumulate yolky pools to the same extent on carbenicillin-treated bacteria. (B) 
Intestinal atrophy is unchanged in mab-3(mu15) mutant males that are grown on 
carbenicillin-treated bacteria. Data±s.e.m (n=10 per timepoint, per condition). 
 
To block E. coli proliferation, bacterial plates were treated with 
carbenicillin as previously described (Garigan et al. 2002). Both mab-3 
males and hermaphrodites were then aged on these plates. Yolk 
accumulation still occurred in both males and hermaphrodites on 
antibiotic-treated plates (Two-way ANOVA, comparison for age in males 
F(3,72)=34.34, p<0.0001. Comparison for age in hermaphrodites 
F(3,72)=31.00, p<0.0001) (Figure 4.19A). However the extent of yolk 
accumulation was unchanged by antibiotic exposure (Two-way ANOVA, 
comparison for carbenicillin in males F(1,72)=1.507, p=0.2235. 
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Comparison for carbenicillin in hermaphrodites F(1,72)=2.633, p=0.1091). 
The intestine also underwent extensive intestinal atrophy on antibiotic-
treated plates in both genders (Two-way ANOVA, comparison for age in 
males F(3,72)=42.05, p<0.0001. Comparison for age in hermaphrodites 
F(3,72)=49.67, p<0.0001) and, again, the degree of atrophy was 
unaffected by antibiotic treatment (Two-way ANOVA, comparison for 
carbenicillin in males F(1,72)=0.4545, p=0.5024. Comparison for 
carbenicillin in hermaphrodites F(1,72)=1.415, p=0.2381) (Figure 4.19B, 
Figure 4.20). Additionally lumen dilation was unaffected by antibiotic 
treatment (Two-way ANOVA, comparison for carbenicillin in males 
F(1,72)=0.026, p=0.8720. Comparison for carbenicillin in hermaphrodites 
F(1,72)=0.1078, p=0.7436). Thus, intestinal pathology in mab-3 males 
appears to be independent of the presence of proliferating E. coli in the 
intestine and certainly not a consequence of constipation.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20. Antibiotic treatment does not prevent lumen dilation in mab-3(mu15) 
mutants males. Treatment with carbenicillin had no effect on lumen dilation in either 
mab-3(mu15) mutant males or hermaphrodites. Data±s.e.m (n=10 per time point, per 
condition). 
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4.2.7 Blocking yolk production does not reduce intestinal atrophy 
in feminised males 
 
Does yolk production in mab-3 males cause intestinal atrophy? To test 
this, I prevented yolk production by using RNAi against the vit genes, 
which produce the protein portion of yolk. Earlier work in our lab showed 
that double RNAi using vit-5,6 RNAi completely blocked accumulation of 
all three yolk protein bands until at least day 11 of adulthood in wild-type 
hermaphrodites (Ezcurra et al. 2017, unpublished). Additionally vit-5,6 
RNAi from egg both reduced yolky pool accumulation and intestinal 
atrophy in hermaphrodites grown at 25°C (Ezcurra et al. 2017, 
unpublished). Therefore I set out to determine whether under those 
conditions, vit-5,6 RNAi had a similar effect on mab-3(mu15) males. 
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Figure 4.21. The effect of vit-5,6 RNAi on yolk accumulation and intestinal atrophy 
in mab-3(mu15) males. Worms were exposed to RNAi from egg and grown at 25°C (A) 
vit-5,6 RNAi reduces yolk accumulation in hermaphrodites and in mab-3(mu15) males 
(B) vit-5,6 RNAi reduces intestinal atrophy in mab-3 hermaphrodites but not in mab-
3(mu15) males. Data±s.e.m (Colours match the line, vs vit-5,6 RNAi at the same 
timepoint. Sidak’s test p<0.001 ***. n=20 per time point per condition.). 
 
I mixed together equal parts of each clone to create the E. coli HT115 
culture used for vit-5,6 RNAi. This was used to inoculated NGM plates 
that contained IPTG. Worms were then bleached to remove E. coli OP50 
and to create a synchronised population. Bleached eggs were pipetted 
onto IPTG plates containing either the control or vit-5,6 clones and 
allowed to grow until the L4 stage. Worms were then selected for 
experiments and grown at 25°C before being imaged on days 1, 4 and 7. 
As previously observed, vit-5,6 RNAi greatly reduced yolky pool 
accumulation in hermaphrodites (Ezcurra et al., 2017, unpublished). It 
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also dramatically reduced the accumulation in mab-3 males (Figure 
4.21A) (See table A.7 for two-way ANOVA statistics). Thus vit-5,6 RNAi 
had the expected impact on yolk accumulation. Intestinal atrophy was 
significantly reduced in day 4 mab-3 hermaphrodites by vit-5,6 RNAi. 
However, surprisingly it had no effect on intestinal atrophy in mab-3 
males (Figure 4.21B) (See table A.8 for two-way ANOVA statistics).   
 
This result could argue against the biomass conversion theory by 
demonstrating that it is possible for yolk accumulation and intestinal 
atrophy to be uncoupled. However, another possibility is that while 
vitellogenesis is switched on in mab-3 males, other mechanisms that 
regulate yolk production in hermaphrodites remain switched off. For 
example, in hermaphrodites presumably there are upstream mechanisms 
that regulate the breakdown of the intestinal biomass for yolk synthesis. If 
yolk production is turned off via RNAi, the hermaphrodites may be able to 
respond to this by generating a signal that results in the inhibition of the 
upstream biomass conversion mechanism. mab-3 males may not have 
the ability to initiate this signal, thus when yolk production is reduced, 
catabolism of the intestine continues. Where the intestinal biomass goes 
in these males is unclear, but perhaps it is used to generate alternative 
proteins that, like yolk proteins, are ultimately exported from the intestine. 
In short: in mab-3 males, intestinal biomass conversion and yolk 
production may not be as tightly coupled as in hermaphrodites. To block 
intestinal atrophy in these males, one would need to inhibit the upstream 
mechanism that directly causes the breakdown of the intestine biomass.  
 
4.2.8 Autophagy promotes intestinal biomass conversion to yolk 
 
A possible element of the upstream intestinal biomass conversion 
mechanism is autophagy, which involves the recycling of large quantities 
of cytoplasm. During autophagy, double-membrane structures called 
autophagosomes form, engulfing an area of cytoplasm. These then fuse 
to lysosomes, forming autophagolysosomes, within which enzymes break 
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down cytosolic components allowing them to be reused by the cell 
(Melendez & Levine 2009; Klionsky 2007). If autophagy facilitates 
intestinal biomass conversion to yolk, then blocking it should prevent 
intestinal atrophy. One way of inhibiting autophagy is to use atg-13 RNAi. 
ATG-13 acts upstream during autophagy (Tian et al. 2009). To induce 
autophagy, ATG-13 is dephosphorylated causing it to be free to bind to 
ATG-1. This association allows ATG-1 to initiate autophagy (Reggiori et 
al. 2004). 
 
Figure 4.22. The process of autophagy. A double membrane vesicle called an 
autophagosome is formed, which encloses a variety of cytosolic components, including 
organelles. This then binds and fuses with a lysosome. The enzymes from the lysosome 
breakdown the cytosolic components, allowing them to be recycled within the cell. 
(image from (Melendez & Levine 2009)). 
 
In wild-type hermaphrodites atg-13 RNAi was able to reduce both yolk 
accumulation and intestinal atrophy (Ezcurra et al., 2017, unpublished). 
Moreover, adult and intestine specific atg-13 RNAi was sufficient to 
induce this effect (Ezcurra et al., 2017, unpublished). Therefore its effect 
on these two pathologies in mab-3(mu15) males was tested by Alexandre 
Benedetto. He confirmed atg-13 RNAi had a similar effect in these males, 
in that it reduced both yolk accumulation and intestinal atrophy (Ezcurra 
et al. 2017, unpublished). These results suggest that autophagy functions 
in the intestine to recycle intestinal biomass into other components, 
including yolk. Thus, autophagy promotes development of pathology in 
the ageing C. elegans intestine.  
 
 
WormBook 
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4.2.9 Later yolk production increases reproductive fitness 
 
Under standard laboratory conditions continued yolk synthesis in ageing 
hermaphrodites appears to be a quasi-programme, as it seems to serve 
no function. However it is possible under certain conditions it could 
provide a benefit for reproductive fitness. Self-reproduction in 
hermaphrodites ceases around day 4 of adulthood due to sperm 
depletion. However mated hermaphrodites reproduce for much longer 
(Hughes et al. 2007), therefore in such animals continued yolk synthesis 
may enhance production of offspring. Possibly mating is relatively 
common in wild populations, where more stressful conditions might boost 
the number of males. Therefore mated hermaphrodites may sacrifice their 
own health by breaking down their intestine to fuel later reproductive 
output. In this way, C. elegans hermaphrodites could be viewed as 
undergoing reproductive death because they funnel all their resources 
into a short, highly productive period of reproduction before expiring. This 
is similar to other species such as the marsupial mouse Antechinus 
stuartii, which have a short, frantic mating period that results in the 
sudden death of the entire adult male population (Naylor et al. 2008).  
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Figure 4.23. The effects of mating on yolk accumulation and intestinal atrophy in 
wild-type hermaphrodites. Worms were exposed to males from L4 stage to day 4 of 
adulthood at 20°C (A) Yolk accumulation is reduced by mating. (B) Intestinal atrophy is 
worsened by mating. Data±s.e.m. (n=20 per time point per condition) (vs unmated at 
same timepoint. Sidak’s p<0.001 ***). 
 
To prove this, I tested whether intestinal atrophy is enhanced in mated 
hermaphrodites. Mated hermaphrodites were generated as previously 
described in chapter 3.1 of this thesis. In brief, hermaphrodites were 
cultured with males between the L4 stage and day 4 of adulthood and 
then kept in hermaphrodite-only groups for the remainder of the 
experiment. As expected, given the extended egg-laying period, mating 
caused a significant reduction in yolk accumulation up until at least day 
14, well beyond the last mating event (Figure 4.23A) (Two-way ANOVA 
comparison for mating F(1,199)=71.49, p<0.0001). This supports a 
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previous study that demonstrated mating caused hermaphrodites to lose 
approximately half of their total fat content (Shi & Murphy 2014). 
Interestingly, intestinal atrophy was exacerbated in mated 
hermaphrodites (Figure 4.23B) (Two-way ANOVA comparison for mating 
F(1,199)=26.81, p<0.0001). This could imply that the presence of males, 
or of mating triggers a signal in hermaphrodites that causes an 
upregulation of intestinal biomass conversion. A previous study showed 
functional sperm from males was required to induce shrinkage in mated 
hermaphrodites (Shi & Murphy 2014).  While they did not look in detail at 
the condition of the internal organs, it is possible this phenomenon 
reflects an increase in biomass conversion and loss of yolk biomass 
through egg laying.  
 
This all suggests that mating causes hermaphrodites to make more yolk 
to provide nutrients for a greater number of embryos, thereby improving 
reproductive fitness. However this seems to be to the detriment of 
hermaphrodite viability, as mated worms appear less healthy and have 
much shorter lifespans than their unmated counterparts (Gems & Riddle 
1996; Shi & Murphy 2014). Whether this is solely due to increased 
intestinal atrophy or because of other detrimental effects from mating 
such as cuticle damage is unclear (Woodruff et al. 2014). Therefore 
further study into reproductive death in C. elegans is warranted. 
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4.3 Discussion 
 
4.3.1 Autophagy-dependent biomass conversion causes intestinal 
atrophy 
 
The intestine had been previously observed to undergo atrophy, with 
proliferation of bacteria within it suggested to cause constipation, which 
was hypothesised to be a major contributor to the development of this 
pathology (McGee et al. 2011; Garigan et al. 2002). However prior to this 
study, intestinal atrophy had not been studied quantitatively, nor had the 
role of proliferating bacteria in its development been formally tested. We 
confirmed intestinal atrophy does occur in worms, with the greatest loss 
in intestinal biomass occurring between days 3 and 7 (Figure 4.8) 
(Ezcurra et al., 2017, unpublished). However, although blocking bacterial 
proliferation did reduce intestinal atrophy to an extent, major atrophy still 
occurred (Figure 4.4). Therefore while proliferating bacteria likely 
contribute to intestinal atrophy, they appear not to be the main cause. 
Furthermore, as intestinal lumen dilation can occur in the absence of 
proliferating bacteria, it appears expansion of the lumen is not a 
consequence of constipation; rather bacteria simply fill the lumen as other 
age-related changes cause it to distend. Thus the previous hypothesis 
that bacterial constipation is the main driver of both intestinal atrophy and 
lumen expansion seems to be invalid. 
 
I have presented evidence from work by myself and also from colleagues 
that run-on of yolk production results in intestinal atrophy in 
hermaphrodites. Yolk production continues well into old age (Ezcurra et 
al., 2017, unpublished), confirming as previously suggested that yolk 
production is not switched off once reproduction has ceased when it is no 
longer required (Herndon et al. 2002).  Blocking yolk production using vit-
5,6 RNAi in hermaphrodites also reduced intestinal atrophy (Ezcurra et 
al., 2017, unpublished). In C. elegans fatty acids and protein can be 
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obtained from the bacterial food source. However the age decline in 
pharyngeal pumping rate implies that availability of food for yolk 
production declines with age (Huang et al. 2004; Chow et al. 2006). 
Therefore the worm intestine may have to start to perform de novo fatty 
acid synthesis and breakdown of intestinal proteins into the amino acids 
used to synthesise vitellogenins. However given that intestinal atrophy 
starts around day 3 when worms still pump relatively fast, one might 
assume that worms are still consuming an adequate food supply to fuel 
yolk production. One possibility is that yolk production occurs at such a 
high rate that worms can never consume enough food to support its 
synthesis. Therefore even from a young age, intestine biomass 
conversion must take place to optimise reproductive fitness.  
 
Males, which do not make yolk, do not undergo intestinal atrophy (Figure 
4.13A). However feminization of the male intestine resulted in yolk 
accumulating in the body cavity, at a higher rate even than in 
hermaphrodites (Figure 4.14). Perhaps this is due to males not producing 
oocytes to act as a yolk sink. Alternatively it could be due to yolk 
production in feminized males being completely uncontrolled as 
regulatory mechanisms that operate in hermaphrodites may not be 
switched on. This could result in the high levels of yolk accumulation I 
observed. The feminized male intestine also underwent extensive 
intestinal atrophy, losing a greater percentage of its biomass than the 
hermaphrodite intestine (Figure 4.15). While vit-5,6 RNAi reduced yolk 
accumulation in feminized males, it did not reduce intestinal atrophy 
(Figure 4.21). This could be because there is a lack of coordination 
between intestinal biomass conversion and vitellogenin production in 
these males, perhaps due to the absence of regulatory mechanisms. By 
contrast, in the hermaphrodite these two processes appear coupled, such 
that if vitellogenin production is blocked, intestinal biomass conversion is 
also inhibited.   
 
To perform biomass conversion, the C. elegans intestine must be able to 
breakdown and recycle cytosolic components to allow them to be reused 
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for yolk synthesis. This process seems to be performed by autophagy, 
which can break down various components of the cytosol, including 
proteins and organelles. In support of autophagy-dependent intestinal 
biomass conversion, inhibiting autophagy using atg-13 RNAi reduced yolk 
accumulation and intestinal atrophy in both hermaphrodites and 
feminized males (Ezcurra et al, 2017, unpublished). This would mean 
during adulthood in C. elegans, intestinal autophagy is a promoter of 
senescent pathology. Autophagy has long been considered to be a 
beneficial process during ageing. The molecular damage accumulation 
theory of ageing suggests a build up of damaged molecules throughout 
life results in a loss of normal cellular function, eventually causing organ 
failure and subsequent death. Autophagy has been proposed to protect 
against this by breaking down damaged components of cells and 
releasing them to be reused (Gelino & Hansen 2012). If this were true, 
continued activity of autophagy should protect against age-related 
pathology and increase lifespan. Indeed some studies suggest that 
autophagy is required for the longevity in daf-2 mutants (Hars et al. 2007; 
Meléndez et al. 2003), and in eat-2 mutants (Hansen et al. 2008), which 
have a reduced pumping rate that may result in dietary restriction (see 
chapter 5) (Raizen et al. 1995). Further work showed that autophagy 
activity specifically in the eat-2 intestine is required for the lifespan 
extension (Gelino et al. 2016). Compared to wild-type, eat-2 mutants 
better maintain their intestinal barrier function during ageing and this was 
also dependent on intestinal autophagy activity (Gelino et al. 2016).  
 
On the other hand, autophagy may be detrimental to health in certain 
conditions. For example, in mammals it could help to support the growth 
of advanced tumours by recycling cellular components where nutrients 
may have started to become limited (Shintani & Klionsky 2004; Kang & 
Avery 2008). Furthermore, in senescent cells autophagy promotes the 
senescence-associated secretory phenotype (SASP), which can promote 
cancer development (Narita et al. 2011). In C. elegans gbp-2 mutants, 
which are sensitive to starvation, high levels of autophagy during 
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starvation resulted in deterioration of the pharyngeal muscle causing a 
decline in function (Kang et al. 2007). 
 
The role of autophagy in wild-type C. elegans longevity and pathology 
development has previously been less clear. Inhibition of autophagy often 
caused a very minor or no reduction to wild-type lifespan (Hars et al. 
2007; Gelino et al. 2016). Furthermore, one study found that inhibition of 
some autophagy genes via RNAi after worm development actually 
extended lifespan, suggesting autophagy during adulthood could be 
detrimental (Hashimoto et al. 2009). Our group also showed that atg-13 
RNAi extends lifespan consistently at 25°C, but not at 20°C (Ezcurra et 
al., 2017, unpublished). A possible explanation for this is that while 
autophagy promotes the progression of some pathologies, it inhibits the 
development of others. Therefore the effect on lifespan of reducing 
autophagy will depend on which pathologies are life limiting and this 
could vary in different wild-type backgrounds or under different 
conditions. Nevertheless I have presented evidence that during 
adulthood, autophagy in the wild-type C. elegans intestine promotes 
biomass conversion into yolk. This results in the development of two age-
related pathologies: yolk accumulation and intestinal atrophy.  
 
4.3.2 Intestinal atrophy as a life-limiting pathology in C. elegans 
 
A question that remains is whether intestinal atrophy actually limits life in 
C. elegans. The intestine accounts for approximately one third of the 
somatic mass and performs multiple functions beyond just nutrient 
absorption (McGhee 2007). It also acts as an essential barrier against the 
external environment, including potentially harmful pathogens. Therefore 
one would assume extensive atrophy of the intestine during ageing could 
conceivably be lethal. 
 
There is now a sizeable amount of evidence that suggests the aged 
intestine is indeed the site of life-limiting pathology. RNAi of the vit genes, 
 168 
which reduced intestinal atrophy, also extended lifespan (Murphy et al. 
2003; Ezcurra et al., 2017, unpublished). Intestinal atrophy is also 
reduced in daf-2 mutants, which have a greatly extended lifespan 
(Ezcurra et al., 2017, unpublished). Furthermore, restoring daf-16 activity 
specifically in the intestine of daf-16;daf-2 double mutants increased 
lifespan and to a greater extent than when daf-16 expression was re-
established in the neurons or muscle (Libina et al. 2003). SKN-1, another 
transcription factor required for longevity in daf-2 mutants, translocates to 
the nuclei of the intestinal cells in daf-2 mutants to activate transcription 
(Tullet et al. 2008). Perhaps most convincingly, the level of intestinal 
atrophy on day 7 can be used to forecast the eventual lifespan of an 
individual worm (Ezcurra et al., 2017, unpublished). Moreover, 
progressive necrosis along the intestine, often initiated from the most 
anterior intestinal cells, occurs concurrently with organismal death in C. 
elegans (Coburn et al. 2013). Together these results imply the 
maintenance of the intestine during ageing is essential for continued 
viability. We propose that autophagy-dependent intestinal biomass 
conversion to yolk causes intestinal atrophy, a senescent pathology that 
is life limiting in C. elegans. 
 
However while atg-13 RNAi reduced intestinal biomass conversion, it only 
extended lifespan at 25°C; no consistent longevity effect was seen at 
20°C by our group. This is despite it preventing intestinal atrophy at both 
temperatures (Ezcurra et al., 2017, unpublished). As previously 
suggested, this implies that the pathologies that limit life vary under 
different conditions. For example, at 25°C, autophagy-dependent 
intestinal biomass conversion causes intestinal atrophy that is the primary 
cause of death. At 20°C, this biomass conversion still occurs, but another 
pathology could reach a lethal threshold first. As in humans, it seems that 
there are multiple causes of death in C. elegans (Figure 4.24). 
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Figure 4.24. Intestinal atrophy as a cause of death in ageing C. elegans. 
Autophagy-dependent intestinal biomass conversion results in the generation of two 
age-related pathologies, yolk accumulation and intestinal atrophy. We propose that 
intestinal atrophy is a life limiting pathology. However presumably other pathologies can 
also limit lifespan depending on the conditions. For example, bacterial infection of the 
uterine tumours or of the pharynx could both potentially be lethal pathologies (Zhao et 
al., 2017). Additionally, we currently do not know what age-related pathology could be 
causing death in males. 
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Chapter 5  Pharyngeal infection is a life-limiting 
pathology in ageing C. elegans 
 
5.1 Introduction to the C. elegans pharynx 
 
In addition to the intestine, another part of the alimentary canal shows 
both a decline in function and extensive tissue degeneration during 
ageing: the pharynx (Herndon et al. 2002; Garigan et al. 2002; Chow et 
al. 2006; Huang et al. 2004). The pharynx is primarily made up of muscle, 
though also contains other cell types including marginal cells, which 
provide structural strength, and gland cells, which secrete digestive 
enzymes into the pharyngeal lumen through long cellular protrusions 
(Altun & Hall 2009b) (Figure 1.6). In response to food, serotonin is 
released, which stimulates the pharyngeal muscle to pump continuously 
in the young adult. This action draws bacteria from the environment into 
the posterior bulb of the pharynx, where the grinder is (Horvitz et al. 
1982) (Figure 5.1). Muscular contractions push the ‘teeth’ of the grinder 
against one another to cause complete maceration of the bacteria before 
it enters the intestine. In this way, when the pharynx operates correctly, it 
prevents intact and potentially pathogenic bacteria from entering the 
worm and also ensures that there is a continuous supply of fresh 
nutrients.  
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Figure 5.1. The grinder of the C. elegans pharynx. The posterior bulb of the pharynx 
contains the grinder. The grinder ‘teeth’ engage with one another to completely 
macerate bacteria in the lumen. pm6, pharyngeal muscle segment 6.  (TEM image from 
(Altun & Hall 2009b)). 
 
5.1.1 Age-related functional decline and tissue degeneration in the 
pharynx 
 
Studies have shown that there is age-related tissue degeneration of the 
pharynx (Herndon et al. 2002; Garigan et al. 2002), particularly in the 
muscle (Chow et al. 2006). Initial studies noted that during ageing the 
structure of the pharynx becomes more irregular. The posterior bulb 
seems to be particularly affected and loses its even, circular shape 
(Herndon et al. 2002; Garigan et al. 2002). The internal structures also 
became harder to distinguish, with the muscle fibres appearing to vanish 
(Herndon et al. 2002). Furthermore bacteria were seen to accumulate in 
the pharyngeal lumen, much like it does in the ageing intestine (Garigan 
et al. 2002). TEM revealed that bacteria were also capable of invading 
the pharyngeal tissue of aged worms (McGee et al. 2011). This suggests 
bacteria may contribute towards pharyngeal decline. The pharyngeal 
muscle also appears to undergo sarcopenia, like human muscle, during 
ageing (Chow et al. 2006). This could be driven by the high pumping rate 
in young adulthood because eat-2 mutants, which have a lower 
pharyngeal pumping rate throughout life (Raizen et al. 1995), had a 
slower rate of pharyngeal muscle deterioration (Chow et al. 2006). The 
Posterior bulb 
Metacorpus 
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authors propose several mechanisms by which high pumping rate in early 
life could cause decay of the pharynx (Chow et al. 2006). They suggest 
pharyngeal pumping may deteriorate muscle that has already been 
weakened by other age-related processes. Alternatively, a high pumping 
rate would presumably require high levels of respiration. This would 
generate large amounts of ROS that could damage cellular components. 
Finally they propose high levels of activity could also cause mechanical 
damage to the pharynx.  
 
An advantage of studying age-related decline in the pharynx is that 
pharyngeal contractions or pumps are reasonably easy to count, even at 
a low magnification. Therefore pumping rate can give a convenient read 
out of pharyngeal function during ageing. The pharynx pumps at a fairly 
constant and fast rate in young animals, with pumping rate peaking on 
day 2 of adulthood (Huang et al. 2004). From day 3 onwards the pumping 
rate declines dramatically and virtually ceases by day 9 (Huang et al. 
2004). Intriguingly, worms that maintained a higher pumping rate for 
longer, typically also lived longer as well. Thus mid-life pumping rate is a 
predictor of lifespan (Huang et al. 2004). Antibiotic treatment reduced the 
age-related decline in pharyngeal pumping rate, but did not completely 
prevent it (Chow et al. 2006), suggesting that bacteria contribute to 
impairment of pharyngeal function. Notably, the pumping rate exhibited 
may not reflect the full functional capacity of the pharynx. Between days 2 
– 12, serotonin exposure in the absence of food could noticeably increase 
pumping rate compared to untreated worms feeding on a bacterial lawn 
(Chow et al. 2006). This implies other factors that could be independent 
of tissue degeneration, such as a decline in endogenous levels of 
serotonin, may contribute to the decline in pumping rate.  
 
Overall these data raise the possibility that the ageing pharynx harbours a 
life-limiting pathology that also results in a decline in function as it 
develops. A high pumping rate in early adulthood may be essential for 
robust growth and reproductive fitness. The caveat is this may cause the 
pharynx to deteriorate and become virtually inoperative in later life (Chow 
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et al. 2006).  Given the relationship between pharyngeal function and 
lifespan (Huang et al. 2004), and the fact the pharynx undergoes 
noticeable age-related degeneration (Herndon et al. 2002; Garigan et al. 
2002; Chow et al. 2006), high pumping rate in young adults could lead to 
the development of a life limiting pathology in ageing C. elegans. This 
suggests the existence of a trade off between the early life benefits of 
high pumping rate, and resulting late life pathology. By this view the 
effects of wild-type alleles, such as that of eat-2, exemplify antagonistic 
pleiotropy.  
 
5.1.2 Studying age-related pharyngeal pathology 
 
Previous studies of pharyngeal pathology have used either Nomarski 
microscopy or electron microscopy (Chow et al. 2006; Herndon et al. 
2002; Garigan et al. 2002; McGee et al. 2011). To determine the level of 
tissue degeneration, qualitative scoring has also been used (Chow et al. 
2006; Garigan et al. 2002), similar to the classification systems we used 
previously to study uterine tumours and gonad atrophy (Riesen et al. 
2014; de la Guardia et al. 2016). Marina Ezcurra developed a more 
detailed pharyngeal pathology scoring system, inspired by the previous 
work, where the pharynx was rated from class 1 – 5 depending on the 
level of degeneration (Ezcurra et al., unpublished) (Figure 5.2). 
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Figure 5.2. The pharynx pathology scoring system. All pharynxes are outlined in 
white. Class 1 is a young, healthy pharynx. Class 2 shows early stages of deterioration, 
such as small, dense inclusions (blue arrows), small blister-liked vacuoles or fading 
muscle striations. Class 3 pharynxes have one of the following major age-related traits: 
bacteria accumulated in the lumen (red arrow); muscle striations no longer visible; large 
blisters (black arrows) or dense inclusions (white arrow). Class 4 pharynxes possess 
two or more of these age-related traits. Class 5 pharynxes have deteriorated to such an 
extent that structures within the posterior bulb of the pharynx can no longer be identified 
(Scale bars = 20µm). 
Class 1 
Class 3 
Class 4 
Class 5 
Class 2 
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In humans, when the cause of death is unclear, one option is to perform 
an autopsy. This involves dissection and the careful examination of the 
internal organs to determine the likely cause of death. Yuan Zhao 
implemented this idea in worms and performed necropsies on them. This 
involved the examination of worms that had died from old age using 
Nomarski microscopy. Conveniently, as worms are transparent, there is 
no need to dissect them to examine the internal organs. The majority of 
corpses retained a surprisingly high degree of structural integrity, with 
different tissue types still easily distinguishable. Initial observations 
suggested that there is a difference between worms that died at a 
relatively young age (between days 8 – 14) and those that died at older 
ages (day 15 onwards). Young corpses showed a highly degenerated 
pharynx with a morbidly swollen posterior bulb. Older corpses did not 
display this pathology; instead the pharynx appeared to have undergone 
age-related atrophy (Figure 5.3). These initial findings suggested the 
interesting possibility that there are at least two distinct causes of death in 
C. elegans, with earlier deaths being caused by pharyngeal pathology. 
Using both the qualitative scoring and necropsy methodology, I set out to 
investigate this possibility, since a key objective of my PhD work was to 
identify pathologies of ageing that cause death in C. elegans. 
 
This study has been a truly cooperative exploration and I would like to 
thank Yuan Zhao, Marina Ezcurra, Matthias Ziehm, Hongyuan Wang, 
Mark Turmaine and Chenhao Yang for contributing work to this chapter. 
When others have conducted work or data was gathered in collaboration, 
it will be indicated as such (as in Figures 5.5, 5.6C, 5.7, 5.8A, 5.9, 
5.10A,B, 5.15 5.20, 5.22A). I would also like to extend a special thank you 
to Yuan Zhao who I have worked with jointly on this project. She has not 
only contributed work to this chapter but has also helped extensively with 
discussions and ideas. She and I are joint first authors on a recent 
publication (Zhao et al. 2017), which includes much of the work presented 
in this chapter.  
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Figure 5.3. Pharyngeal pathology in C. elegans corpses. Early deaths in C. elegans 
are associated with swollen pharynxes (‘big P death’), while later deaths are associated 
with smaller pharynxes (‘small p death’). (Scale bar = 20µm). (Observation by Yuan 
Zhao, images from Ann Gilliat.)  
 
5.2 Results 
5.2.1 Pharyngeal pathology increases with age and correlates with 
lifespan 
 
First I decided to examine the dynamics of pharyngeal pathology in an 
ageing C. elegans population by quantifying tissue degeneration and 
measuring changes to pharyngeal size. A group of worms were removed 
from the population and their pharynxes imaged at regular time points 
from day 1 onwards. The cross-sectional area of the posterior bulb of the 
pharynx (henceforth pharynx size) was measured and then each pharynx 
was given a qualitative score based on the degree of tissue deterioration. 
The pharynx pathology score increased during ageing, consistent with 
prior work (Figure 5.4A) (Chow et al. 2006; Garigan et al. 2002). The 
largest increase occurred between days 4 and 7, after which no further 
significant increase was observed (Figure 5.4A). This suggests that the 
majority of pharyngeal deterioration occurs within this small timeframe, 
relatively early in life. The pharyngeal size also increased steadily during 
ageing and was observed to have grown significantly by day 9 (Figure 
5.4B). Presumably, a proportion of this size increase is due to normal 
Day 11 
Day 24 
P death 
p death 
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development, as worm body length continues to increase up until day 4 
(Shi & Murphy 2014). However a fraction of the increase could be due to 
the aberrant pharyngeal swelling observed by Y. Zhao in worms that 
expired early in survival assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Age-related changes to the C. elegans pharynx in wild-type 
hermaphrodites. (A) The pharyngeal pathology score increases significantly during 
ageing, indicating deterioration of the pharynx. Data mean±s.e.m. (Black vs day 1, blue 
vs previous day; p<0.004 **, p<0.001 *** Wilcoxon-Mann-Whitney test. To adjust for 
multiple comparisons, p<0.004 was considered to be significant.) (B) The cross-
sectional area of the posterior pharyngeal bulb also increases significantly during 
ageing. Data mean±s.e.m. (Black vs day 1; p<0.05 *, p<0.01 ** Tukey HSD test). (For 
both A and B days 1-9 n=8, days 11-18 n=10) 
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To determine what pathologies may be life limiting in C. elegans, M. 
Ezcurra monitored a number of pathologies, including pharyngeal 
deterioration, in individually cultured worms.  Worms were removed from 
their plates and carefully placed on microscopy slides. Using low light 
conditions, worms were imaged on a cooled microscopy stage, which 
reduced worm movement. Once imaging was completed, worms were 
returned to their plates (Figure 5.5A). This was repeated at several time 
points, up until day 18. The lifespan of each worm was recorded and then 
compared to its pathology state earlier in life. Importantly, continuous 
imaging using this technique did not affect lifespan (Figure 5.5B). M. 
Ezcurra found that, out of all the pathologies tested, only two correlated 
with lifespan at more than one of the timepoints examined (Table 5.1). 
One was intestinal atrophy, which showed correlations with lifespan on 
days 4 and 11. This was unsurprising given the results from chapter 4. 
The other was pharyngeal deterioration, which showed correlations with 
lifespan on days 7 and 11 (Figure 5.5C,D). This demonstrates that the 
level of pharyngeal function and tissue deterioration in mid-life can be a 
predictor of lifespan (Huang et al. 2004). This provides further evidence 
that the pharynx could be harbouring a lethal age-related pathology.   
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Figure 5.5. Tracking development of age-related pathologies in individual worms. 
(A) Worms were kept on individual plates and repeatedly imaged, on a slide, under a 
microscope at various time points. After imaging, worms were recovered to allow for a 
survival assay to be performed. (B) This imaging protocol did not affect life span 
(p=0.16, log rank, control vs imaged. Imaged n=16, control n=61). (C) On day 7, a 
significant correlation was seen between life span and pharyngeal pathology (n=16). (D) 
On day 11, a significant correlation was seen between life span and pharyngeal 
pathology (n=8). (Method in A developed by Marina Ezcurra (Ezcurra et al., 2017, 
unpublished). Data in B,C and D collected by Marina Ezcurra).  
 
Table 5.1. Correlations between life span and pathology severity. Data was 
collected as described in Figure 5.5A and significant correlations (green) were sought 
using linear regression. (Day 4 n=16, day 7 n=16, day 11 n=8, day 14 n=4) (Data 
collected by Marina Ezcurra and analysed by Yuan Zhao). 
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5.2.2 Early deaths are associated with pharyngeal swelling 
 
We decided to determine whether pharyngeal swelling was in fact closely 
associated with early mortality in C. elegans. A necropsy analysis was 
performed on a large population (n=585), where corpses from worms that 
had died during survival assays were imaged using Nomarski microscopy 
and their pharynxes measured. To establish a value beyond which a 
pharynx can be defined as swollen, we measured the size of pharynxes 
from healthy day 7 and 10 animals and calculated the mean area. 
Healthy animals were defined as being class A, which are fast moving 
worms or worms that move quickly when prodded with a worm pick. We 
then added one S.D. to the mean area of these pharynxes, giving us a 
value of 1833µm2. Any pharynxes with an area larger than this were 
defined as swollen. One S.D. below this mean is 1480µm2 and pharynxes 
below this value were defined as atrophied.  
 
The necropsy profile revealed that 38% of worms died with swollen 
pharynxes (Figure 5.6A). The bulk of these worms also died prior to day 
15. The rest of the population died with pharynxes that appeared to have 
undergone atrophy. Therefore C. elegans possesses at least two clear 
categories of death, in terms of pharyngeal pathology. We decided to 
name deaths with a swollen pharynx as P deaths (‘big’ P death) and 
those with an atrophied pharynx as p deaths (‘small’ p death). In regards 
to lifespan, as anticipated worms that underwent P death died decidedly 
earlier (median lifespan = 11 days) than those that experienced p death 
(median lifespan = 21 days) (Figure 5.6B). 
 
To analyse the development of pharyngeal pathology in P and p death 
during life, Y. Zhao monitored pharyngeal size in individual worms until 
death. Worms were imaged at x200 magnification on plates, which were 
cooled on ice prior to imaging to inhibit movement. This revealed 
pharyngeal swelling did occur before death, which meant that the swelling 
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was not caused by the decomposition of the corpses. Furthermore the 
swelling only started to occur a few days before death, before plateauing 
a day or so prior to the death of the worm (Figure 5.6C). This is 
emphasised by an anomalous worm, which underwent P death much 
later in life on day 33, yet swelling only started to happen after day 28 
(Figure 5.6C). On the other hand, the pharynxes of worms that underwent 
p death start to atrophy after day 10 and then continuously decreased in 
size until death. Together these results show that early mortality is closely 
connected to a potentially lethal, pharyngeal pathology in C. elegans. 
 
Figure 5.6. Early death in C. elegans is associated with pharyngeal swelling and 
reduced lifespan (P death). (A) The majority of P deaths occurred before day 15 and 
were associated with a large pharynx size, whereas p deaths were associated with a 
smaller pharynx size. For comparison the size range of a healthy pharynx is indicated 
(grey dotted lines represent the mean area of healthy day 7 and 10 pharynxes ± S.D.). 
(n=157) (B) P deaths have a much lower lifespan than p deaths with median lifespans of 
11 days and 21 days respectively (n=585).  (C) Pharyngeal swelling in P deaths 
happened only just before death. In p deaths, the pharynx size continued to decrease up 
until death (n=29). (Data in C collected by Yuan Zhao).  
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5.2.3 Two forms of death explain mortality deceleration in ageing C. 
elegans populations 
 
C. elegans’ mortality rate rises with age, however a significant decrease 
in the mortality rate acceleration is often observed in mid life, around days 
8-12 (Figure 5.7A) (Vaupel et al. 1994; Brooks et al. 1994; Johnson et al. 
2001). This means a two stage Gompertz model is more appropriate for 
ageing C. elegans populations (Johnson et al. 2001). The mortality rate 
deceleration was proposed to be due to population heterogeneity, which 
exists despite the population being genetically identical (Johnson et al. 
2001). Such heterogeneity must be expressed relatively early in life to 
result in subpopulations with different mortality rates. Given that P death 
mostly occurs in early to mid life, we decided to determine whether P and 
p deaths had different mortality rates and if this could explain the long 
observed mortality rate deceleration in C. elegans populations. 
 
Firstly Y. Zhao, with assistance from M. Ziehm, confirmed that the 
populations she had subjected to necropsy analysis also showed a 
mortality rate deceleration, with a significant slope change seen on day 
11 (Figure 5.7B). Next they analysed the mortality rates of P and p death. 
They discovered the mortality rate of P death accelerates much faster 
than p death, causing a spike in mortality around day 11 (Figure 5.7C). 
Therefore P death represents a vulnerable subset of worms that die 
earlier. Thus, the mortality rate deceleration in C. elegans populations is 
due to two distinct subpopulations with different mortality rates.  
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Figure 5.7. Mortality rate deceleration in ageing C. elegans populations. (A) 
Mortality rate deceleration has been previously observed in ageing C. elegans 
hermaphrodite populations (Vaupel et al. 1994; Brooks et al. 1994; Johnson et al. 2001). 
The deceleration is observed relatively early in the life span. For example, in these data 
it was observed at around ~8.3 days and ~12 days respectively (red line). (B) C. 
elegans populations that underwent necropsy analysis also showed a mortality rate 
deceleration occurring around day 11 (red line), with a statistically significant slope 
change at this point (p=2.81x10-9, slope test). (C) Examining the mortality rates of the P 
and p death subpopulations revealed the deceleration is due to population 
heterogeneity, caused by a subset of worms with pharyngeal infection dying faster and 
earlier. (n=622) (Data in B and C collected by Yuan Zhao and analyzed by Matthias 
Ziehm and Yuan Zhao). 
 
5.2.4 Bacterial infection is the primary cause of pharyngeal 
swelling 
 
Next we wanted to establish what was causing the morbid swelling of the 
pharynx in P death. Examination of swollen pharynxes under high 
magnification revealed they had a grainy appearance that appeared 
similar to the densely packed E. coli that I had previously seen in the 
intestinal lumen and uterine tumours. Furthermore, previous work had 
shown that the pharynxes of worms with an impaired immune system 
were particularly vulnerable to infection by the pathogenic bacteria 
Vaupel et al., 1994 Johnson et al., 2001 
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Salmonella typhimurium and Salmonella enterica (Tenor & Aballay 2008; 
Haskins et al. 2008). A small number of E. coli were also seen within the 
pharyngeal tissue of an aged worm, indicating the invasive capabilities of 
this species (McGee et al. 2011).  Finally, proliferative E. coli has also 
been shown to be detrimental to C. elegans longevity (Gems & Riddle 
2000; Garigan et al. 2002). Therefore we set out to determine whether 
bacterial infection of the pharynx by E. coli OP50 was the primary cause 
of pharyngeal swelling in P death. 
 
To try and identify any live bacteria that had invaded the pharynx, I 
stained both day 1 and day 8 worms with the vital dye, SYTO13. This is a 
nucleic acid dye that has been previously used to stain live bacteria 
associated with a rectal infection in C. elegans (Nicholas & Hodgkin 
2004). Worms on day 1 took up the dye efficiently and as expected there 
was no evidence of bacteria within the pharyngeal tissue. On day 8, 
uptake of the dye appeared to be much less, perhaps due to the age-
related decrease of pharyngeal pumping rate (Huang et al. 2004). Out of 
approximately 20 worms examined on day 8, only one showed possible 
staining within the pharyngeal tissue. However it was difficult to be certain 
whether this staining was due to bacteria (data not shown). Thus, it may 
be difficult to stain the pharynxes of older worms when the method is 
dependent on efficient uptake of the dye by a functioning pharynx.  
 
We continued to seek evidence of live bacteria within the pharyngeal 
tissue. C. Yang categorised live day 10 or 11 worms into two groups: 
those with either swollen or unswollen pharynxes. He then dissected out 
the posterior bulb of the pharynx before washing and then pulverizing the 
tissue. The subsequent solution was then spread onto plates to allow the 
colony forming units (CFUs) to be counted. This revealed swollen 
pharynxes had a bacterial load that was 42 fold larger than unswollen 
pharynxes (Figure 5.8A).  
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Figure 5.8. Bacterial infection causes pharyngeal swelling. (A) Swollen pharynxes 
from day 10 and 11 live, wild-type worms have significantly higher CFUs than unswollen 
pharynxes. Data mean±s.e.m. (p<0.05 * Student’s t test. Swollen n=8, unswollen n=10). 
(B) Comparison of the distribution of red fluorescence in the corpses of wild-type worms 
grown on OP50-RFP that underwent either P or p death. All worms that undergo P 
death have widespread red fluorescence in the pharynx, whereas the vast majority that 
undergo p death do not. (P death n=70, p death n=75)  (C) Corpses from wild-type 
worms fed on OP50-RFP, with the posterior bulb highlighted in white. P corpses had 
widespread red fluorescence throughout the pharynx. p corpses either had no red 
fluorescence in the pharyngeal tissue or had small inclusions of red fluorescence (white 
arrows), often near the grinder (Scale bar = 40µm). (Data in A collected by Chenhao 
Yang). 
 
Next I performed a necropsy analysis on worms grown on OP50-RFP to 
observe the pattern of any bacterial invasion within the pharyngeal tissue. 
OP50-RFP was prepared as described in chapter 2. In brief, bacteria 
were grown in the presence of tetracycline to select for the plasmid 
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possessing the RFP gene, before being resuspended in broth containing 
no antibiotic. This was to ensure bacterial pathogenicity was not reduced 
by the presence of antibiotic. A fluorescent and brightfield image of the 
pharynx from each corpse was collected. From this, I observed three 
patterns of RFP distribution within the pharyngeal tissue: no RFP present; 
small RFP inclusions and widespread RFP. P deaths worms all had 
widespread RFP that completely filled the pharyngeal tissue (Figure 
5.8B,C). Interestingly in p death, the vast majority had small RFP foci 
present in the pharyngeal tissue (68%), while only a relatively small 
proportion had no RFP present in the pharynx (24%) (Figure 5.8B,C). 
This suggests that many p death worms do experience minor bacterial 
invasion of the pharynx, but are able to contain it.  
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Figure 5.9. Evidence from electron microscopy of bacterial invasion of the 
pharynx. Images are from day 8 live adults. (A) A swollen pharynx (Ph) is completely 
invaded with bacteria (B), with evidence of bacteria dividing in the tissue (dB). (Scale bar 
= 5µm). (3 swollen pharynxes were imaged). (B) In this unswollen pharynx, bacteria are 
only seen in the lumen (L). The muscle (M), mitochondria (Mt) and grinder (G) are all 
clearly visible (Scale bar = 2µm). (C) In this unswollen pharynx, bacteria can be seen 
within a small bacterial inclusion (BI) within the pharyngeal tissue, where the bacteria is 
surrounded by a double membrane (DM) (Scale bar = 2µm). (2 unswollen pharynxes 
were imaged). (Images collected jointly by Ann Gilliat and Yuan Zhao, with technical 
assistance from Mark Turmaine). 
 
To confirm definitively that bacteria are present within the tissue of 
swollen pharynxes, Y. Zhao and I performed TEM on worms with 
technical assistance from M. Turmaine. We aged worms on OP50-RFP 
until day 8 and then noted if the pharynx was swollen or not before 
dividing them into two groups based on whether or not RFP was present 
within the pharynx. Those with no RFP were assumed to have not 
developed infection while those with widespread RFP were assumed to 
have advanced infection. These worms were then prepared and imaged 
using TEM. In the three worms we imaged that had widespread RFP, all 
the pharynxes were swollen and entirely invaded by bacteria (Figure 
5.9A). Additionally, some bacteria within the pharynx had a lengthened 
appearance, indicating bacterial proliferation may be occurring (Figure 
5.9A). In contrast we did not see such extensive invasion in the two 
pharynxes we imaged from worms that had had no RFP within the 
pharyngeal tissue. In one, no invasive bacteria were observed (Figure 
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5.9B), while in the other a small number of bacteria were identified 
(Figure 5.9C). However these bacteria were sequestered within a double 
membrane structure (Figure 5.9C), suggesting containment of the 
infection.  
 
Finally we wanted to confirm that proliferative bacteria were required for 
the development of pharyngeal swelling. Y. Zhao blocked bacterial 
division using carbenicillin while I killed bacteria via exposure to UV light. 
Both treatments have been previously shown to extend lifespan (Gems & 
Riddle 2000; Garigan et al. 2002), and we were able to replicate this 
finding (Figure 5.10B,D). Furthermore both treatments abolished P death 
(Figure 5.10A,C). This confirms live and proliferative bacteria are required 
for the occurrence of this pathology. 
 
Figure 5.10. Blocking bacterial proliferation prevented P death and extended 
lifespan. (A) Treating plates with carbenicillin to prevent bacterial proliferation 
completely prevented P death. (B) Carbenicillin treatment extended lifespan. (C) 
Exposing plates to UV light killed bacteria and completely prevented P death. (D) UV 
treatment extended lifespan. (A, C Data mean±s.e.m, p<0.05 *, p<0.01 **, Student’s t 
test. B, D see appendix, Table A.2 for survival statistics table and sample sizes). (Data 
in A and B collected by Yuan Zhao). 
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5.2.5 Pharyngeal infection is associated with a sudden decline in 
function 
 
As stated in the introduction to this chapter, the pharynx undergoes a 
major age-related decline in function (Huang et al. 2004). This decline 
occurs primarily between days 4 and 10, which is a similar timeframe to 
when pharyngeal infection seems to develop. TEM revealed extensive 
deterioration of the pharyngeal tissue in swollen pharynxes, with the 
muscle fibres virtually absent (Figure 5.9A). Therefore it is logical to 
assume that progression of this pathology should impair pharyngeal 
function and eventually inhibit it entirely, contributing to the age-related 
decline in pharyngeal pumping rate (Huang et al. 2004). To explore this 
idea, I monitored the pumping rate in individual worms throughout their 
lifespan and performed necropsy analysis once they had expired. This 
revealed that in most worms that eventually underwent p death, 
pharyngeal pumping rate decreased gradually throughout life, up until 
death (Figure 5.11A). However in worms that ultimately experienced P 
death, there was often a sudden and dramatic decrease in pumping rate, 
not long before death (Figure 5.11A). Indeed this sudden decline in 
function occurred just prior to the start of pharyngeal swelling (Figure 
5.11B). Soon thereafter, pharyngeal pumping ceased entirely (Figure 
5.11B). Therefore the previously observed correlation between the period 
of pharyngeal function and lifespan is likely to be partially explained by 
the development of this pathology (Huang et al. 2004). Thus, early 
mortality with pharyngeal infection is closely associated with a loss of 
pharyngeal function.  
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Figure 5.11. Bacterial infection is associated with a sudden decline in pharyngeal 
function. (A) Pumping rate throughout the life of individual worms that eventually died 
from either P or p death (n=43). (B) A few days before pharyngeal swelling is first 
observed in P deaths (day 0), there is a major decline in pharyngeal function. Data 
mean±s.e.m (n=17). (Pharyngeal swelling monitored by Y. Zhao) (C) Carbenicillin 
treatment is able to slow the age-related decline in pharyngeal pumping rate. Data 
mean±s.e.m (n=10 per time point per condition, except on day 1 n=8 per condition). 
 
Prior work did reveal a potential link between proliferative bacteria and a 
decline in pharyngeal function. Treatment with the antibiotic ampicillin 
was shown to slightly reduce the age-related decline in pharyngeal 
function (Chow et al. 2006). I was able to replicate this result using the 
antibiotic carbenicillin (two-way ANOVA comparison for carbenicillin 
F(1,104)=15.21 p=0.0002) (Figure 5.11C). If the occurrence of P death is 
the primary cause of the correlation between pharyngeal pumping span 
and lifespan then complete suppression of pharyngeal infection should 
remove or reduce this correlation. Carbenicillin was not able to 
significantly reduce the correlation between both pharyngeal pumping 
span and fast pharyngeal pumping span with lifespan (Figure 5.12A,B). 
This suggests other pharyngeal pathologies that are independent of 
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infection, such as perhaps sarcopenia (Chow et al. 2006), contribute 
towards the decline in function and associated mortality (Huang et al. 
2004).    
 
 
Figure 5.12. The effect of carbenicillin treatment on the correlation between 
pharyngeal function and lifespan. (A) As previously shown (Huang et al. 2004), there 
is a correlation between fast pharyngeal pumping span (days at >149 pumps/min) and 
pharyngeal pumping span (days at 6-149 pumps/min) with life span. (n=54). (B) These 
correlations were reduced on carbenicillin. (n=41). (Linear model comparison between 
proliferating and non-proliferating bacteria. Pharyngeal pumping span p=0.056, fast 
pharyngeal pumping span p=0.13). 
 
5.2.6 Mechanical damage may promote pharyngeal infection 
 
Pharyngeal infection could be due to a systematic age-related decline in 
immune function across the entire worm. Alternatively, it could be due to 
a more localised defect, which occurs specifically in the pharynx. To 
explore this, I decided to determine whether worms with pharyngeal 
infection are more likely to experience bacterial infection elsewhere.  
Worms were grown on OP50-RFP and then scored on days 10 and 14 for 
the presence of RFP within the pharynx and uterine tumours. Those with 
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extensive RFP in the region of interest were defined as infected. This 
revealed on both days 10 and 14 that worms with infected pharynxes 
were not more likely than other members of the population to have 
infected uterine tumours (Figure 5.13A,B). This suggests there is not a 
systematic loss of immune function in worms that undergo P death. 
Rather this implies there is an age-related defect that promotes bacterial 
infection, which is restricted to the pharynx.  
 
Figure 5.13. Uterine tumour infection in worms with infected pharynxes. Wild-type 
hermaphrodites were grown on OP50-RFP at 20°C. (A) On day 10, those with 
pharyngeal infection were no more likely to have infected uterine tumours than other 
members of the population. (101 worms examined) (B) On day 14, those with 
pharyngeal infection were no more likely to have infected uterine tumours than other 
members of the population. (63 worms examined). 
 
To determine where bacterial infection starts and therefore gain insights 
into the main route of invasion into the pharynx, worms with early 
infection were examined. These worms were grown on OP50-RFP and 
inspected on days 8, 9 or 10. Those with low levels of RFP were 
assumed to be in the initial stages of infection and were selected for 
confocal microscopy. Worms where three different pharyngeal cells types 
(either muscle, marginal or g1 gland cells) had been tagged with GFP 
were used for this study. This was to establish if infection preferentially 
starts in a particular cell type. After imaging, worms were divided into 
three categories: those where RFP was seen in both GFP+ and GFP- 
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cells, those where RFP was only seen in the GFP+ cells and those where 
no RFP was seen in the GFP+ cells. When RFP was only seen in the 
GFP+ cells, this suggested that infection had begun within this cell type. 
Infection was observed in all three cell types (Figure 5.14A), however 
infection never began in marginal cells and rarely in g1 gland cells (Figure 
5.14B). In fact, infection mostly started within muscle cells and frequently 
in close proximity to the grinder (Figure 5.14A,B). To explore this further, 
TEM was performed on worms that had early infection on day 8 and 
confirmed that initial bacterial invasion was often observed near the 
pharyngeal grinder (Figure 5.15A,B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14. Bacterial infection in different cell types within the pharynx. (A) The 
posterior pharyngeal bulb is indicated (outlined in white) with either the muscle, marginal 
or g1 gland cells (outlined in red) tagged with GFP. Colonies can be seen within GFP 
positive cells, often near the grinder (white arrows). (B) Out of the three cell types 
examined, bacterial infection appears to mostly begin within muscle (pharyngeal muscle 
n=14, marginal cells n=12, g1 gland cells n=16). 
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Figure 5.15. Evidence from electron microscopy that bacterial infection starts near 
the grinder. Images are from day 8 live adults with early infection. (A) A relatively large 
number of bacteria (B) can be seen near the grinder (G) of the pharynx (Ph). There is 
also evidence of proliferation (dB) within the tissue. A small bacterial inclusion (BI) can 
be seen, where bacteria are contained within a double membrane structure. (B) In very 
early infection, a small number of bacteria (B) can be seen near the grinder (G). L, 
lumen. (Scale bars = 2µm). (3 pharynxes with early infection were imaged) (Images 
collected jointly by Ann Gilliat and Yuan Zhao, with technical assistance from Mark 
Turmaine). 
 
Next we wanted to explore whether a subpopulation worms (~40%) were 
predisposed from early in life to develop pharyngeal infection and 
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bacteria at various time points throughout adulthood. If 40% of worms 
had acquired a predisposition to pharyngeal infection early in life then 
exposure to proliferative bacteria, even later in life, should expose this 
vulnerability and cause those 40% of worms to undergo P death. 
Unexpectedly, shifting worms onto proliferative bacteria from day 4 
onwards resulted in a gradual decrease in the proportion of P death 
(Figure 5.16A). Shifts from day 6 onwards also caused increases in 
lifespan (Figure 5.16B). To confirm this result was not due to the residual 
effects of ingested carbenicillin, the experiment was repeated using UV-
killed bacteria, which produced similar results (Figure 5.16C,D). These 
data suggest that there is a short period during early adulthood where 
worms must be exposed to proliferative bacteria for P death to occur. 
 
 
Figure 5.16. The effect on lifespan and the occurrence of P death of initially 
growing worms on non-proliferating bacteria. (A) Worms grown on carbenicillin-
treated plates until day 1 of adulthood had normal levels of P death. Transfer to 
proliferating bacteria later in life resulted in decreases in P death frequency. Data 
mean±s.e.m. (B) Transfer to proliferating bacteria later in life (from day 6 shift onwards) 
caused significant increases in lifespan. (See appendix, Table A.3 for survival statistics 
table and sample sizes). (C) Worms grown with UV-killed bacteria until day 1 of 
adulthood had normal levels of P death. Transfer to proliferating bacteria later in life 
resulted in decreases in P death frequency. (D) Transfer to proliferating bacteria, even 
early in life (from day 2 shift onwards), caused significant increases in lifespan. (See 
appendix, Table A.3 for survival statistics table and sample sizes).  
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Taking all these results together we hypothesised that high pharyngeal 
activity in early life causes mechanical damage to the pharyngeal cuticle 
near the grinder. This could result in fissures in the cuticle, providing a 
route for bacterial invasion. As this damage would occur in young worms, 
it might also explain why pharyngeal infection starts to develop relatively 
early in life, resulting in the early wave of P death. The shift experiments 
also imply that to develop P death, worms must be exposed to 
proliferative bacteria in early life, at the same time that the pharyngeal 
cuticle is being damaged.   
 
 
 
 
 
 
 
 
Figure 5.17. The effect of feeding powdered glass on C. elegans longevity and 
pharyngeal infection. Worms were fed powdered glass from L4 larval stage until day 4, 
before being transferred onto untreated plates.  (A) Feeding on ground glass had no 
effect on lifespan. (See appendix, Table A.4 for survival statistics table and sample 
sizes). (B) Feeding on ground glass did not alter the level of P death. Data mean±s.e.m. 
(Student’s t test). 
 
If this theory were correct, then increasing the damage inflicted to the 
pharyngeal cuticle should increase P death. In an attempt to do this, 
worms were shifted at the L4 stage to plates where the surface was 
covered in microscopic glass particles that, upon examination under high 
magnification, appeared similar in size to bacteria (data not shown). As 
the glass particles had a jagged shape, it was hoped ingestion of them 
could exacerbate mechanical damage to the pharyngeal cuticle. Worms 
remained on the glass plates until day 4, as this is the period when the 
pharynx is pumping fastest (Huang et al. 2004). Exposure to glass had no 
effect on either lifespan or the levels of P death (Figure 5.17A,B). 
However no glass particles were observed within the intestine of these 
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worms, even under high magnification, making this result difficult to 
interpret. 
 
In another attempt to increase pharyngeal damage, worms were 
maintained in the presence of exogenous serotonin. Serotonin stimulates 
pharyngeal pumping and has been previously shown to increase pumping 
rate in the absence of bacteria, where pumping rate is much lower 
(Horvitz et al. 1982; Chow et al. 2006). However to study bacterial 
infection and P death, worms must be exposed to serotonin in the 
presence of bacteria. Serotonin (dissolved in HCl) or HCl alone was 
added topically to plates and worms were grown on these plates from the 
L4 larval stage until day 8. A two-way ANOVA revealed an overall 
significant effect of the bacterial lawn and serotonin on both days 4 and 7 
(day 4 comparison of bacterial lawn F(1,36)=199.6 p<0.0001, comparison 
for serotonin F(1,36)=228.3 p<0.0001. Day 7 comparison of bacterial 
lawn F(1,36)=60.08 p<0.0001, comparison for serotonin F(1,36)=76.48 
p<0.0001). This is to be expected as both the bacterial lawn and 
serotonin stimulate pharyngeal pumping. On day 4, serotonin did 
dramatically increase pumping rate in worms that were located away from 
the bacterial lawn (Figure 5.18C), as previously shown (Chow et al. 
2006). However it only slightly increased pumping rate in worms on the 
bacterial lawn (Figure 5.18C). On day 7, again serotonin increased 
pumping rate in worms away from the bacterial lawn, however it did not 
have an effect while worms were on the lawn (Figure 5.18D). Given these 
results, it was not surprising that serotonin had no significant effect on 
lifespan or the levels of P death (Figure 5.18A,B). In fact in both 
conditions, P death was lower than expected (~20%), suggesting HCl 
may reduce bacterial pathogenicity. Furthermore, long-term exposure to 
serotonin seemed to have various deleterious and pleiotropic effects, 
resulting in an increased proportion of animals being censored during the 
experiment. In a bid to reduce these effects and allow worms to become 
fully grown adults before treatment, the exposure time was reduced. This 
time worms were only grown on serotonin plates from day 4 to 8. 
However similar results were obtained (Figure 5.19) (Two way ANOVA. 
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Day 4 comparison for bacterial lawn F(1.36)=364.0 p<0.0001, 
comparison for serotonin F(1,36)=172.8 p<0.0001. Day 7 comparison for 
bacterial lawn F(1,36)=157.4 p<0.0001, comparison for serotonin 
F(1,36)=66.83 p<0.0001). 
 
Figure 5.18. The effects of serotonin exposure until mid-life on longevity, 
pharyngeal infection and pharyngeal pumping rate. Worms were exposed to 12mM 
serotonin (dissolved in HCl) or 1mM HCl from L4 larval stage until day 8, before being 
transferred onto untreated plates. (A) Serotonin had no effect on lifespan. (See 
appendix, Table A.5 for survival statistics table and sample sizes) (B) Serotonin had no 
effect on the percentage death with pharyngeal infection. (C) On day 4, serotonin can 
dramatically increase pharyngeal pumping rate when worms are off bacteria, but only 
has a small effect when worms are on bacteria. (n=10 per condition) (D) On day 7, 
serotonin can increase pharyngeal pumping rate when worms are off bacteria, but not 
when worms are on the bacterial lawn (n=10 per condition). Data mean±s.e.m. (p<0.05 
*, p<0.01** p<0.001 *** Sidak’s test). 
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Figure 5.19. The effects of serotonin exposure, only in mid-life, on longevity, 
pharyngeal infection and pharyngeal pumping rate. Worms were exposed to 12mM 
serotonin (dissolved in HCl) or 1mM HCl from day 4 until day 8 before being transferred 
onto untreated plates. (A) Serotonin had no effect on lifespan. (See appendix, Table A.5 
for survival statistics table and sample sizes) (B) Serotonin showed a trend for reducing 
the percentage death with pharyngeal infection. (C) On day 4, serotonin can increase 
pharyngeal pumping rate when worms are off bacteria, but slightly decreases pumping 
rate of worms on the lawn. (n=10 per condition) (D) On day 7, serotonin can increase 
pharyngeal pumping rate when worms are off bacteria, but not when worms are on the 
bacterial lawn. Data mean±s.e.m. (n=10 per condition) (p<0.05 *, p<0.01** p<0.001 *** 
Sidak’s test). 
 
Finally Y. Zhao and H. Wang tried the reverse experiment by exploring a 
situation where pharyngeal damage may be reduced. They looked at the 
levels of P death in various mutants, including eat-2(ad1116), where the 
pharyngeal pumping rate is lower than wild-type levels (Raizen et al. 
1995). In most cases these mutations caused a reduction in frequency of 
P death (Figure 5.20A). It has been previously shown that eat-2 mutants 
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have an extended lifespan and this was presumed to be due to DR, which 
was proposed to be caused by this mutation reducing food intake 
(Lakowski & Hekimi 1998). However by analysing the survival curves of 
both P and p death in eat-2, Y. Zhao and H. Wang showed that the timing 
of both P and p death was not altered in this mutant (Figure 5.20B). This 
suggests that the lifespan extension in eat-2 is mostly due to amelioration 
of pharyngeal infection rather than DR. Nevertheless it remains possible 
that, in certain conditions, the DR effect caused by mutation of eat-2 does 
have a larger contribution toward the longevity of this mutant. 
 
 
Figure 5.20. Lowering pharyngeal pumping rate reduces the level of P death. (A) 
The prevalence of P death is reduced in the majority of mutants that have a reduced 
pharyngeal pumping rate. (N2 n=47, eat-5 n=48, eat-13 n=39, unc-10 n=48, phm-2 
n=32, eat-10 n=10, eat-18 n=50, eat-2 n=55, unc-36 n=19, eat-7 n=39, phm-3 n=18) (B) 
The timing of both P and p death is unaffected in eat-2(ad1116) mutants. Data collected 
by Yuan Zhao and Hongyuan Wang (See appendix, Table A.6 for survival statistics and 
sample sizes). 
 
Overall these results provide evidence that the high pharyngeal pumping 
rate in early adulthood promotes mechanical senescence. When this 
occurs in the presence of proliferative bacteria early in life, it can cause 
pharyngeal infection later in life and subsequent P death.  
 
5.2.7 Evidence of wound healing in the pharyngeal cuticle as 
defence against bacterial infection 
 
We considered why only a fraction of an ageing C. elegans population 
experience P death. Conceivably, it could be due variations in pharyngeal 
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pumping rate early in life. Those that pump faster may accumulate more 
damage to the pharyngeal cuticle and thus be more vulnerable to 
bacterial invasion. The pumping rate of individual worms was recorded on 
day 1 and then necropsy analysis was performed upon their death. This 
revealed that there was no significant difference in the pumping rate on 
day 1 of adulthood between P and p death (Figure 5.21). Therefore 
variation in pumping rate in early adulthood does not explain the 
development of the two subpopulations.  
 
 
 
 
 
 
 
 
Figure 5.21. Pharyngeal pumping rate on day 1 of adulthood of P and p death 
worms. Worms that died from P death did not have a higher pumping rate on day 1 than 
worms that eventually died from p death. (P death n=14, p death n=10) (Student’s t 
test).  
 
As development of P death required exposure to proliferative bacteria 
early in life (Figure 5.16A,C), we hypothesised that in early adulthood the 
pharyngeal cuticle is able to initiate a wound healing response upon 
injury. We supposed the high pumping rate in early adulthood results in 
injury in the majority of worms, or perhaps in all of them. However, if 
efficient wound healing occurs, the resulting perforations could be sealed. 
Nonetheless, due to the stochastic nature of this damage, a proportion of 
worms may sustain higher levels of injury. In such worms, wound healing 
might not be rapid enough to repair all the injuries before extensive 
bacterial invasion has taken place. Therefore these worms will become 
the subpopulation that ultimately undergoes P death. Additionally, the 
presence of proliferating bacteria within or near the injuries could impede 
wound healing. This might explain why worms maintained for longer on 
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non-proliferating bacteria had lower levels of P death when subsequently 
exposed to proliferating bacteria (Figure 5.16A,C). 
 
Previous work showed that injuries caused to the C. elegans body wall 
cuticle, either using a needle or a laser beam, can heal resulting in the 
formation of scar tissue (Figure 5.22B) (Pujol et al. 2008). This 
demonstrates that C. elegans is capable of mounting a wound-healing 
response when damage occurs. Therefore to determine whether the 
pharyngeal cuticle can generate a wound healing response as well, we 
set out to find evidence of scar tissue within the pharynx. Worms 
expressing either PQN-2 or ABU-1 tagged with GFP were kindly sent to 
us by David Raizen’s group. These two proteins are found within the 
pharyngeal cuticle (David Raizen, correspondence). If either of these 
proteins were assimilated into any scar tissue, this should result in small 
puncta of GFP in the pharyngeal cuticle, particularly near the grinder. 
These worms were examined on days 1, 2, 3, 4 and 8 using 
epifluorescence microscopy and on day 9 using confocal microscopy. 
However no GFP puncta were detected in either strain (data not shown), 
suggesting either the absence of scars, or that if scars did form, they did 
not contain either PQN-2 or ABU-1. 
 
Next TEM images of day 8 worms were examined for any evidence of 
scar tissue, particularly near the pharyngeal grinder. This revealed 
electron dense material close to the grinder, analogous to the scars 
previously seen in the body wall cuticle (Figure 5.22A,B) (Pujol et al. 
2008). These images were sent to N. Pujol for an opinion and she also 
believed the pharyngeal cuticle to contain scar tissue. This implies that 
while the pharyngeal cuticle does become injured relatively early in life, it 
is able to launch a wound healing response. This results in the repair of 
any breaches to the external environment and therefore protects against 
bacterial invasion. 
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Figure 5.22.	Evidence of scarring in the C. elegans pharynx. (A) Image is from a day 
8 live adult. A large mass of material can be seen near the grinder (G). This appears to 
be caused by injury and subsequent wound healing, resulting in a scar (S). B, bacteria; 
L, lumen; Mt, mitochondria. (Scale bar = 2µm). (Images collected jointly by Ann Gilliat 
and Yuan Zhao, with technical assistance from Mark Turmaine). (B) Further evidence 
these masses are scars comes from their similarity to scars (S) that form in the 
epidermis of C. elegans after wound healing (Image from (Pujol et al. 2008)). 
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5.3 Discussion 
5.3.1 Latent infection may lead to P death in ageing C. elegans 
 
The results from this chapter demonstrate that a subpopulation of worms 
is subject to bacterial infection of the pharynx, which is associated with 
pharyngeal swelling and an early demise. This infection requires both 
exposure to proliferative bacteria, and wild-type pharyngeal function in 
early adulthood. The high pharyngeal pumping rate in early life is 
presumably beneficial to worms, as it allows for the rapid ingestion of 
food to fuel both the growth and huge reproductive output that occurs 
during this period. However, the evidence in this chapter suggests that 
high pharyngeal activity causes mechanical senescence. This promotes 
initial bacterial invasion and, in a subset of worms, subsequent death with 
pharyngeal infection, which we designated as P death.  
 
What remains unknown is the complete mechanism by which pharyngeal 
infection develops and ultimately results in P death. Furthermore it is 
unclear how worms that undergo p death are able to escape this fate. We 
propose the following model as an explanation to these queries (Figure 
5.23). As previously explained, in young worms the pharynx is healthy 
and functioning at full capacity. This high pumping rate causes injuries to 
the pharyngeal cuticle near the grinder. This is because the cuticle in this 
area experiences a high level of mechanical strain due to the force the 
grinder must exert to fully break down bacteria at high speed. Live 
bacteria in the pharyngeal lumen take advantage of the wounds in the 
cuticle and use them as route through which to invade the pharyngeal 
tissue. A wound healing response then occurs at the injury site, resulting 
in the formation of a scar. This closes the wound and should prevent 
further invasion. Two scenarios are then possible. Firstly, the bacteria 
that successfully invaded into the pharyngeal tissue, before wound 
healing occurred, continue to proliferate throughout the pharynx. This 
increase in bacterial load causes tissue degeneration, pharyngeal 
swelling and ultimately P death. Alternatively the bacteria from the initial 
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invasion could be contained, possibly within the double membrane 
structures seen in the TEM images (Figure 5.9C). Their proliferation could 
also be suppressed by action of the immune system. In some of these 
worms, these contained invasions remain latent until age-related 
deterioration occurs, e.g of the anti-bacterial responses. This could lead 
to the bacteria being free to resume proliferation throughout the pharynx 
and subsequently cause P death. This particular scenario proposes that 
the development of P death occurs in two distinct steps. Firstly, initial 
bacterial invasion, which ensues after mechanical injury. Then further 
escalation of the infection, which is promoted by age-related decline. In 
this model, the pharyngeal pathology associated with P death cannot 
simply be viewed as a result of infection and therefore something that 
should be ignored or eliminated for the purposes of ageing studies. 
Rather it is a pathology whose development requires the ageing process. 
Furthermore, it is a potential model for the study of damage or infections 
that remain latent until late life, when they become detrimental or virulent 
once again, due to the age-related decline of protective mechanisms.  
 
Examples of this can also be seen in humans. Contact sports, such as 
rugby, often cause significant knee or hip injuries to participants. These 
may eventually heal, yet ex-international rugby players are more likely to 
develop osteoarthritis in their hips and knees in later life than the rest of 
the general population (Davies et al. 2016). Another example of this 
phenomenon is the Varicella zoster virus, which causes chicken pox in 
young children. Once the individual has recovered, the virus is not 
cleared from the body but remains in a latent state within nerve cells. In 
old age, it can reactivate and cause shingles, a disease much more 
severe than chicken pox (Herpes Zoster and Functional Decline 
Consortium 2015). Perhaps the example most relevant to the work 
presented here is latent tuberculosis (Campion et al. 2015). 
Mycobacterium tuberculosis can invade the lungs but then be enclosed 
within granulomas, similar to how initial E. coli invasion of the pharynx is 
sometimes also contained. These individuals have no symptoms and can 
carry the latent infection for many years. However in 5-15% of cases, the 
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bacteria are able to escape suppression, resulting in full progression of 
the disease. This demonstrates the importance of understanding the age-
related mechanisms that can lead to the resurgence, in late life, of 
infections or injuries obtained early in life.  
 
 
 
 
Figure 5.23. A proposed mechanism for the development of P death. High pumping 
rate during adulthood causes a localized injury to the pharyngeal cuticle near the 
grinder. This creates a route through which bacteria can invade into the pharyngeal 
tissue. Wound healing occurs at the injury site, resulting in the formation of a scar. In 
some worms the infection immediately starts to progress; in others it is slightly delayed 
as invasions are initially contained, before age-related deterioration results in the 
infection starting to spread. In these worms the bacteria proliferates throughout the 
pharynx causing it to swell. This results in a lethal pathology and subsequent P death. In 
p deaths, presumably if initial invasions do occur, the worm is able to keep them 
contained throughout life. The age-related pathology that kills worms that undergo p 
death is still not clear. 
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In worms that eventually undergo p death, either the mechanisms that 
inhibit the advancement of pharyngeal infection remain active throughout 
life, or other pathological changes that promote re-emergence of infection 
do not occur. Therefore the initial bacterial invasion remains contained, 
which could result in the OP50-RFP foci seen within the pharynxes of 
corpses from worms that underwent p death (Figure 5.8B,C). The lethal 
pathology in p death is currently unknown, though previous work from 
chapter 4 and M. Ezcurra et al. suggests that it could be intestinal 
atrophy. 
 
5.3.2 Deconvolving mortality to solve the mysteries of ageing 
 
Nearly 25 years ago, Cynthia Kenyon made the remarkable discovery 
that mutation of daf-2 caused huge increases in lifespan in C. elegans 
(Kenyon et al. 1993). Since then many studies have shown that various 
other genes can also extend lifespan across a wide range of species, 
from yeast to mice (Kenyon 2010). Yet despite all these years of 
research, the biological mechanisms that drive the ageing process are 
still unknown. Why is this? The majority of work in the ageing field has 
focused mostly on searching for genes and pathways that have effects on 
lifespan. However it is difficult to establish a link between the biochemical 
activity of a gene product and a numerical parameter such as lifespan 
and mortality rate. For example, if mutation of a gene extends lifespan, 
while this result is interesting, a survival assay does not provide details on 
how pathologies are affected in these mutants. Without this information, it 
is very difficult, even impossible, to determine whether or how this gene 
contributes to the ageing process.   
 
To solve this longstanding problem, we propose that future work on 
ageing can be helped by a more pathology centred approach, including a 
method we termed ‘mortality deconvolution’. This involves the 
investigation of both mortality and necropsy data. This should help us to 
understand how various mutations or treatments actually extend lifespan, 
 208 
in terms of how they affect different senescent pathologies. If a pathology 
is lethal in a proportion of the population, extending lifespan must 
suppress or postpone its development. Given there are a large number of 
lethal age-related pathologies in humans and at least two forms of death 
in ageing C. elegans, different interventions that extend lifespan may 
achieve this by affecting different pathologies. If mortality deconvolution is 
performed, these differential effects on pathology may be revealed. For 
example, in this work, by deconvolving eat-2(ad1116) mutant mortality, Y. 
Zhao and H. Wang were able to demonstrate the longevity caused by 
mutation of eat-2 is mostly due to a suppression of P death, rather than 
because of DR, as previously thought (Lakowski & Hekimi 1998). 
Furthermore, later work from Y. Zhao showed that the lifespan extension 
seen in glp-1(e2141) mutants was due to a delay in the occurrence of p 
death, with no effect seen on P death (Zhao et al., 2017). With such new 
approaches we can begin to be understand how the activity of certain 
genes contributes towards the biology of the ageing process. Thus lethal, 
senescent pathologies can be identified and their development inferred, 
paving the way for the discovery of treatments that could promote 
longevity.  
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Chapter 6 Conclusions 
 
Here we have examined the development and underlying causes of a 
number of age-related pathologies across a range of different tissues in 
C. elegans. A central aim of my PhD was to determine what causes 
mortality in ageing C. elegans. To achieve this we set out to identify the 
tissue in the worm that develops life-limiting senescent pathology. 
Throughout this study we examined both previously described 
pathologies, such as uterine tumours, and novel ones that were 
discovered during this work, such as pharyngeal and tumour infection 
(Table 6.1). The C. elegans germline does undergo age-related 
deterioration, however work presented here in chapter 3 and elsewhere 
suggests that this is not lethal (Riesen et al. 2014; de la Guardia et al. 
2016). On the other hand, we have demonstrated in chapter 5 that 
pharyngeal infection is almost certainly a cause of age-related mortality. 
We propose that this initial bacterial invasion is promoted by cuticular 
injury, caused by high pharyngeal activity in early life. This work has been 
supported by a recent publication that revealed that wild-type C. elegans 
dies prematurely due to bacterial infection (Podshivalova et al. 2017). In 
chapter 4, we also succeeded in gathering morphometric data on the 
ageing intestine, which allowed the dynamics of intestinal atrophy to be 
scrutinised, revealing that the majority of intestinal biomass is lost 
relatively early in adult life. Furthermore yolk accumulation and intestinal 
atrophy occur at similar times in the hermaphrodite (Ezcurra et al., 
unpublished). This suggests these two pathologies are related. We 
propose that intestine biomass conversion to yolk drives intestinal 
atrophy. Additionally, M. Ezcurra and A. Benedetto have shown that 
various interventions that extend lifespan also suppress intestinal 
atrophy, implying that this pathology could also be lethal (Ezcurra et al., 
unpublished). 
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In many cases we have provided evidence that quasi-programmes may 
be the main cause of the development of some of these pathologies, 
along with other contributory factors such as mechanical damage to the 
pharyngeal cuticle. For example, quasi-programmed apoptosis in the 
germline and run-on of yolk production in the intestine both appear to 
contribute to the development of age-related pathology in their respective 
tissues. This provides support for the hyperfunction theory of ageing. 
However degeneration of these tissues might not solely be due to quasi-
programmes. Firstly, when apoptosis is blocked the hermaphrodite gonad 
still degenerates (de la Guardia et al. 2016). Secondly, even when 
intestinal biomass conversion is reduced by inhibiting autophagy, 
intestinal atrophy still occurs (Ezcurra et al, unpublished). Finally, it is 
unclear what age-related deteriorations result in widespread proliferation 
of bacteria within pharyngeal tissue. For example, damage to anti-
bacterial proteins could lead to advanced pharyngeal infection. Therefore 
in these situations it is possible molecular damage could be driving the 
development of pathology. 
 
Thus while this thesis have provided further evidence that hyperfunction 
promotes age-related pathology in C. elegans, it cannot be ruled out that 
molecular damage could also be a major contributory factor to the ageing 
process. Additionally, as emphasised in section 1.5, it is likely that in 
humans many different mechanisms will interact to promote age-related 
pathology. 
 
We have also revealed sexual dimorphism in ageing C. elegans, as the 
male gonad and intestine seems to be largely protected from the 
pathologies seen in the hermaphrodite. Perhaps this is because males 
have a very different reproductive state to hermaphrodites, thus 
protecting them from pathologies that are driven by the large reproductive 
output of the hermaphrodite.  
 
Hopefully future work will identify more life-limiting pathologies in both 
male and hermaphrodite C. elegans. For example, it is unknown what 
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kills worms that undergo p death. One possibility is intestinal atrophy, but 
it is likely there are still many other causes of death that have yet to be 
identified. The study of non-lethal pathology is also warranted as these 
pathologies are still related to ageing and can provide information about 
mechanisms that drive pathology, such as in the case of germline 
pathology in C. elegans. Furthermore even if they do not affect lifespan 
they may affect health span, such as reproductive ageing in humans. 
Thus by unravelling the complex mechanisms that drive age-related 
pathology, we hope future researches will gain fascinating insights into 
the ageing process. 
 
 
Pathology Possible causes 
Uterine tumours (Golden et al. 
2007) 
Endoreduplicating unfertilised oocytes 
(McGee et al. 2012) 
Bacterial invasion 
Intestinal atrophy (Herndon et 
al. 2002; McGee et al. 2011) 
(primarily between days 3 – 7) 
Constipation (Garigan et al. 2002) 
Intestinal biomass conversion 
Irregular intestinal atrophy Contraction or atrophy of intestinal cell 
boundaries 
Intestinal lumen dilation 
(Garigan et al. 2002) 
Constipation (Garigan et al. 2002) 
Intestinal atrophy caused by intestinal 
biomass conversion 
Yolk accumulation (Herndon 
et al. 2002; Garigan et al. 
2002; DePina et al. 2011; 
McGee et al. 2011) 
Continued synthesis post-reproduction 
(DePina et al., 2011; Garigan et al., 
2002; Herndon et al., 2002) 
Intestinal biomass conversion 
Pharyngeal swelling Bacterial invasion (McGee et al. 2011) 
Pharyngeal atrophy Sarcopenia (Chow et al. 2006) 
Other bacterial effects 
Table 6.1. The possible causes of pathologies examined in this study. Pathologies 
and possible causes in black have been previously described. Those in red have been 
discovered or proposed during this project.  
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Appendix 1. Statistics 
 
Strain/condition Number of 
deaths/ 
censors 
Mean 
[median] 
life span 
(days) 
% change 
vs. WT (no 
FUDR) 
p vs. WT 
(no FUDR) 
(log rank) 
% change 
vs. no 
FUDR 
p vs. no 
FUDR 
(log rank) 
N2 (wild-type) [C] 87/33 
[1] 46/14 
[2] 41/19 
17.0 [16] 
17.5 [16] 
16.8 [14] 
    
mdl-1(tm311) [C] 98/22 
[1] 49/11 
[2] 49/11 
12.9 [14] 
12.4 [14] 
13.3 [11] 
-24.1 [-12.5] 
-29.1 [-12.5] 
-20.8 [-21.4] 
<0.0001 
<0.0001 
0.0027 
  
N2 (wildtype) 
50µM FUDR 
[C] 112/8 
[1] 55/5 
[2] 57/3 
16.0 [16] 
17.3 [16] 
14.6 [14] 
-5.9 [0] 
-1.1 [0] 
-13.1 [0] 
0.0323 
0.5571 
0.0227 
-5.9 [0] 
-1.1 [0] 
-13.1 [0] 
0.0323 
0.5571 
0.0227 
mdl-1(tm311) 
50µM FUDR 
[C] 103/17 
[1] 54/6 
[2] 49/11 
12.2 [11] 
12.7 [11] 
11.6 [11] 
-28.2 [-31.3] 
-27.4 [-31.3] 
-31.0 [-21.4] 
<0.0001 
<0.0001 
<0.0001 
-5.4 [-21.4] 
+2.4 [-21.4] 
-12.8 [0] 
0.1854 
0.8005 
0.0320 
Table A.1. Survival statistics for wild-type and mdl-1 treated with FUDR from L4. 
[n] trial number, [C] combined data from all trials. 
 
 
 
Strain/condition Number of 
deaths/censored 
Mean 
[median] 
life span 
(days) 
% change vs. 
control 
p vs. control  
(log rank) 
N2 (control) [C] 157/42 
[1] 67/18 
[2] 90/24 
17.6 [18] 
16.6 [16] 
18.3 [19] 
  
N2 (UV-killed) [C] 157/44 
[1] 83/18 
[2] 74/26 
26.6 [28] 
27.7 [28] 
25.5 [25] 
+51.1 [+56] 
+66.9 [+75] 
+39.3 [+32] 
<0.0001 
<0.0001 
<0.0001 
N2 (control) [C] 419/75 
[1] 42/8 
[2] 277/51 
[3] 59/6 
[4] 41/10 
17.7 [17] 
17.9 [17] 
18.8 [20]  
17.2 [15] 
18.7 [18] 
 
 
 
 N2 (carbenicillin) [C] 225/13 
[1] 50/0 
[2] 68/1 
[3] 67/9 
[4] 40/3 
29.4 [30] 
30.4 [32] 
30.5 [30]  
29.7 [29] 
27.1 [27] 
+66.1 [+76]  
+69.8 [+88] 
+62.0 [+50] 
+73.0 [+93] 
+45.2 [+50] 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Table A.2 Survival statistics for growing wild-type worms on non-dividing 
bacteria. [n] trial number, [C] combined data from all trials. 
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Strain/condition Number of 
deaths/censored 
Mean 
[median] 
life span 
(days) 
% change vs. 
control 
p vs. control  
(log rank) 
N2 (control) [C] 95/33 
[1] 37/19 
[2] 58/14 
19.1 [18] 
19.5 [21] 
18.8 [18] 
  
N2 (day 1 shift off 
carbenicillin) 
[C] 110/15 
[1] 50/7 
[2] 60/8 
19.0 [19] 
19.0 [19] 
19.1 [18] 
-0.5 [+5.6] 
-2.6 [-9.5] 
+1.6 [0.0] 
0.9469 
0.4215 
0.4972 
N2 (day 2 shift off 
carbenicillin) 
[C] 111/14 
[1] 52/5 
[2] 59/9 
18.9 [21] 
19.2 [21] 
18.6 [21] 
-1.0 [+16.7] 
-1.5 [0.0] 
-1.1 [+16.7] 
0.8428 
0.6741 
0.6125 
 N2 (day 4 shift off 
carbenicillin) 
[C] 109/9 
[1] 54/1 
[2] 55/8 
19.1 [18] 
18.1 [17] 
20.0 [21] 
0.0 [0.0] 
-7.2 [-19.0] 
+6.4 [+16.7] 
0.9957 
0.1169 
0.1600 
N2 (day 6 shift off 
carbenicillin) 
[C] 107/8 
[1] 50/4 
[2] 57/4 
20.7 [21] 
20.0 [19] 
21.2 [21] 
+8.4 [+16.7] 
+2.6 [-9.5] 
+12.8 [+16.7] 
0.1291 
0.7477 
0.0115 
N2 (day 11 shift off 
carbenicillin) 
[C] 107/1 
[1] 48/0 
[2] 59/1 
21.3 [21] 
21.1 [21] 
21.5 [21] 
+11.5 [+16.7] 
+8.2 [0.0] 
+14.4 [+16.7] 
0.0598 
0.9389 
0.0092 
N2 (day 15 shift off 
carbenicillin) 
[C] 101/1 
[1] 47/0 
[2] 54/1 
23.5 [24] 
24.3 [24] 
22.8 [23] 
+23.0 [+33.3] 
+24.6 [+14.3] 
+21.3 [+27.8] 
<0.0001 
0.0037 
<0.0001 
N2 (carbenicillin) [C] 116/13 
[1] 50/8 
[2] 66/5 
27.2 [28] 
24.8 [24] 
29.0 [30] 
+42.4 [+55.6] 
+27.2 [+14.3] 
+54.3 [+66.7] 
<0.0001 
0.0002 
<0.0001 
N2 (control) [1] 67/18 
 
16.6 [16]   
N2 (day 1 shift off UV-
killed) 
[1] 66/9 16.6 [14] 0.0 [-12.5] 0.7922 
N2 (day 2 shift off UV-
killed) 
[1] 61/14 19.6 [21] +18.1 [+31.25] 0.0233 
 N2 (day 4 shift off UV-
killed) 
[1] 62/13 19.2 [21] +15.7 [+31.25] 0.0979 
N2 (day 6 shift off UV-
killed) 
[1] 61/14 20.3 [21] +22.3 [+31.25] 0.0201 
N2 (day 11 shift off UV-
killed) 
[1] 65/10 21.7 [21] +30.7 [+31.25] 0.0010 
N2 (day 15 shift off UV-
killed) 
[1] 64/11 22.6 [23] +36.1 [+43.8] <0.0001 
N2 (UV-killed) [1] 83/18 
 
27.7 [28] +66.9 [+75.0] <0.0001 
Table A.3. Survival statistics for maintaining wild-type worms on non-dividing 
bacteria, until various time points in adulthood. [n] trial number, [C] combined data 
from all trials. 
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Strain/condition Number of 
deaths/ 
censors 
Mean 
[median] life 
span (days) 
% change vs. 
control 
p vs. 
control 
(log rank) 
Control 
 
[C] 184/31 
[1] 94/12 
[2] 90/19 
14.4 [14] 
13.1 [12] 
15.7 [15] 
  
Glass 
(from L4 stage to day 4) 
[C] 200/18 
[1] 99/8 
[2] 101/10 
14.2 [14] 
12.9 [12] 
15.5 [15] 
-1.4 [0] 
-1.5 [0] 
-1.3 [0] 
0.6269 
0.4393 
0.4403 
Table A.4. Survival statistics for worms fed ground glass. [n] trial number, [C] 
combined data from all trials. 
 
 
Strain/condition Number of 
deaths/ 
censors 
Mean 
[median] life 
span (days) 
% change vs. 
HCl control 
p vs. HCl 
control 
(log rank) 
1 mM HCl 
(from L4 stage to day 8) 
[1] 64/19 
 
15.4 [16]   
12mM serotonin  
(from L4 stage to day 8) 
[1] 42/41 
 
13.7 [14] 
 
-11.0 [-12.5] 
 
0.2078 
 
1 mM HCl  
(from day 4 to day 8) 
[1] 76/34 14.8 [14]   
 
12mM serotonin  
(from day 4 to day 8) 
[1] 87/30 13.6 [12] -8.1 [-14.3] 
 
0.4341 
 
Table A.5. Survival statistics for worms treated with serotonin. 
 
 
Strain/ condition Number of 
deaths/ 
censored 
Mean 
[median] 
lifespan 
(days) 
% change vs. 
N2 control 
p vs. 
control  
(log rank) 
N2 (control) [C] 109/31 
[1] 46/24 
[2] 63/7 
18.6 [19] 
18.8 [18] 
18.4 [19] 
  
eat-2(ad1116) [C] 109/23 
[1] 55/15 
[2] 54/8 
21.4 [21] 
21.2 [21] 
21.6 [23] 
+15.1 [+10.5] 
+12.8 [+16.7] 
+17.4 [+21.1] 
0.0009 
0.0440 
0.0039 
Table A.6. Survival statistics for the eat-2 mutant. [n] trial number, [C] combined data 
from all trials. 
 
Genotype Comparison F Df P Significance 
mab-3 male Interaction 8.008 2 ,114 0.0006 *** 
 Age 23.78 2, 114 <0.0001 **** 
 vit-5,6 45.91 1, 114 <0.0001 **** 
mab-3 herm Interaction 10.47 2, 114 <0.0001 **** 
 Age 54.10 2, 114 <0.0001 **** 
 vit-5,6 51.90 1, 114 <0.0001 **** 
him-5 male Interaction 2.721 2, 114 0.0701 n.s 
 Age 9.904 2, 114 0.0001 *** 
 vit-5,6 0.0095 1, 114 0.9225 n.s 
him-5 herm Interaction 12.91 2, 114 <0.0001 **** 
 Age 71.09 2, 114 <0.0001 **** 
 vit-5,6 73.31 1, 114 <0.0001 **** 
Table A.7 Two-way ANOVA statistics for the effect of vit-5,6 RNAi on lipid pool 
scores during ageing in mab-3(mu15) and him-5(e1490) males and 
hermaphrodites. 
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Genotype Comparison F Df P Significance 
mab-3 male Interaction 0.0247 2, 114 0.9756 n.s 
 Age 101.9 2, 114 <0.0001 **** 
 vit-5,6 0.5983 1, 114 0.4408 n.s 
mab-3 herm Interaction 7.431 2, 114 0.0009 *** 
 Age 131.9 2, 114 <0.0001 **** 
 vit-5,6 6.175 1, 114 0.0144 * 
him-5 male Interaction 2.273 2, 114 0.1077 n.s 
 Age 4.165 2, 114 0.0180 * 
 vit-5,6 0.0572 1, 114 0.8113 n.s 
him-5 herm Interaction 2.262 2, 114 0.1088 n.s 
 Age 81.55 2, 114 <0.0001 **** 
 vit-5,6 30.88 1, 114 <0.0001 **** 
Table A.8 Two-way ANOVA statistics for the effect of vit-5,6 RNAi on intestinal 
atrophy during ageing in mab-3(mu15) and him-5(e1490) males and 
hermaphrodites. 
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INTRODUCTION 
 
In most animals, advancing age is accompanied by the 
deteriorative process of aging (senescence). Aging is the 
main cause of severe illness and death in humans, but 
the proximate biological mechanisms that cause it have 
proved difficult to identify. One approach to understand 
aging is to study simple model organisms [1], such as 
the nematode Caenorhabditis elegans which is 
particularly suitable for this purpose given e.g. its 
sequenced genome and very short lifespan (2-3 weeks).  
The identification from the 1980s onwards of many C. 
elegans mutants with altered aging rate [1] led to 
optimism that discovery of gene products of aging 
control genes would reveal the mechanisms of aging in 
this organism. Yet  although  many  signaling  pathways  
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and processes affecting aging rate have been identified, 
the nature of aging itself has remained obscure. For 
example, mutation of the daf-2 insulin/IGF-1 receptor 
gene can more than double adult lifespan [2]. This 
increase requires the presence of the DAF-16 FoxO 
transcription factor [2-4], suggesting that transcriptional 
targets of DAF-16 encode proximal biochemical 
determinants of aging. But these target genes have 
proved to be very numerous [5, 6], 2,274 by one 
estimate [7], complicating the search for DAF-16 target 
genes that control aging. Understanding DAF-16/FoxO 
action is important, particularly because the role of 
insulin/IGF-1 signaling and FoxO in the control of 
aging shows evolutionary conservation, e.g. in the 
fruitfly Drosophila [8], and perhaps even in humans, 
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Abstract: In C. elegans, increased lifespan in daf‐2 insulin/IGF‐1 receptor mutants is accompanied by up‐regulation of the
MDL‐1 Mad basic helix‐loop‐helix leucine zipper transcription factor. Here we describe the role of mdl‐1 in C. elegans
germline proliferation and aging. The deletion allele mdl‐1(tm311) shortened lifespan, and did so significantly more so in
long‐lived daf‐2 mutants implying that mdl‐1(+) contributes to effects of daf‐2 on lifespan. mdl‐1 mutant hermaphrodites
also lay increased numbers of unfertilized oocytes. During aging, unfertilized oocytes in the uterus develop into tumors,
whose development was accelerated by mdl‐1(tm311). Opposite phenotypes were seen in daf‐2 mutants, i.e. mdl‐1 and
daf‐2 mutant germlines are hyperplastic and hypoplastic, respectively. Thus, MDL‐1, like its mammalian orthologs, is an
inhibitor of cell proliferation and growth that slows progression of an age‐related pathology in C. elegans (uterine tumors).
In addition, intestine‐limited rescue of mdl‐1 increased lifespan but not to wild type levels. Thus, mdl‐1 likely acts both in
the intestine and the germline to influence age‐related mortality.  
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where age changes in allele frequency e.g. of the IGF-1 
receptor and FoxO3A genes have been detected [1].  
 
One approach to understand DAF-16 action is to map 
the gene regulatory network in which it acts. Previously 
we used a genome-wide approach to identify genes to 
which DAF-16 both binds and causes a change in gene 
expression [9]. This identified a mere 65 high 
confidence DAF-16 direct targets, which were enriched 
for genes encoding proteins involved in signaling and 
gene regulation, and transcription factors. Among the 
latter class was mdl-1 (Mad-like 1), which encodes a 
basic helix-loop-helix (bHLH) TF homologous to 
mammalian Mad transcription factors [10] (Figure 1A). 
In mammals, Mad TFs act as heterodimers with Max 
bHLH TFs. Mad competes with Myc bHLH TFs to 
dimerize with Max, and bind to target genes containing 
E-box sequences (5’-CANNTG-3’) [11]. Myc/Max 
dimers mainly activate gene expression, and are a major 
activator of cell proliferation of growth. By contrast, 
Mad/Max dimers mainly inhibit gene expression, 
antagonizing Myc/Max, and suppressing cell division 
and growth [11]. Inhibition of gene expression by 
Mad/Max is facilitated by recruitment of the Sin3 
histone deacetylase (HDAC) corepressor complex. Myc 
TFs are potent oncogenes, while Mad TFs show some 
properties of tumor suppressors [11].  
 
Our attention was drawn to mdl-1 for several reasons. 
First, many genes that promote growth also promote 
aging [12]. Thus, growth suppressors activated by DAF-
16 are candidates for downstream effectors slowing 
aging, and MDL-1, as a Mad TF, is a potential growth 
suppressor and, in fact, can suppress activated 
cMyc/Ras-induced cell transformation in mammalian 
cells [10]. Second, four mammalian Mad TFs, mad1, 
mxi1, mad3 and mad4, are up-regulated by FoxO3a in a 
human colorectal adenocarcinoma cell line [13]. Thus, 
regulatory interactions between FoxO and Mad show at 
least some evolutionarily conservation between 
nematodes and mammals. Consistent with this, in C. 
elegans mdl-1 is an activator of intestinal expression of 
ftn-1 (H ferritin, an iron storage protein) [14], while in 
mammals, Myc can repress H ferritin expression, which 
contributes to cell proliferation [15].  
 
C. elegans possesses several Max-like (mxl) genes, 
including mxl-1 which can form heterodimers with 
MDL-1 but, surprisingly, lacks Myc [10, 16, 17]. 
Previous RNAi screens have not detected major effects 
of expression knockdown of mdl-1 or mxl-1 
(Wormbase.org). However, mdl-1 exerts some influence 
upon the germline, as follows. Loss of daf-2 inhibits 
lethal, gld-1-induced distal germline tumors via 
decreased cell division and increased DAF-16/p53-
dependent apoptosis [18], and mdl-1 is a mediator of 
this inhibition [19]. Moreover, RNAi of mdl-1 can 
reduce daf-2 mutant longevity, but has little effect on 
lifespan in daf-2(+) worms [6].  
 
In this study, we explore the possible role of mdl-1 as a 
downstream effector of DAF-16 in the control of aging. 
In particular, we detail the phenotypic effects of 
mutation of mdl-1. We report that mdl-1 acts as a 
repressor of germline hyperplasia and hypertrophy 
which otherwise contributes to age-related pathology in 
the germline.  
 
RESULTS 
 
mdl-1(tm311) increases production of unfertilized 
oocytes 
 
To investigate mdl-1 gene function, we studied the mdl-
1(tm311) mutant allele, which contains a 471 bp base 
pair deletion that removes exon 2 of the gene (Figure 
1A). This results in a frame shift after 51/281 amino 
acid residues and loss of the entire bHLH domain, 
implying that this is a null allele. The mutation was first 
backcrossed 6x into the Caenorhabditis Genetics Center 
wild type male stock to remove possible second site 
mutations, and ensure a wild type background [20]. 
Previous work on mdl-1 and the function of Mad TFs in 
mammals led to several expectations about the possible 
effects of mdl-1(0). First, since it is a DAF-16-activated 
gene, it might suppress daf-2 mutant traits, e.g. 
constitutive dauer larva formation (Daf-c), stress 
resistance and increased longevity (Age). Second, since 
Mad TFs inhibit cell division and growth, mdl-1(0) 
might increase either somatic growth or germline 
proliferation.  
 
We first examined effects of mdl-1(0) on somatic 
development and growth in wild type and daf-2 mutant 
backgrounds. mdl-1(0) had no detectable effect on 
larval or adult growth (Figure 1B), but caused a slight 
reduction in constitutive dauer formation in daf-
2(m577) mutants (Figure 1C). Next we probed the 
effects of mdl-1 on the germline, first by looking at 
levels of fertility. The number of progeny produced by 
self-fertilized hermaphrodites was not affected by mdl-
1(0), either in terms of overall brood size or 
reproductive schedule (Figure 1D,E). As self sperm 
becomes depleted, N2 hermaphrodites start laying 
unfertilized oocytes [21]. Notably, mdl-1(0) caused a 
marked increase in the number of unfertilized oocytes 
laid, from 121 ± 15 to 219 ± 30, an 81% increase 
(Figure 1D). mdl-1(RNAi) applied to RNAi-sensitive 
rrf-3(pk1426) mutants also increased unfertilized oocyte 
number (data not shown).  
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In daf-2(m577) mutants, progeny number was also not 
different to N2, but the number of unfertilized oocytes 
laid was significantly reduced (Figure 1D,E), consistent 
with previous findings [22]. For convenience, to 
describe this mutant  phenotype  we  introduce  the  term  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Uno (abnormal in unfertilized oocyte production), and 
Uno-o, to describe mutants that are unfertilized oocyte 
over-producers (e.g. mdl-1), and Uno-d, to describe 
mutants that are unfertilized oocyte deficient (e.g. daf-
2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Phenotypic analysis of mdl‐1(tm311) mutant. (A) mdl‐1 gene and protein description, including tm311 deletion and
effects on protein, DAF‐16 binding sites (chromatin profile [DamID] data and DBEs) and site of ChIP analysis. For chromatin profile, y axis
represents log2 ratio of DAF‐16 binding relative to control, and peaks correspond to potential DAF‐16 binding sites [9]. (B –F). Phenotypic
effects of mdl‐1(0). (B) Little effect on larval and adult growth. Samples sizes ranged from 23‐39. (C) mdl‐1(0) slightly reduces daf‐2(m577)
Daf‐c, measured at 22.9˚C. * 0.01 < p < 0.05 (Student’s t test). 4 trials conducted, in which mdl‐1(0) reduced dauer formation in 3. (D, E)
Effect of mdl‐1 and daf‐2 on fertility. Number of broods scored: N2, 19; daf‐2, 20; mdl‐1, 17. (D) Mean total progeny and unfertilized
oocytes. * 0.01 < p < 0.05, *** p < 0.001 (Student’s t test). (E) Mean daily progeny and unfertilized oocyte numbers.  
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Figure 2. mdl‐1 causes hyperplasia and hypertrophy. (A, B) mdl‐1(0) causes oocyte stacking in 1 day old worms. (A)
Nomarski images. (B) Quantitation of stacking. Sample sizes: N2, 23; mdl‐1, 17. *** p < 0.001 (Student’s t test). (C) No effect of
mdl‐1 on number of germline nuclei. p > 0.05 (Student’s t test). (D, E) mdl‐1 increases levels of germline apoptosis. (D)
Epifluorescence images of SYTO12 stained cells in young adult hermaphrodite germline. (E) Quantitated data. Number of gonads
scored: N2, 153; mdl‐1, 132. *** p < 0.001 (Student’s t test). (F, G) mdl‐1 increases cytoplasmic streaming in the proximal gonad.
(F) Single image obtained from a time‐lapse recording. Arrows represent DIC‐particle tracks. DIC‐particles were tracked over a
period of 1 minute. Scale bar: 20 µm. (G) Cytoplasmic streaming rate (mean particle speed ± standard error). 30 particle speed
measurements performed for each genotype. Number of worms examined: N2, 4; mdl‐1, 3. *** p < 0.001 (Student’s t test). (H)
Absence of effect of mdl‐1(0) on gonad disintegration (25˚C). p > 0.05 for all comparisons of N2 vs. mdl‐1 of the same age
(Wilcoxon Mann test). (I) Uterine status scale for quantitation of uterine tumor formation rate (5 classes). Class 1, normal uterus
containing eggs (day 1 adult). Class 2, slightly abnormal uterine contents, but no tumor visible. Class 3, small tumor. Class 4,
medium sized tumor. Class 5, large tumor, filling body cavity and squashing the intestine. Dotted line, outline of uterus. T, tumor.
(J) mdl‐1(0) increases uterine tumor formation (25˚C), data summed from 3 trials. * 0.01 < p < 0.05 (Wilcoxon Mann test). 
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mdl-1(tm311) causes germline hyperplasia and 
hypertrophy 
 
The mdl-1 Uno-o phenotype suggests increased cell 
production in the germline distal to the spermatheca. To 
test this we compared proximal gonad contents in wild 
type and mdl-1 animals on day 1 of adulthood. This 
revealed increased oocyte density, or stacking [23, 24], 
in mdl-1 (Figure 2A,B), implying increased oocyte 
synthesis. This in turn suggests increased germ cell 
proliferation in the distal gonad.  To probe this, we 
examined germ cell number by staining nuclei with the 
fluorescent DNA-binding dye 4',6-diamidino-2-
phenylindole (DAPI), but no effect of mdl-1 was 
detected (Figure 2C). However, an increase in the 
overall rate of germline cell turnover in mdl-1 mutants 
could leave cell number unaffected.  
 
If the distal proliferative zone is the source of germ cell 
nuclei, then the major sink is germline apoptosis. At 
least 50% [25] and as many as 97% [26] of germ cells 
undergo p53-independent, “physiological” apoptosis, 
their cytoplasm supplying expanding oocytes near the 
gonad bend. Using the SYTO 12 dye to detect apoptotic 
cell corpses, we found that mdl-1 mutants showed a 
significant increase in apoptotic cell number in the 
germline in 3 out of 4 trials (Figure 2D, E).  
 
The transfer of cytoplasm released by germ cells to 
nascent oocytes occurs by a process of cytoplasmic 
streaming (Figure 2F) [27]. We examined the effect of 
mdl-1(0) on the rate of cytoplasmic streaming in the 
mid-late pachytene region of the distal gonad, on day 1 
of adulthood. Cytoplasmic streaming rate in mdl-1 
worms was significantly greater than in wild type 
(Figure 2G). Taken together, these results suggest that 
an increase in production of germ cells is matched by an 
increase in apoptosis, resulting in little change in overall 
germ cell number in the distal arm. Overall, this 
suggests that the increase in oocyte production is driven 
by a hyperplastic state in the distal gonad.  
 
Next we studied the effect of mdl-1 on pathologies of 
aging in the germline. The aging hermaphrodite gonad 
undergoes dramatic pathological changes. The distal 
gonad shrivels and eventually disintegrates [28, 29], 
while in the uterus large, amorphous masses (tumors) 
with very high DNA content develop [24, 29-31]. These 
tumors form from unfertilized oocytes which undergo 
multiple rounds of endoreduplication, and can grow to 
fill the entire body cavity in the mid-body. Continued 
germline apoptosis in late life contributes to gonad 
disintegration, and increased apoptosis rate is sufficient 
to increase gonad disintegration rate (Y. de la Guardia 
and D. Gems, unpublished). However, despite their 
increased apoptosis rate (Figure 2D,E) gonad 
disintegration rate was not detectably altered in mdl-1 
mutants (Figure 2H).  
 
Casual observation of mdl-1 hermaphrodites under 
Nomarski microscopy suggested an increase in uterine 
tumors in these mutants. To verify this, we used a semi-
quantitative approach [28] with a uterine status scale. 
According to the appearance of the uterus, worms were 
scored from 1 (healthy, no tumors) to 5 (large tumors) 
(Figure 2I) (see Materials and Methods). Using this 
scale to compare N2 and mdl-1 mutants confirmed that 
uterine tumors grow significantly faster in mdl-1 worms 
(Figure 2J).  
 
mdl-1 does not mediate effects of daf-2 on germline 
proliferative status 
 
We next investigated whether MDL-1, like DAF-16, is 
an effector of daf-2 mutant phenotypes. We first 
verified that DAF-16 acts directly on mdl-1 to increase 
its expression, as predicted by mRNA and chromatin 
profiling studies [9]. Quantitative RT-PCR confirmed 
that mdl-1 mRNA levels are higher in daf-2 than in daf-
16; daf-2 strains (Figure 3A). Chromatin immuno-
precipitation and PCR (ChIP-PCR) confirmed that 
DAF-16 binds to the mdl-1 promoter (Figure 3B). This 
implies that mdl-1 expression is activated by DAF-16 
binding to its promoter.  
 
mdl-1 mutants are Uno-o while daf-2 mutants are Uno-
d (Figure 1D,E) [22], and DAF-16 activates mdl-1 
expression (Figure 3A,B) [9]. This could imply that 
increased mdl-1 activity in daf-2 mutants reduces 
oocyte production. To test this we asked whether mdl-
1(tm311) would suppress daf-2 Uno-d, but it did not. 
Instead, daf-2(m577); mdl-1 worms were Uno-d 
(Figure 3C), i.e. daf-2 is epistatic to mdl-1. daf-
2(m577) also suppressed mdl-1 effects on oocyte 
stacking and uterine tumor formation (data not shown). 
These results negate our hypothesis that daf-2 Uno-d is 
caused by mdl-1 over-activity. A different model was 
suggested by additional epistasis data as follows. In a 
daf-2(+) background, daf-16 suppressed mdl-1 Uno-o, 
consistent with the observation that daf-16 over-
expression in a daf-2(+) background can cause 
germline hyperplasia [32]. Thus, DAF-16 promotes 
oocyte production in a daf-2(+) background but 
inhibits it in a daf-2(m577) background (Figure 3D). 
Moreover, mutation of daf-16 in a daf-2; mdl-1 mutant 
did not restore MDL-1 Uno-o (Figure 3C). This 
suggests that MDL-1 suppresses the effect of DAF-16 
on oocyte production in daf-2(+) worms, but plays no 
role in daf-2 mutants (Figure 3D).  
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Figure 3. Distinct epistatic relationships between daf‐2 and mdl‐1 in hyperplasia and hypertrophy. (A, B). mdl‐1 is a
direct transcriptional target of DAF‐16. (A). mdl‐1 mRNA levels are increased in daf‐2 relative to daf‐2; daf‐16 (Q‐PCR data). **
0.001 < p < 0.01. (B) DAF‐16 binds to the mdl‐1 promoter (ChIP‐PCR data). One experiment is shown which contained 3
immuno‐precipitation replicates from the same chromatin preparation (error bars show the standard deviation between them).
The dotted line shows the average inputs from 3 genes/genomic regions that do not show enrichment for DAF‐16 binding in
daf‐2 vs daf‐16; daf‐2 in this particular trial, i.e. it reflects background DAF‐16 binding levels. Significant DAF‐16 binding was
detected one of two additional trials. The position of the DAF‐16 binding site detected is shown in Figure 1A. (C) mdl‐1, daf‐2
and daf‐16 epistasis analysis with respect to unfertilized oocytes production (Uno). Total unfertilized oocyte production per
worm was measured at 25˚C. Means of 12 broods assessed; error bars, standard error. ** 0.001 < p < 0.01; *** p < 0.001
(Student’s t test). (D) Model for interactions between DAF‐2, DAF‐16 and MDL‐1, deduced from interactions between
mutations. DAF‐16 promotes oocyte production in daf‐2(+) worms, but inhibits it in daf‐2(m577) worms. MDL‐1 acts via DAF‐16
to inhibit oocyte formation in daf‐2(+) worms, but does not influence oocyte production in daf‐2(m577) worms. (E) Resistance
to 7.5 mM tert‐butylhydroperoxide (t‐BOOH). Sample sizes (censored values): N2, 67 (7); daf‐2(m577), 61 (8); mdl‐1, 67 (8); daf‐
2; mdl‐1, 70 (12). Probability of being the same: N2 vs. mdl‐1, p = 0.24; daf‐2 vs. daf‐2; mdl‐1, p < 0.001 (log rank test).  
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daf-2 mutants exhibit various forms of stress resistance, 
including oxidative stress resistance (Oxr) [33]. We 
tested whether MDL-1 contributes to daf-2 Oxr, 
specifically to tert-butylhydroperoxide (t-BOOH). In a 
wild-type background, mdl-1(0) did not affect Oxr, 
while daf-2(m577) markedly increased Oxr (Figure 3E). 
Notably, in a daf-2(m577) background, mdl-1(0) 
significantly decreased Oxr. This implies that MDL-1 
contributes to daf-2 Oxr.  
 
MDL-1 contributes to daf-2 mutant longevity by 
reducing baseline hazard 
 
Next, we examined the effect of mdl-1 on aging. First 
we compared effects of mdl-1(RNAi) on lifespan in rrf-
3 and rrf-3; daf-2(e1368) strains (25˚C), and detected a 
reduction in lifespan only in the latter strain (data not 
shown), consistent with previous observations [6]. We 
then assessed the effect of mdl-1(tm311) on lifespan in 
wild-type or daf-2(m577) mutant backgrounds. mdl-1 
decreased lifespan in both wild-type and daf-2 
backgrounds, but the decrease was proportionally 
greater in the latter (Figure 4A, Table S1). This 
corresponded to a significantly greater mdl-1-induced 
increase in mortality in a daf-2 background (4.5-fold vs 
1.8-fold; significant interaction term, p < 10-15, Cox 
proportional hazard analysis), suggesting that mdl-1 
activity contributes to the daf-2 longevity increase. 
 
To further characterize the effect of mdl-1 on aging, we 
examined its effect on the pattern of age-specific 
mortality  in  wild-type  and  daf-2(m577)  backgrounds.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aging animal populations typically show exponential 
increases in mortality rate, and in C. elegans this occurs 
in two stages, with an initial faster exponential increase 
and a subsequent slower exponential increase [34, 35]. 
We fitted mortality data to a logistic model, which 
contains 3 components: a baseline hazard (initial 
mortality rate, parameter a), a mortality increase rate 
(parameter b) and a late-life mortality deceleration 
(parameter s).  
 
In this analysis we wanted to probe whether mdl-
1(tm311) shortens lifespan by accelerating aging or 
whether it could act by a life-shortening effect unrelated 
to aging. An effect of mdl-1 on parameters b and s 
would imply an effect on aging, whereas an effect on 
parameter a could imply a non-aging related deleterious 
effect. In fact, mdl-1 increased baseline hazard (a) 
without affecting the mortality increase rate (b) (Figure 
4B-D). By contrast, relative to wild type, daf-2(m577) 
markedly decreased parameters b and s, while also 
slightly increasing parameter a. Reducing insulin/IGF-1 
signaling has long been known to slow the age-related 
mortality rate increase [36]. In a daf-2 background, mdl-
1(0) again increased baseline hazard, and had no 
significant effect on parameters b and s (p > 0.05) 
(Figure 4C,D). In summary, this analysis confirms that 
daf-2 increases lifespan by slowing demographic aging, 
while mdl-1 shortens lifespan mainly by increasing 
baseline hazard. That mdl-1 shortens lifespan more in a 
daf-2 background could imply that MDL-1 contributes 
to daf-2 longevity by reducing baseline hazard (see 
Discussion).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Effects of mdl‐1 on aging. (A) Effects of mdl‐1(tm311) on lifespan (for statistics, see Table S1, combined data). (B)
Effect of mdl‐1 on age‐specific mortality profiles. (C, D) Mortality analysis using logistic model. (C) Estimated values of logistic
model parameters. (D) Probability, p, of parameters in compared genotypes being the same, holding other parameters constant. 
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Uterine tumors do not limit lifespan 
 
mdl-1(0) accelerates formation of uterine tumors, which 
frequently grow very large, filling the body cavity in the 
mid-body region and squashing the intestine [31]. One 
possibility is that uterine tumors can contribute to 
mortality and that increased tumor formation in mdl-
1(0) mutants causes a shortened lifespan. To test this, 
we  examined  the  effect  of  mdl-1  on  lifespan  in  the  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
absence of uterine tumors. glp-4(bn2) mutants have a 
temperature-sensitive germline proliferation defect; if 
raised at 15˚C to L4 and then switched to 25˚C, oocyte 
production is blocked but longevity is not increased [7]. 
We first confirmed that glp-4 blocks formation of 
uterine tumors (Figure 5A). We then compared lifespan 
in glp-4, mdl-1 and glp-4; mdl-1 worms. glp-4 worms 
were normal-lived, but both mdl-1 strains were similarly 
short lived (Figure 5B; Table S2).  
Figure 5. No effect of uterine tumors on lifespan. (A) Uterine tumors are not seen in glp‐4(bn2) mutants
(raised at 15˚C to L4 then shifted to 25˚C). Uterine classes 2‐5 indicate presence of tumors. Each dot corresponds to
a uterine status measurement. (B) glp‐4 does not suppress mdl‐1 effects on lifespan (for statistics, see Table S2, trial
1). (C) FUdR suppresses formation of uterine tumors at 50ÖM or greater. Stars represent a significant difference to
worms of the same genotype in the absence of FUdR. No significant difference in tumor levels between N2 and mdl‐
1 were detected at this age at any FUdR concentration. * 0.01 < p < 0.05; ** 0.001 < p < 0.01; *** p < 0.001
(Wilcoxon Mann test). (D) 50 M FUdR does not suppress mdl‐1 shortevity or increase N2 lifespan (for statistics, see
Table S2, trial 1). (E) Effect of mdl‐1 on glp‐4 longevity (for statistics, see Table S2, trial 2).  
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We also blocked uterine tumor formation using the 
inhibitor of DNA replication 5-fluoro-deoxyuridine 
(FUdR), which is also commonly used to treat 
colorectal cancer. Application of FUdR at low 
concentrations (e.g. 10-25ÖM) from L4 stage is a 
convenient means to block progeny production, and has 
little effect on lifespan [37]. 50ÖM FUdR, but not lower 
FUdR concentrations, was sufficient to block formation 
of uterine tumors (Figure 5C). We then compared 
effects of 50ÖM FUdR on lifespan in wild type and mdl-
1 worms, and saw no effect on lifespan in either case 
(Figure 5D; Table S2). These results show that 
accelerated formation of uterine tumors do not cause the 
shorter lifespan of mdl-1 worms. They also demonstrate 
that uterine tumors do not limit lifespan in wild type 
worms under standard culture conditions. This contrasts 
with the case of daf-16 over-expression, where life 
shortening is suppressed by blocking germline 
hyperplasia either with glp-1 or FUdR [32]. 
 
A number of interventions that remove the 
hermaphrodite germline cause increased lifespan, 
including raising glp-4(bn2) mutants at 25˚C, and this 
effect is daf-16 dependent [38, 39]. Notably, mdl-1(0) 
also reduced the longevity of glp-4 mutants raised at 
25˚C (Figure 5E, Table S2). mdl-1 shortened lifespan 
more in a glp-4 background than in a wild-type 
background (Table S2). This suggests that mdl-1(+) 
contributes to glp-4 longevity as well as daf-2 
longevity. 
 
Evidence that mdl-1 can act in the intestine to 
promote longevity 
 
The intestine plays an important role in daf-2 mutant 
longevity [40], and is a site of mdl-1 expression [10]. 
One possibility is that mdl-1 affects intestinal protein 
synthesis. Mutation of daf-2 causes a global reduction 
in protein synthesis, which may contribute to longevity 
[41, 42]. In aging hermaphrodites, yolk proteins 
(vitellogenins) become very abundant indeed [43, 44], 
and this accumulation is suppressed daf-2, apparently 
by inhibition of protein translation in the intestine [45] 
where yolk is synthesized [46]. Thus, vitellogenin 
accumulation rate gives some indication of intestinal 
protein synthesis rate. However, mdl-1(0) did not alter 
vitellogenin accumulation, either in wild type or daf-2 
mutant backgrounds (Figure 6A,B). One possibility is 
that mdl-1 mutants do synthesize more vitellogenin, but 
due to increased laying of unfertilized oocytes, this does 
not result in increased vitellogenin accumulation. To 
check this we compared sterile glp-4 and glp-4; mdl-1 
worms (shifted at L4 to 25˚C), but again no effect of 
mdl-1 was seen (Figure 6A,B).  
 
Next, we asked whether intestine-limited rescue of mdl-
1 using the ges-1 promoter [47] would rescue mdl-1 
shortevity. A transgene array from which mdl-1 was 
expressed using its own promoter was able to restore 
wild-type lifespan to mdl-1(tm311) mutants (Figure 6C; 
Table S3). Notably, pges-1::mdl-1 too increased 
lifespan in mdl-1 mutants, though the effect was smaller 
such that lifespan was not restored to wild type. This 
suggests short lifespan in mdl-1 mutants is caused by 
loss of mdl-1 from several sites, including the intestine. 
Possibly, a second site of action of mdl-1 on lifespan is 
the germline, given its impact on that tissue. 
 
The extent of loss of Myc among nematodes 
 
One puzzle relating to mdl-1 function is the absence of 
Myc in C. elegans. In mammals, the Mad/Max/Myc 
system works in concert with the Tor pathways to control 
growth [48]. C. elegans also lacks key components of the 
Tor pathway, including the Tsc1/Tsc2 complex [49], and 
4E-BP [50] (Figure 7A). To try to understand the 
significance of the absence of Myc in the broader context 
of nematode gene loss, we tested for the presence of 
Myc, Tsc1, Tsc2 and 4E-BP throughout the Nematoda. It 
was previously noted that Myc orthologs are absent not 
only from C. elegans and C. briggsae, but also the filarial 
parasite Brugia malayi (nematode order Spirurida), and 
even the bilharzia parasite Schistosoma mansoni (phylum 
Platyhelminth) [51]. Searching the genomes of 13 
nematode species, including representatives of the major 
nematode orders, no Myc orthologs were detected 
(Figure 7B). Myc was also absent from all 5 
platyhelminth species examined. This implies that Myc 
evolved in the common ancestor of arthropods and 
chordates after divergence from the common ancestor of 
nematodes and platyhelminths, as previously suggested 
[51]. Thus, the Myc-less Mad-Max circuit in C. elegans 
appears to represent a more ancient regulatory system.  
 
By contrast, both Tsc1/Tsc2 and 4E-BP were found in 
several nematode groups but were absent from many 
others, in a pattern indicating that each gene has been lost 
several times during nematode evolution. For Tsc1 and 
Tsc2, gene loss was correlated, i.e. both genes were either 
present or absent. There was no correlation between loss 
of Tsc/Tsc2 and 4E-BP: nematode species exist with 
Tsc1/Tsc2 but lacking 4E-BP and vice versa. The 
distribution of Tsc1/Tsc2 is surprising in that most 
nematode and all platyhelminth groups lack this complex, 
apart from spirurid nematodes, and two rhabditid species. 
Sequence comparisons of Tsc1 and Tsc2 protein 
sequences from nematodes and other animal groups is 
consistent with multiple instances of gene loss (rather 
than horizontal gene transfer) (Figure 7C). 
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Figure 6. Tests for action of mdl‐1 in the intestine. (A,B) Effect of mdl‐1 on yolk accumulation. (A) Example of
Coomassie stained gel with C. elegans protein extracts. (B) Bar graph data is derived from densitometric measurement
of protein on gels (means of 3 biological replicates; error bars, standard error). It shows levels of the major yolk protein
YP170 normalized to myosin levels (which are not expected to change), and again to levels in N2 on day 1. Actin/myosin
ratio gives an indication of the reliability of myosin as a standard. * 0.01 < p < 0.05; ** 0.001 < p < 0.01, compared to N2
of the same age. (C) Effects on lifespan of pges‐1::mdl‐1(+) rescue of mdl‐1(0) (for statistics, see Table S3, trial 2).  
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DISCUSSION 
 
In this study we have shown that MDL-1 acts as an 
inhibitor of germline proliferation, and of oocyte 
hypertrophy, thereby inhibiting a salient aging-related 
pathology (uterine tumors). These properties of mdl-1 
mutants recapitulate effects of Mad TFs in mammals, 
e.g. mice lacking the Mad TF Mxi1 show hyperplasia in 
a number of tissues (e.g. prostatic epithelium), and are 
tumor prone [52]. We also confirm that MDL-1 inhibits 
aging, consistent with the observed association between 
tumor suppressors and inhibition of aging [53, 54]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does mdl-1 act downstream of daf-16? 
 
Our initial hypothesis was that activation of mdl-1 
expression by DAF-16 contributes to daf-2 longevity. 
The results of analysis of mdl-1 expression (Figure 
3A,B) and the effects on lifespan of mdl-1(tm311) 
(Figure 4A) are consistent with this hypothesis. We also 
noted that mdl-1 and daf-2 have opposing effects on the 
germline: mdl-1(0) causes Uno-o, increased oocyte 
stacking and increased uterine tumors (this study), while 
mutation of daf-2 has opposite effects [22, 29]. This 
suggested that the effects of daf-2 on the germline 
Figure 7. Extent of loss of Myc, Tsc1/Tsc2 and 4E‐BP among the Nematoda. (A) Outline of missing
elements of Tor and Myc/Max/Mad pathways in C. elegans. Green, tumor‐suppressor/anti‐aging; orange,
oncogene/pro‐aging. In brackets, proteins missing from C. elegans.  (B) Presence and absence of Myc, Tsc1,
Tsc2 and 4E‐BP among nematodes and platyhelminths. Red, absent; dark blue, present; pink, not found; pale
blue, putative but somewhat divergent 4E‐BP. Not found: a caveat to this analysis may be the incompleteness
of the genomic sequences of some of these species with draft assemblies being available for G. pallida and H.
contortus and only contigs available for T. muris. (C) Phylodendrograms of Tsc1 and Tsc2 sequences for
nematodes and other animal groups. Note that species and sequence phylogenies correspond. 
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might be mediated by mdl-1. However, epistasis 
analysis shows that this is not the case for oocyte 
production (Figure 3C). Instead mdl-1 appears to have 
no effect on the germline in daf-2 mutants, but to inhibit 
promotion of germline proliferation by DAF-16 in daf-
2(+) worms (Figure 3D).  
 
Does mdl-1 affect aging? 
 
The life-shortening effect of mdl-1(0) is mainly the 
result of increased base-line hazard (Figure 4B-D). This 
could imply that mdl-1(0) does not affect aging but, 
rather, shortens lifespan by causing a pathology that is 
distinct from aging. In similar fashion, a comparison of 
mortality in two groups of people during the 1940s, 
either in Australia or interned by the Japanese, showed 
increased base-line hazard but not increased 
demographic aging in the latter [55]. It is interesting to 
consider whether this necessarily means that the effect 
of mdl-1 on lifespan does not involve an effect on 
aging. The impact of mdl-1(0) on lifespan is greater in a 
daf-2 background, suggesting that MDL-1 does 
contribute to daf-2 longevity, i.e. that mdl-1 does affect 
aging. Arguably, the critical point here is that something 
that affects demographic aging necessarily affects 
biological aging, while something that affects base-line 
hazard may or may not affect biological aging. In other 
words, the biological process of aging is not always the 
same thing as demographic aging.  
 
One working definition of biological aging is the set of 
endogenously generated pathologies that increase in 
later life [56]. In principle, interventions that reduce one 
or more age-related pathology (i.e. part or all of aging) 
could increase lifespan by reducing base-line hazard, 
demographic aging, or both. One possibility is that the 
wider the spectrum of age-related pathologies that an 
intervention suppresses, the more likely will a reduction 
in demographic aging be seen. In conclusion, mdl-1(0) 
may or may not affect aging. Its greater effect on daf-2 
could imply that it does; however, an alternative 
possibility is that mdl-1(0) causes a pathology that is 
distinct from those seen during aging, and that daf-2(-) 
slightly increases the severity of this pathology, or 
increases its effect on mortality.  
 
Where and how does mdl-1 act to impact lifespan? 
 
The phenotype of mdl-1(tm311) mutants demonstrates 
that MDL-1 acts as a repressor of growth and 
proliferation in the germline. This is consistent with the 
role of Mad TFs as repressors of growth and proliferation 
in mammals [11]. A long-standing hypothesis about 
aging is that it is caused by molecular damage, but more 
recently it has been suggested that aging is caused by the 
run on of developmental and reproductive processes in 
late life, leading e.g. to pathological hyperplasia, 
hypertrophy and atrophy [57-59]. The action of MDL-1 
as a DAF-16-activated suppressor of growth is broadly 
consistent with this model.  
 
The mdl-1 mutant phenotype also suggests that this 
gene may affect lifespan through its effects on the 
germline. One possibility is that over-production of 
oocytes or increased formation of uterine tumors per se 
cause a decrease in lifespan. However, our findings 
argue against this: suppression of these effects in mdl-1 
mutants using glp-4 or FUdR does not suppress the life-
shortening effects of mdl-1(0) (Figure 5B,D).  A second 
possibility is that mdl-1(0) affects signaling from the 
germline; removal of the germline can extend lifespan, 
and this effect is daf-16 dependent [39]. Consistent with 
this possibility, mdl-1(0) shortens lifespan somewhat 
more in long-lived germlineless glp-4 mutants than in 
otherwise wild-type worms (Figure 5E).  
 
Another possible site of mdl-1 action on lifespan is the 
intestine, which plays a significant role in the control of 
aging [40], and where mdl-1 is expressed [10]. Notably, 
intestine-limited rescue of mdl-1(+) in otherwise mdl-
1(0) worms was sufficient to modestly increase lifespan. 
However, how mdl-1 acts in the intestine remains 
unclear. Mutation of daf-2 increases intestinal 
expression of ftn-1, which encodes the iron storage 
protein ferritin. This increase is wholly daf-16 
dependent and partially mdl-1 dependent [14]. Free iron 
is required for growth (e.g. ferroprotein synthesis) but 
also generates oxidative stress. Thus, increased activity 
of MDL-1 in daf-2 mutants might retard intestinal aging 
as part of a program of suppression of protein 
biosynthesis. However, we did not detect an effect of 
mdl-1 on accumulation of the most abundant protein 
class in C. elegans hermaphrodites, the vitellogenins 
(Figure 6A,B), which are synthesized in the intestine 
[46]. However, it remains possible that other aspects of 
protein synthesis are reduced by mdl-1.  
 
Alternatively, mutation of mdl-1 might increase levels 
of free iron in the intestine, perhaps accelerating aging 
by increasing oxidative damage, as suggested by the 
free radical theory. Consistent with this, mdl-1(0) 
partially suppress daf-2 Oxr (Figure 3E), suggesting that 
MDL-1 promotes Oxr in daf-2 mutants. However, mdl-
1(0) alone did not affect Oxr; moreover, free iron levels 
appear to have little effect on aging under standard 
culture conditions [60]. More broadly, a range of studies 
suggest that oxidative damage is not a central 
determinant of aging, particularly in C. elegans [61, 62]. 
Together, these findings suggest that the intestine is one 
of several sites of action of mdl-1 on lifespan. 
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The significance of uterine tumors in C. elegans 
 
The oocyte-derived growths in the C. elegans uterus have 
been noted in previous studies and referred to as ‘tumor-
like’ growths [30], masses [24] and oocyte clusters [29]. 
Dictionary definitions of the word tumor vary, but in the 
common understanding of tumor, as in “a growth — a 
mass of tissue — that has no function” [63], these entities 
are tumors, hence our use of the term in this study. 
Arguably, C. elegans uterine tumors are both different 
and similar to mammalian cancer. It seems likely that C. 
elegans uterine tumors result from aging-associated 
overgrowth rather than mutations in oncogenes or tumor 
suppressor genes. But much of mammalian cancer, like 
worm uterine tumors, is part of the aging process. While 
it is clear that aging and cancer are associated, the 
relationship between the two remains unclear. One 
possibility is that aging results in changes in tissue 
microenvironment, e.g. due to senescent cell 
accumulation, that create more permissive conditions for 
cancer growth [64]. Aging-related tumors can occur even 
in the absence of transforming mutation, as in benign 
prostatic hyperplasia (BPH). We postulate that C. elegans 
uterine tumors, like BPH, exemplify the non-mutational-
ly driven component of aging-associated cancer.  
 
The regulatory network within which mdl-1 might 
function 
 
In mammals, Mad TFs act antagonistically to Myc TFs, 
which promote the cell cycle, growth and apoptosis, and 
reduce H ferritin expression [11, 15]. Consistent with 
this, MDL-1 inhibits germline growth and apoptosis 
(this study), and activates ftn-1 expression [14]. 
Moreover, in mammals over-expression of Myc can 
induce endomitosis and cause increased ploidy [65], 
often seen in tumors, and also in senescent cells [66, 
67], while MDL-1 antagonizes growth of uterine tumors 
formed from endomitotic oocytes (this study). Thus, 
MDL-1 in C. elegans behaves as one would expect of 
an antagonist of Myc – which is perhaps surprising 
given that C. elegans does not possess Myc. Indeed, 
Myc appears to be absent from the entire Nematode 
phylum (this study) [51].  
 
In mammals, the Tor pathway and Myc TFs work in 
concert to control protein synthesis. Myc TFs activate 
expression of translational machinery genes, including 
eIF4E, eIF4A and eIF4G, which are components of the 
eIF4F complex that promotes translational initiation [48]. 
C. elegans lacks many genes that are present in other 
animal phyla [68], which can limit its usefulness as a 
model organism. Besides Myc, this also affects the worm 
Tor pathway, which lacks several key proteins, notably 
Tsc1/Tsc2 and 4E-BP. Thus, C. elegans possesses what 
appears to be a different version of the IIS/Tor/Mad 
network of higher animals. To fully understand the worm 
network requires understanding these differences. 
 
Several interpretations have been made of the absence 
of Myc in C. elegans. First, that it reflects the relatively 
restricted C. elegans cell proliferation program [10]. 
Second, that in C. elegans the Myc role is played by a 
different bHLH TF, for example MML-1 (Myc and 
Mondo-like 1) [16]. However, arguing against this 
interpretation, MML-1 resembles Mondo rather than 
Myc, it dimerizes with MXL-2 while MDL-1 dimerizes 
with MXL-1, and deletion of mxl-2 has only minor 
phenotypic effects (abnormal migration of ray 1 
precursor cells in the male tail), and does not affect e.g. 
growth or lifespan [16]. 
 
Another possibility is that the Myc-less Mad-Max circuit 
ensures rapid growth, i.e. the nematode machinery for 
protein translation is, in the absence of DAF-16 and 
MDL-1, constitutively active. Consistent with this, 
Tsc1/Tsc2 and 4E-BP, which both antagonize growth, are 
absent from C. elegans, and most other nematodes 
(Figure 7B). Notably, in Drosophila, inhibition of growth 
resulting from reduced Tor kinase activity (e.g. by over-
expression of Tsc1 and Tsc2) can be rescued by 
overexpression of dMyc [69]. An intriguing detail is the 
presence of Tsc1/Tsc2 in several spirurid nematodes 
(Figure 7B, Table S4); notably this group includes the 
longest lived nematode species known, e.g. the maximum 
lifespan of adult Loa loa is at least 20 years [70]. Another 
possibility is that the growth inhibitory functions of 
Tsc1/Tsc2 and 4E-BP have been taken over by DAF-
16/FoxO, which is a major regulator of protein synthesis 
in C. elegans [41, 42, 45]. Thus, perhaps DAF-16 
suppresses growth in soma and germline, while MDL-1 
suppresses growth in the germline alone. 
 
Conclusions 
 
These results confirm that the Mad TF MDL-1 
contributes to the daf-2 longevity phenotype, and reveal a 
major role in inhibition of germline growth and reduction 
of uterine tumor development. They also suggest a role 
for intestinal MDL-1 in longevity assurance. The action 
of mdl-1 as a DAF-16 activated gene that inhibits growth 
is broadly consistent with the possibility that the effects 
of insulin/IGF-1 signaling and DAF-16 on aging are a 
function of their effects on growth. 
 
EXPERIMENTAL PROCEDURES 
 
C. elegans culture and strains. Worms were cultured as 
previously described [71], at 20˚C unless otherwise 
stated. Nematode strains used include N2 (wild type), 
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DR1567 daf-2(m577)III, SS104 glp-4(bn2)I, GA1200 
mdl-1(tm311)X (6X out-crossed),  GA91 daf-
16(mgDf50)I; daf-2(m577), GA1204 daf-2(m577); mdl-
1(tm311), GA1208 daf-16(mgDf50); daf-2(m577); mdl-
1(tm311), GA1226 daf-16(mgDf50); mdl-1(tm311), 
GA1230 glp-4(bn2); mdl-1(tm311), GA1604 mdl-
1(tm311); wuEx267[mdl-1 + rol-6(su1006)], GA1605 
mdl-1(tm311); wuEx268[pges-1::mdl-1 + rol-
6(su1006)]. Primers to identify mdl-1(tm311) were 
atggaacagcaactcaaccttgg and ttaaacttggaggttgattggcaag, 
and heterozygotes aatgatgtgatctcgggctcg. Primers to 
genotype daf-16(mgDf50) were as described [72]. 
 
Strain construction. Multiple mutant strains were 
generated using standard genetic and molecular 
methodologies. Strains carrying mutations on the X 
chromosome (e.g. mdl-1(tm311)) were crossed with N2 
males to generate hemizygous mutant males which were 
mated with L4 hermaphrodites of the strain carrying the 
second mutation of interest. F1 offspring were picked, 
and allowed to self-fertilise and 80 F2 were picked, 
allowed to lay eggs overnight, lysed and stored at -
20˚C. Genomic deletions were identified using PCR. In 
the presence of the temperature sensitive daf-2(m577) 
allele, F1 animals were shifted to 25˚C to select for 
dauer formation in the F2, dauers were picked and left 
to recover at 15˚C to lay eggs, the F2 were lysed and 
tested for deletions. The daf-16(mgDf50); daf-2(m577); 
mdl-1(tm311) triple mutant was constructed by mating 
daf-16; daf-2 males with daf-2; mdl-1 hermaphrodites. 
The F2 generation was cloned, lysed and offspring 
raised at 25˚C. daf-16(mgDf50) homozygotes in the F3 
were initially identified as non-dauer formers, and mdl-
1(tm311) homozygotes identified by PCR. 
 
mdl-1 transgenic lines were created by microinjection 
using PCR products and PCR fusion [73]. Primers used 
to make GA1604 were aaattgcacatgcagagacg and 
gaaagatacggaaggtgtgc. Primers used to make GA1605 
were ttgtctattggtatggctgc; ggttgagttgctgttccattacaaggaa 
tatccgcatctg; gcgctaccaataaggctaag; aatggaacagcaactc 
aacc; gaaagatacggaaggtgtgc; and tttacaacacgatccacacg. 
 
Staining protocols. To quantify germ cell number, 
nuclei were stained using DNA-binding dye 4',6-
diamidino-2-phenylindole (DAPI). Animals were fixed 
in methanol, washed with M9 buffer and incubated in 
the dark in a 500ng/ȝl DAPI solution for 30 min. 
Thereafter they were washed again in M9 buffer. To 
quantify the number of apoptotic cells in living animals, 
nematodes were stained with SYTO 12 Green 
Fluorescent Nucleic Acid Stain (Molecular Probes). The 
animals were incubated in the dark in a 33ȝM SYTO 12 
solution for 4 hr, and then placed on an OP50 lawn for 1 
hr.  
Quantitative RT-PCR and chromatin immuno-
precipitation PCR (ChIP-PCR). RT-PCR and ChIP-PCR 
were performed largely as previously described [9, 74]. 
Primers for RT-PCR amplification from mdl-1 mRNA 
were cccgtttgcgtgtcattgt and atggattgtgagagtgttgagaat. 
Primers for ChIP-PCR of an mdl-1 promoter region 
(Figure 1A) were ccccctcgttttctccatgt and 
gccgctcgctccaatg. 
 
Microscopy. Freshly prepared agar pads were created 
by dropping 35µl of 2% agarose onto a glass slide. 
Worms were anaesthesised using 5µl 0.2% levamisole. 
Nomarski microscopy was performed on a Zeiss 
Axioskop2 plus microscope with a Hamamatsu ORCA-
ER digital camera C4742-95. Images were acquired 
using Volocity 5.5 software, with 10x eyepieces and a 
40x objective lens. For body size measurements, worms 
were synchronized and hatched overnight in M9 buffer. 
The next day, ~30 worms per strain were imaged, and 
the remainder cultured on OP50 and thereafter imaged 
consecutively for 6 days. Volocity 5.5 was used to 
quantify the length of the worm from head to tail and 
the width across the pharyngeal-intestinal valve region. 
 
Uterine tumor scoring system. Uterine status was scored 
from 1 to 5, where scores of 3-5 indicates the presence 
of a tumor. Class 1 denotes a normal, youthful uterus 
containing fertilized eggs and/or unfertilized oocytes of 
normal appearance. Class 2 denotes a uterus whose 
contents appear somewhat abnormal, but without a clear 
increase in size. Class 3 denotes a uterus containing a 
small tumor. Class 4 denotes a uterus containing a 
medium sized tumor, that does not fill the body cavity 
in the mid-body region.  Class 5 denotes a uterus where 
the tumor is large, and fill the entire body cavity in the 
mid-body region, and even causes distension of the 
body wall. For the scoring, the tumor images was 
randomised, and the scoring was performed blinded by 
3 different scorers. The non-parametric Wilcoxon test 
was used to compare tumor classes between worm 
strains and within the same strain on day 1 and day 4. 
The analysis was performed using the statistical 
programme JMP 9 (SAS Institute Inc.)  
 
Fertility measurements. Brood sizes were assayed as 
previously described [22]. Briefly, 10-12 L4 
hermaphrodites, raised at 20˚C were cloned on 
individual plates, shifted to 25˚C and transferred daily 
for 7 days. Plates were incubated at 20˚C for 24 hr to 
allow offspring to hatch and then larvae, unfertilized 
oocytes and dead eggs were scored.  
 
Yolk level measurements. For each test sample, 50 
hermaphrodites at day 1 and 4 of adulthood were 
transferred into an Eppendorf tube filled with 1 ml M9 
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buffer. Worms were spun at 800 rpm for 2 min and 
supernatant removed, leaving 25 µl. Then 25 µl of 2x 
Laemmli buffer (Sigma) was added, and samples 
incubated at 70˚C for 15 min, vortexed every other 
minute and then shifted to 95˚C for 5 min. Lysates were 
centrifuged at 13,000 rpm at 4˚C for 15 min. 20 µl of 
each sample was loaded onto a Criterion XT Tris-
Acetate gel. The gel was run at 200V in SDS-PAGE 
chamber with 1x 3-(N-morpholino) propanesulfonic 
acid (MOPS) buffer for 45 min. The gel was fixed in 
methanol, acetic acid and ultrapure water in ratio of 
50:10:40 for 30 min. The fixing solution was then 
discarded and replaced with Coomassie fixation 
solution (50:3:40:10 methanol: Coomassie stock 
solution: ultrapure water: acetic acid). 12.0 g of Brilliant 
Blue R-250, 300 ml methanol and 60ml acetic acid were 
used to prepare Coomassie stock solution. The gel was 
incubated overnight in destaining solution (45:10:45 
methanol: acetic acid: ultrapure water). Protein bands 
on the gel were visualised by a Image Quant GE 
Healthcare scanner system connected to a computer, 
and analysed by ImageQuant software with which 
densitometry was performed. Each experiment was 
done in triplicate. 
 
Lifespan measurements. These were conducted as 
previously described [22]. Briefly, 5 plates per 
condition were seeded with OP50 2 days before the start 
of the experiment. 10 ȝM FUdR was topically applied 
before beginning the trial. Animals were raised at 20˚C, 
or for assays including glp-4(bn2) mutants, animals 
were raised at 15˚C and switched to 25˚C at L4 stage. 
All animals were transferred to fresh plates on day 5 
and 10. Deaths were scored and losses due to causes 
other than death were censored. Lifespan data were 
deposited in SurvCurv [75] <IDs filled in proof>. 
 
Dauer formation measurement.  Dauer formation was 
assessed at 22.9˚C as previously described [22]. Briefly, 
12 L4s were picked and raised to adulthood at 20˚C for 
2 days. These gravid adults were then placed on 35mm 
plates to lay eggs for 6 hrs at the test temperature, after 
which the adults were removed and the larvae were 
allowed to develop at the test temperature. Dauers and 
normal larvae were scored 72 hr after the midpoint of 
the egg lay and the percentage dauer formation was 
calculated by dividing the number of dauer larvae by 
the total number of offspring. 
 
Oxidative stress resistance. 1 day old adults were tested 
for resistance to 7.5 mM tert-butylhydroperoxide (t-
BOOH) as previously described [33]. Briefly, L4 
animals were picked from mixed stage plates raised at 
20˚C, then shifted to 25˚C overnight. NGM agar was 
supplemented with 7.5 mM t-BOOH and the plates 
were left to dry overnight. The next day, each plate was 
supplemented with a blob of densely grown OP50, and 
15 young adults were added per plate. The trial was 
conducted at 25˚C and animals were scored every 2 to 3 
hr until the last animal had perished. 
 
Bioinformatics. Myc, Tsc1, Tsc2 and 4E-BP orthologs 
were sought by local alignment searches of the 4 
protein sequences to the gene models in Mus musculus 
using BLASTP searches. Since not all genomes were 
available in WormBase, orthologs for the parasitic 
helminths (B. xylophilus, E. granulosus, E. 
multilocularis, T. solium, H. microstoma, S. mansoni 
and S. japonicum) were derived from GeneDB. 
Orthologs for G. pallida, H. contortus, O. volvulus, S. 
ratti and T. muris were sought using the data available 
on the Sanger Institute Resources. Orthologs to T. 
muris were sought by local alignment searches of the 4 
genes to contigs, using a “protein versus translated 
DNA” a TBLASTN search. Finally, orthologs of P. 
pacificus were sought among the gene predictions 
available from www.pristionchus.org. Multiple 
sequence alignments of the Tsc1/2 protein sequences 
were done using MUSCLE [76]. All trees were 
constructed and visualised as previously described 
[74].  
 
Statistical analysis. Lifespans were analysed using the 
Cox Proportional Hazard method with the Efron 
approximation for ties of the survival package in R. The 
logistic mortality models were fitted to the lifespan data 
and parameter difference tested using the Survomatic R 
package. The body sizes were analysed using a linear 
regression model taking into account the trial as random 
factor in R. The Wilcoxon Mann test was used for 
tumors and the brood sizes were compared using a 
standard Student’s t Test. 
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The nematode Caenorhabditis elegans is an excellent modelorganism for investigating the biology of ageing. Althoughmuch progress has been made in terms of identifying genes
and pathways that affect lifespan1,2, the underlying mechanisms
of ageing remain poorly defined. One obstacle has been the
difficulty of relating gene function to lifespan, given that the
latter is a numeric, demographic parameter that contains little
information about biological processes or structures to which
gene function can readily be related. A complimentary
approach is to study age-related pathologies and functional
decline in relation to lifespan. As in humans, various senescent
pathologies develop in ageing C. elegans, including deterioration
of the pharynx, intestine, gonad and neurons3–6. While some
pathologies do not appear to contribute to mortality7, others may
be life limiting. Identification of lethal senescent pathologies may
provide us with the missing link between the biochemical
function of gene products and their effects on lifespan.
In this study, we use necropsy analysis to investigate the causes
of death in C. elegans and reveal two distinct modes of death, one
that largely occurs earlier in life than the other. Thus
interventions that alter lifespan in C. elegans reflect effects on
timing and/or frequency of one or both types of death. We show
how such differential effects can be resolved by mortality
deconvolution, involving combined analysis of mortality and
necropsy data.
Results
Necropsy analysis reveals two modes of death. What do ageing
C. elegans die of? To identify possible causes of death, we tracked
pathologies in individual wild-type adult hermaphrodites as they
aged (Supplementary Fig. 1; Supplementary Table 1) and tested
for correlation between pathology severity and age at death.
This revealed significant correlations between age at death and
several pathologies, including pharyngeal deterioration (Fig. 1a;
Supplementary Table 1). This, together with the previous obser-
vation that pharyngeal pumping span (that is, the length of time
that the pharynx is active) correlates with lifespan8, suggests that
pharyngeal pathology could be life limiting.
Next, necropsy analysis was performed, for which corpses of
nematodes that had expired from old age were collected daily and
examined. This revealed two distinct types of corpse with respect
to pharyngeal pathology (Supplementary Fig. 2). The first showed
severe swelling of the posterior pharyngeal bulb, with a 20–120%
increase in cross-sectional area (Fig. 1b). The second showed
marked atrophy of the posterior bulb, with up to a 70% decrease
in cross-sectional area (Fig. 1b). For convenience, we designated
these corpse types ‘P’ (‘big P’) and ‘p’ (‘small p’), respectively.
Notably, P deaths mainly occurred earlier than p deaths
(Fig. 1c), with a median age of death (lifespan) of 12 and 22 days,
respectively (Fig. 1d). The distinct timing contributes to the high
variance in age at death seen in C. elegans populations despite
their isogenicity9,10, where 450% of the total variance can be
explained by the existence of two types of death (Supplementary
Table 2). In P deaths, pharyngeal swelling appeared only in the
last few days prior to death (Fig. 1e). Swelling was preceded by a
major reduction in pharyngeal pumping rate (Fig. 1f), likely
contributing to the correlation between pharyngeal pumping span
and age of death8.
As in many animal species (and humans), C. elegans mortality
rate increases with age. However, there is a hitherto unexplained
deceleration of the age increase in mortality rate around
day 10–12 (refs 11–13), postulated to reflect population
heterogeneity in frailty14. The occurrence of this deceleration,
which reflects a mid-life surge in death rate, was confirmed in the
wild-type populations subjected to necropsy analysis in this study,
in which a slope change can be detected, with the most significant
change on day 11 of adulthood (Fig. 1g; Supplementary Fig. 3a,b).
The surge in mortality in mid-life was also seen in our archive
mortality data collected at two locations (Supplementary
Fig. 3c,d). In contrast, p mortality showed an exponential
increase in mid-to-late life that, combined with the peak of P
mortality in mid adulthood, leads to an apparent slowing of the
mortality rate acceleration (Fig. 1h).
Pharyngeal swelling is caused by bacterial infection. Next, we
explored the possible causes of P deaths, first asking: what is the
immediate cause of pharyngeal swelling? The pharynx of
immunocompromised C. elegans is susceptible to bacterial
infection15 and proliferation of the Escherichia coli food source
limits worm lifespan4,16. Comparison of E. coli content in
surgically excised pharynxes from live, aged worms found a
42-fold greater number of colony-forming units in swollen
pharynxes compared to unswollen ones (Supplementary Fig. 4a),
suggesting that the swelling is due to increased bacterial content.
To visualize localization of bacteria within pharyngeal tissue, we
fed worms with E. coli expressing red fluorescent protein (RFP).
Red fluorescence was seen throughout the pharyngeal tissue in
worms that undergo P death (Fig. 2a), whereas p corpses typically
contained no fluorescence or only small fluorescent inclusions in
the posterior bulb, perhaps reflecting contained invasions
(Fig. 2b; Supplementary Fig. 4b). Live worms in the early stages
of bacterial invasion revealed RFP co-localized with green
fluorescent protein (GFP) markers of several different
pharyngeal cell types but most often with pharyngeal muscle
near the grinder (Fig. 2d; Supplementary Fig. 4c,d). Moreover,
examination of swollen pharynxes using transmission electron
microscopy (TEM) showed them to be filled with bacteria
(Fig. 2c), while unswollen pharynxes contained either no invading
E. coli or small, membrane-bound bacterial inclusions usually
near the grinder cuticle (Supplementary Fig. 5). These results
suggest a route for initial bacterial invasion through the
pharyngeal cuticle in the grinder region.
To test whether pharyngeal swelling is caused by bacterial
proliferation, E. coli were treated with an antibiotic (carbenicillin)
or ultraviolet irradiation. In each case, P death was eliminated
(Fig. 2e), and lifespan extended (Supplementary Fig. 6a,b;
Supplementary Table 3) as observed previously4,16. As expected,
blocking bacterial proliferation also removed the mortality rate
deceleration seen around day 11 (Fig. 2f); this is also consistent
with the absence of mid-life mortality deceleration in populations
maintained in the recently described automated systems,
including worm corrals17 and lifespan machines18, as P death is
either eliminated or significantly reduced in both cases
(Supplementary Fig. 7). However, elimination of P death did
not completely abrogate the correlation between pharyngeal
pumping span and lifespan (Supplementary Fig. 6c,d), which
could imply that pharyngeal pathology contributes to mortality in
additional ways.
High pharyngeal pumping rate promotes P death. Thus P death
is associated with pharyngeal invasion and proliferation of
bacteria, but why do these deaths occur relatively early, with the
majority occurring before day 15? Shifting worms raised on non-
proliferating bacteria to proliferating bacteria at time points after
day 4 progressively reduced the frequency of P death and
reduced early mortality (Fig. 3a,b; Supplementary Fig. 8a–d;
Supplementary Table 4), suggesting that a narrow time window
exists in early adulthood where worms are susceptible to phar-
yngeal infection. This, together with initial occurrence of invasion
near the grinder, could imply that the high rate of pumping in
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young adults8 injures the pharyngeal cuticle, perhaps due to
mechanical stress, causing cuticular perforations and vulnerability
to invasion. If this is correct, then reducing pharyngeal pumping
rate should suppress P deaths. We therefore examined a range of
pumping defective mutants, including eat-2(ad1116) mutants,
which have a reduced pumping rate19. In most cases, P deaths
were reduced or eliminated (Fig. 3c). This suggests that a wild-
type, high rate of pharyngeal pumping leads to bacterial invasion
of pharyngeal tissue.
The longevity of eat-2 mutants has previously been attributed
to dietary restriction20. However, results of mortality and
necropsy analysis indicated that the eat-2 lifespan extension
observed was largely attributable to reduction in the frequency of
P death, since the lifespans of P and p subpopulations did not
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significantly differ between N2 and eat-2 (Fig. 3d; Supplementary
Table 5). This suggests, against expectation, that the longevity of
eat-2 mutants is attributable, at least in part, to suppression of P
death rather than to dietary restriction.
Wound healing may protect against bacterial infection. Why
do only a proportion of worms undergo P death? One possibility
is that some worms have a higher pharyngeal pumping rate
during early adulthood, resulting in sufficient damage to the
cuticle to allow bacterial invasion to occur. However, in early
adulthood there was no difference in pumping rate between
worms that subsequently underwent P versus p death
(Supplementary Fig. 8e). This argues against predisposition due
to intrinsic differences in pumping rate. Another possibility
suggested by the early adult time window for predisposition to
P death is that early mechanical injury to the pharyngeal cuticle
subsequently heals, preventing further infection in the majority of
worms; the C. elegans external cuticle has an efficient wound
healing capacity21. TEM of the grinder region in older worms
revealed major cuticular scars (Supplementary Fig. 9), similar in
appearance to cuticular scars described previously21, consistent
with injury and subsequent healing. Together these results suggest
that rapid pumping in early adulthood leads to mechanical
damage to the pharyngeal cuticle, allowing initial invasion of
E. coli. In some worms, subsequent proliferation of invading
E. coli leads to pharyngeal infection and P death, while in others
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invasion remains contained after cuticular healing (Supplemen-
tary Fig. 10). The reason behind such heterogeneity remains to be
discovered but could reflect differences in burden of initial
invasion or in the ability to heal or to fight invasion.
Differential effects on P and p in long-lived mutants. In this
study, we have shown how combined pathology and mortality
analysis allows deconvolution of C. elegans mortality profiles,
providing a means to understand how interventions alter lifespan
in terms of effects on pathology. Examples modelling the effects
on mortality and survival due to theoretical alterations in fre-
quency or timing of P and/or p deaths are shown in Fig. 4, many
of which resemble real lifespan data observed here and in pre-
vious studies (Supplementary Fig. 11). For example, lack of a
germline in glp-1(e2141) delays p deaths by 410 days but has
little effect on either the timing or frequency of P death (Fig. 3e,f;
g h
ba
fe
0
0
50
100
P deaths
p deaths
All deaths
Egg shift
P deaths
p deaths
all deaths
L4 shift
Age (days)
Pe
rc
en
t s
ur
vi
va
l
Pe
rc
en
t s
ur
vi
va
l
0
0
50
100 Control
Carbenicillin
Day 1 shift
Day 6 shift
Day 15 shift
Age (days)
Age (days)
Pe
rc
en
t s
ur
vi
va
l
0
50
100 N2
ced-1
N2 P death
N2 p death
ced-1 P death
ced-1 p death
0
50
100
Pe
rc
en
ta
ge
 d
ea
th
w
ith
 p
ha
ry
nx
 in
fe
ct
io
n
NS
0
50
100
Pe
rc
en
ta
ge
 d
ea
th
w
ith
 p
ha
ry
nx
 in
fe
ct
io
n **
dc
0
50
100
Pe
rc
en
ta
ge
 d
ea
th
w
ith
 p
ha
ry
nx
 in
fe
ct
io
n
0
50
100
Pe
rc
en
ta
ge
 d
ea
th
w
ith
 p
ha
ry
nx
 in
fe
ct
io
n
0
0
50
100
Age (days)
Pe
rc
en
t s
ur
vi
va
l N2 P death
N2 p death
eat-2 P death
eat-2 p death
N2
eat-2
10 20 30 40 50
Co
ntr
ol
Da
y 1
 sh
ift
Da
y 2
 sh
ift
Da
y 4
 sh
ift
Da
y 6
 sh
ift
Da
y 1
1 s
hif
t
Da
y 1
5 s
hif
t
Ca
rbe
nic
illin
N2
un
c-
10
ea
t-1
8
ea
t-7
ea
t-1
0
ea
t-5
ea
t-2
un
c-
36
ea
t-1
3
ph
m-
2
ph
m-
3 10 20 30 40
glp-1 (e2141)
glp-1 (e2141)
10 20 30 40
0 10 20 30 40
50
L4
 sh
ift
Eg
g s
hif
t
N2
ce
d-1
Figure 3 | High pharyngeal pumping rate promotes P death. (a) Effect of maintenance on non-proliferating E. coli (carbenicillin) during early life on
frequency of P deaths. Exposure to proliferating bacteria in early-mid adulthood is required for P death to occur. (Trials: 2, for sample size, see
Supplementary Table 4). (b) Maintenance on non-proliferating E. coli (carbenicillin) during early life reduces early mortality (data as in a). (c) Effect of
pumping-defective mutants on the frequency of P. (Trials: 1–2). (d) Effect of eat-2(ad1116) on lifespan. Whole population (black) or P and p deaths resolved
(red and blue, respectively). Log-rank test between N2 and eat-2 whole populations P¼0.0007, P death subpopulations P¼0.1996, p death
subpopulations P¼0.0815. (Trials: 2, for sample sizes, see Supplementary Table 5). (e) Germline defective mutant glp-1(e2141ts) increases lifespan without
affecting P death frequency when shifted to 25 !C as eggs. (Trials: 2, for sample sizes see Supplementary Table 6). (f) Effect of glp-1 on lifespan, when
shifted to 25 !C at either egg (dotted) or L4 larval stage (solid). Median lifespan: L4 shift P deaths 9 days, p deaths 17 days; egg shift P deaths 9 days,
p deaths 27 days (data as in e). (g) ced-1(e1735) mutant increases the frequency of P deaths. (Trials: 2, for sample sizes, see Supplementary Table 7).
(h) Effect of ced-1 (dotted) on lifespan compared to wild-type (solid). Median lifespan: ced-1 P deaths 13 days, p deaths 20 days; wild-type P deaths 13 days,
p deaths 23 days (data as in g).
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Supplementary Table 6), which explains the atypical neck-and-
shoulder shape of its survival curve22. Another example is the
short-lived ced-1(e1735) mutant, which is hyper-susceptible to
pharyngeal invasion by pathogenic bacteria15. Its short lifespan
on E. coli is due to increased frequency (without changes in
timing) of P death, as well as faster die-off of p worms (Fig. 3g,h;
Supplementary Table 7). In contrast, eat-2 provides an example of
how increased lifespan can result from reduced P death frequency
(Fig. 3d). Thus different lifespan-altering interventions can act by
differentially affecting different pathologies.
Discussion
As a model organism, C. elegans has generated numerous insights
and discoveries in the ageing field that have proven to be
applicable in higher organisms. However, a long-standing
obstacle is that it is difficult to follow the causal chain connecting
genes and proteins to demographic parameters, such as lifespan
and mortality rate. We argue that to better understand ageing in
C. elegans requires knowledge not just of genes that influence
lifespan but also of the pathologies of ageing and how these cause
death. This study describes a novel approach to understanding
demographic data in C. elegans based on the combined analysis of
pathology and mortality (and conceptually similar approaches
have been used in human clinical studies, c.f. the competing risks
model23). This provides a route to discover the biological
mechanisms of ageing underlying survival curves and mortality
profiles in this powerful model organism.
But is P death attributable to ageing, or is it merely the result of
bacterial infection? In order to maximize the contribution of
intrinsic determinants of senescence, would it not be better
simply to exclude P death, for example, by using antibiotics?
Certainly, excluding P death can facilitate analysis of intrinsic
determinants of senescence. However, our results suggest that the
P subpopulation is itself a useful model for studying the biology
of ageing. For example, they suggest that damage incurred early
(mechanical damage to the pharyngeal cuticle and contained
infections within pharyngeal tissue) lie latent during early–mid
adulthood but then recrudesce in later life, potentially due to
action of intrinsic determinants of senescence (Supplementary
Fig. 8e). Thus the P subpopulation may be used to investigate
how early damage can interact with later intrinsic causes of
ageing to determine senescent pathology and mortality.
Methods
Culture methods and strains. Standard C. elegans maintenance was performed
using standard protocol24. Strains were grown at 20 !C on nematode growth media
(NGM) plates seeded with E. coli OP50 to provide a food source. C. elegans strains:
An N2 hermaphrodite stock recently obtained from the Caenorhabditis Genetics
Center was used as wild type (N2 CGCH)25. For necropsy analysis: CB3203 ced-
1(e1735) I, CB4037 glp-1(e2141) III, DA597 phm-2(ad597) I, DA1116 eat-2(ad1116) II,
DA493 phm-3(ad493) III, DA522 eat-13(ad522) X, DA698 unc-36(ad698) III,
DA521 egl-4(ad450) IV, DA606 eat-10(ad606) IV, DA464 eat-5(ad464) I, DA591
unc-10(ad591) X, DA1110 eat-18(ad1110) I. For confocal microscopy: BC12677
dpy-5(e907) I; sIs11111 [rCesC32F10.8::GFPþ pCeh361] (GFP in muscle cells),
BC12754 dpy-5(e907) I; sIs12567[rCesC07H6.3::GFPþ pCeh361] (GFP in marginal
cells), BC16329 dpy-5(e907) I; IsEx16329[rCesF20B10.1::GFPþ pCeh361] (GFP in
g1 pharyngeal gland cells).
E. coli OP50 expressing red fluorescent protein (OP50-RFP) was generated by
transforming OP50 with plasmid pRZT3 (kindly provided by J.F. Rawls, Duke
University, originally from W. Bitter, Vrije University)26. pRZT3 contains genes for
tetracycline resistance and RFP (DsRed), under the control of a constitutive lac
promoter. OP50-RFP was grown on lysogeny broth (LB) plates and in LB broth in
the presence of 25 mgml" 1 tetracycline. However, before NGM plates were seeded,
OP50-RFP was resuspended in LB broth without tetracycline. This was to avoid
effects of tetracycline on bacterial pathogenicity that might occur even in the
presence of the tetracycline-resistance plasmid. Worms were then raised from
hatching on OP50-RFP.
To examine the role of proliferating bacteria on pharyngeal swelling, bacterial
growth was prevented in two ways. Carbenicillin was added topically onto a 2-day-
old bacterial lawn to a final concentration of 4mM. Unless otherwise specified,
worms were transferred from untreated OP50 at L4 stage. For ultraviolet killing,
80 ml of OP50 was added to each NGM plate and left overnight at 20 !C. Plates
were then exposed to ultraviolet light for 30min. Worms were raised on ultraviolet-
killed bacteria from aseptic eggs.
Lifespan and Ziehm tables. Lifespan measurements were performed as follows.
Trials were conducted at 20 !C unless otherwise specified and without 5-fluoro-20-
deoxyuridine (FUDR). Worms were transferred daily during the reproductive
period. Mortality was scored daily to ensure that corpses were fresh and not
decomposed, to aid necropsy analysis. Worms that were scored as dead were
collected for microscopy. Lifespan measurements were repeated at least twice
unless otherwise stated, and survival plots were generated using the combined
lifespan data.
In addition to standard presentations of survival data in the form of survival
curves and tables of analysed statistics (for example, mean lifespan, comparison
statistics), we have also included tables of raw mortality data. The purpose of the
latter is to enable future investigators to reanalyse the data, for example, in data
mining approaches or for the purpose of resolving discrepancies between different
published reports. To this end, we employ a mortality data reporting format
developed by M. Ziehm, which applies minimal reporting standards to ensure
0
50
100
P deaths reduced by 90%
P deaths delayed by 10 days
P deaths increased by 90%
p deaths delayed by 10 days
Wild-type
Changed
Age (days)
Pe
rc
en
t s
ur
vi
va
l
0
0
50
100
0
50
100
0
50
100
Pe
rc
en
t s
ur
vi
va
l
0
–8
–4
0
All deaths
P deaths
p deaths
Wild type
B
C
D
E
Age (days)
Lo
g 
m
or
ta
lity
 ra
te
10 20 30 40
20 40
Age (days)
0 20 40
Age (days)
0 20 40
Age (days)
0 20 40
a
b c
d e
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P death is 40% of the population and p death is 60%. The resulting survival
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Supplementary Fig. 11.
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inclusion of all essential information about experimental conditions. Data include
specification of causes of data censoring, as follows: bag¼ bag of worms
(death from internal hatching of eggs); cont¼ contaminated (bacterial or fungal
infection); dis¼ disappeared (investigator failed to locate worm); kil¼ killed
(worm accidentally killed during handling); cen¼ censored (censored without a
recorded reason); otw¼ on the wall (worms climbed wall of Petri dish and died
from desiccation); and rup¼ rupture (internal organs extensively extruded through
vulva). We include, for other investigators who choose to take this approach, an
unpopulated Ziehm table (Supplementary Data 1).
Survival and mortality analysis. For survival analysis of P or p deaths only
(Fig. 1d), all observations from worms with pharynx pathology of the other type
were excluded. For mortality analysis (Fig. 1h), log mortality rate of the P and
p cohorts were calculated with the other type censored, which allows presentation
of the risks in relation to the whole population. Survival and mortality plots were
generated using GraphPad Prism with no smoothing.
For the archive data collected at University of Missouri-Columbia (1994–1996)
and UCL (1998–2000), mortality plots were generated using SurvCurv27 using a
sliding window smoothing of ±2. Analysis of mortality data revealed that for
unknown reasons N2 worms lived 3 days longer at UCL than at UMC. Therefore,
we adjusted for this 3-day difference when combining and plotting the
mortality data.
Microscopy. Live worms or corpses were mounted onto 2% agar pads. Live worms
were anaesthetized by placing them in a drop of 0.2% levamisole. Nomarski images
of worms were collected using a Zeiss Axioskop 2 plus microscope with a
Hamamatsu ORCA-ER digital camera C4742-95 and Volocity 6.3 software
(Macintosh version) for image acquisition. The presence of E. coli OP50-RFP in the
pharynx was assayed using a rhodamine filter cube (excitation: 540–552 nm;
emission: 4590 nm).
Before confocal or electron microscopy, aged worms were separated into three
groups based on the pattern of red fluorescence from E. coli OP50-RFP in their
pharynxes: a pharynx full of RFP was taken to be fully infected; a pharynx with
medium-sized RFP inclusions was taken to be at an early stage of infection; and a
pharynx with no RFP was taken to have no infection. Confocal images were
acquired using Zen2009 software driving a LSM-710 confocal station with an
inverted Zeiss Axio Observer microscope.
For electron microscopy, worms were prepared using a standard protocol
(protocol 8 (ref. 28)). In brief, animals were washed in M9 and then cut in half
using 30G needles. Heads were collected in fixing solution (2.5% glutaraldehyde,
1% paraformaldehyde in 0.1M sucrose, 0.05M cacodylate) on ice, rinsed 3 times in
0.2M cacodylate, fixed in 0.5% OsO4 and 0.5% KFe(CN)6 in 0.1M cacodylate on
ice and sequentially washed in 0.1M cacodylate and 0.1M NaAcetate. Worms were
then stained in 1% UAc in 0.1M NaAcetate (pH 5.2) for 60min, rinsed 3 times in
0.1M NaAcetate and rinsed overnight in distilled water. Samples were then
embedded in 3% seaplaque agarose, dehydrated and infiltrated through ethanol and
propylene-resin series and then cured in 60 !C oven for 3 days. Serial 1 mm sections
were taken for light microscopy and at the region of interest ultra-thin sections
were cut at 70–80 nm using a diamond knife on a Reichert ultramicrotome.
Sections were collected on 300 mesh copper grids and stained with lead citrate
before being viewed in a Joel 1010 transition electron microscope. Images were
recorded using a Gatan Orius camera. Images were obtained using the Gatan
imaging software and then exported into TIFF format.
Measuring E. coli content of the pharynx. Worms on day 10 or 11 of adulthood
(20 !C) were divided into two groups, those with and without pharyngeal swelling.
The posterior bulb of the pharynx was then dissected out using a 31G needle.
These were placed in 120 ml M9 buffer and macerated using the needle. The
resulting lysates were vortexed for 30 s and then centrifuged for 1min at
13,000 r.p.m. Bacterial concentration in supernatants was determined after serial
dilution in M9 solution by plating onto LB plates, followed by counts of colony-
forming units.
Necropsy analysis. A series of microscope images at " 400 or " 630 magnifi-
cation were collected along the length of each corpse using Nomarski optics and
examined for the presence of any unusual pathologies beyond those typically seen
in elderly hermaphrodites4,5,29. The pharynx in particular was examined closely to
determine whether bacteria was visible within the tissue, and then the area of the
posterior bulb was measured using either the Image J or the Volocity 6.3 software.
Measuring pharyngeal pumping rate. Worms were examined in situ on NGM
agar plates using a Nikon SMZ645 microscope for 15 s, and the number of pharynx
pumps was scored manually using a clicker counter. This was repeated three times
for each worm, from which mean pumps per minute was calculated.
Longitudinal pathology analysis on individual worms. Worms were cultured
individually at 20 !C. On days 4,7,11 and 14 of adulthood, each worm was imaged
individually. For imaging, microscope slides were prepared by taping two cover-
slips on the slide, at each edge, leaving an empty space in the middle for the agarose
pad. The worm was then placed on a 2% agarose pad on the slide. Another
coverslip was then placed on top but resting on the two side coverslips to reduce
the pressure exerted on the worm. The slide was then placed on a PE120 Peltier
cooling stage (Linkam Scientific) set to 4 !C. Within a couple of minutes of cooling,
the nematodes ceased to move, and images were taken at " 630 magnification
using a Zeiss Axioskop. After imaging, each worm was carefully recovered by
pipetting 20ml of M9 buffer between the top coverslip and the agar pad. The
coverslip was lifted gently to minimize stress to the worm. The worm was then
returned to an NGM plate. Images of pharynxes, distal gonads and uterine tumours
were scored on an ordinal scale with scores 1–5 (refs 4,7). Score 1 represents a
healthy tissue; score 2 indicates some minor tissue disorder; scores 3/4 are where
minor/major pathology has developed and score 5 is where pathology development
has reached its maximum. Yolk pools and intestinal atrophy were analysed using
semi-quantitative approaches, measuring the area of the yolk pools and intestinal
width relative to body area or width, respectively. Lifespans were recorded
every day.
Statistics. For lifespan assays, survival and mortality graphs were generated using
the Graphpad Prism software, and statistical tests for significant difference between
survival curves were performed using the log-rank test. Log-rank tests of both the
P cohort versus the p cohort and the P cohort versus all deaths showed highly
significant differences (Po10# 15 and Po10# 6, respectively), and the p cohort is
also significantly different (P¼ 10# 3) from the cohort of all deaths. For analysis of
mortality deceleration, the significance of slope change was tested using GraphPad
Prism comparing slopes of linear regression lines30. Correlations from single worm,
longitudinal pathology analysis were analysed using the Spearman Rank test. The
correlation between pumping span and age at death was calculated using a linear
regression model, and the comparison of these slopes between worms either on
proliferative or non-proliferated bacteria were calculated using a linear model in
JMP 11.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request. For the survival assays we
have shown, raw data are available in the form of Ziehm tables provided in
Supplementary Data 1 of this publication.
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